id	sid	tid	token	lemma	pos
bam-8776	1	1	metabolic	metabolic	NOUN
bam-8776	1	2	syndrome	syndrome	NOUN
bam-8776	1	3	and	and	CCONJ
bam-8776	1	4	breast	breast	NOUN
bam-8776	1	5	cancer	cancer	NOUN
bam-8776	1	6	patients	patient	NOUN
bam-8776	1	7	eur	eur	PROPN
bam-8776	1	8	j	j	PROPN
bam-8776	1	9	transl	transl	PROPN
bam-8776	1	10	myol	myol	ADV
bam-8776	1	11	30	30	NUM
bam-8776	1	12	(	(	PUNCT
bam-8776	1	13	3	3	NUM
bam-8776	1	14	):	):	PUNCT
bam-8776	1	15	xx1	xx1	PROPN
bam-8776	1	16	-	-	PUNCT
bam-8776	1	17	xx7	xx7	PROPN
bam-8776	1	18	,	,	PUNCT
bam-8776	1	19	2020	2020	NUM
bam-8776	1	20	1	1	NUM
bam-8776	1	21	investigation	investigation	NOUN
bam-8776	1	22	of	of	ADP
bam-8776	1	23	the	the	DET
bam-8776	1	24	association	association	NOUN
bam-8776	1	25	between	between	ADP
bam-8776	1	26	metabolic	metabolic	NOUN
bam-8776	1	27	syndrome	syndrome	NOUN
bam-8776	1	28	and	and	CCONJ
bam-8776	1	29	breast	breast	NOUN
bam-8776	1	30	cancer	cancer	NOUN
bam-8776	1	31	patients	patient	NOUN
bam-8776	1	32	delaram	delaram	VERB
bam-8776	1	33	eskandari	eskandari	ADJ
bam-8776	1	34	(	(	PUNCT
bam-8776	1	35	1	1	NUM
bam-8776	1	36	)	)	PUNCT
bam-8776	1	37	,	,	PUNCT
bam-8776	1	38	niloofar	niloofar	PROPN
bam-8776	1	39	khodabandehloo	khodabandehloo	PROPN
bam-8776	1	40	(	(	PUNCT
bam-8776	1	41	2	2	NUM
bam-8776	1	42	)	)	PUNCT
bam-8776	1	43	,	,	PUNCT
bam-8776	1	44	abbas	abbas	PROPN
bam-8776	1	45	gholami	gholami	PROPN
bam-8776	1	46	(	(	PUNCT
bam-8776	1	47	3	3	NUM
bam-8776	1	48	)	)	PUNCT
bam-8776	1	49	,	,	PUNCT
bam-8776	1	50	hosein	hosein	PROPN
bam-8776	1	51	samadanifard	samadanifard	PROPN
bam-8776	1	52	(	(	PUNCT
bam-8776	1	53	1	1	NUM
bam-8776	1	54	)	)	PUNCT
bam-8776	1	55	,	,	PUNCT
bam-8776	1	56	alireza	alireza	PROPN
bam-8776	1	57	hejrati	hejrati	NOUN
bam-8776	1	58	(	(	PUNCT
bam-8776	1	59	3	3	NUM
bam-8776	1	60	)	)	PUNCT
bam-8776	1	61	(	(	PUNCT
bam-8776	1	62	1	1	X
bam-8776	1	63	)	)	PUNCT
bam-8776	1	64	department	department	NOUN
bam-8776	1	65	of	of	ADP
bam-8776	1	66	endocrinology	endocrinology	NOUN
bam-8776	1	67	,	,	PUNCT
bam-8776	1	68	school	school	NOUN
bam-8776	1	69	of	of	ADP
bam-8776	1	70	medicine	medicine	NOUN
bam-8776	1	71	,	,	PUNCT
bam-8776	1	72	hazrat	hazrat	NOUN
bam-8776	1	73	-	-	PUNCT
bam-8776	1	74	e	e	NOUN
bam-8776	1	75	rasool	rasool	NOUN
bam-8776	1	76	hospital	hospital	NOUN
bam-8776	1	77	,	,	PUNCT
bam-8776	1	78	iran	iran	PROPN
bam-8776	1	79	university	university	PROPN
bam-8776	1	80	of	of	ADP
bam-8776	1	81	medical	medical	ADJ
bam-8776	1	82	sciences	sciences	PROPN
bam-8776	1	83	.	.	PUNCT
bam-8776	2	1	tehran	tehran	PROPN
bam-8776	2	2	,	,	PUNCT
bam-8776	2	3	iran	iran	PROPN
bam-8776	2	4	;	;	PUNCT
bam-8776	2	5	(	(	PUNCT
bam-8776	2	6	2	2	X
bam-8776	2	7	)	)	PUNCT
bam-8776	2	8	school	school	NOUN
bam-8776	2	9	of	of	ADP
bam-8776	2	10	medicine	medicine	NOUN
bam-8776	2	11	,	,	PUNCT
bam-8776	2	12	hazrat	hazrat	NOUN
bam-8776	2	13	-	-	PUNCT
bam-8776	2	14	e	e	NOUN
bam-8776	2	15	rasool	rasool	NOUN
bam-8776	2	16	hospital	hospital	NOUN
bam-8776	2	17	,	,	PUNCT
bam-8776	2	18	iran	iran	PROPN
bam-8776	2	19	university	university	PROPN
bam-8776	2	20	of	of	ADP
bam-8776	2	21	medical	medical	ADJ
bam-8776	2	22	sciences	sciences	PROPN
bam-8776	2	23	.	.	PUNCT
bam-8776	3	1	tehran	tehran	PROPN
bam-8776	3	2	,	,	PUNCT
bam-8776	3	3	iran	iran	PROPN
bam-8776	3	4	;	;	PUNCT
bam-8776	3	5	(	(	PUNCT
bam-8776	3	6	3	3	X
bam-8776	3	7	)	)	PUNCT
bam-8776	3	8	department	department	NOUN
bam-8776	3	9	of	of	ADP
bam-8776	3	10	internal	internal	ADJ
bam-8776	3	11	medicine	medicine	NOUN
bam-8776	3	12	,	,	PUNCT
bam-8776	3	13	school	school	NOUN
bam-8776	3	14	of	of	ADP
bam-8776	3	15	medicine	medicine	NOUN
bam-8776	3	16	,	,	PUNCT
bam-8776	3	17	hazrat	hazrat	NOUN
bam-8776	3	18	-	-	PUNCT
bam-8776	3	19	e	e	NOUN
bam-8776	3	20	rasool	rasool	NOUN
bam-8776	3	21	hospital	hospital	NOUN
bam-8776	3	22	,	,	PUNCT
bam-8776	3	23	iran	iran	PROPN
bam-8776	3	24	university	university	PROPN
bam-8776	3	25	of	of	ADP
bam-8776	3	26	medical	medical	ADJ
bam-8776	3	27	sciences	sciences	PROPN
bam-8776	3	28	.	.	PUNCT
bam-8776	4	1	tehran	tehran	PROPN
bam-8776	4	2	,	,	PUNCT
bam-8776	4	3	iran	iran	PROPN
bam-8776	4	4	this	this	DET
bam-8776	4	5	article	article	NOUN
bam-8776	4	6	is	be	AUX
bam-8776	4	7	distributed	distribute	VERB
bam-8776	4	8	under	under	ADP
bam-8776	4	9	the	the	DET
bam-8776	4	10	terms	term	NOUN
bam-8776	4	11	of	of	ADP
bam-8776	4	12	the	the	DET
bam-8776	4	13	creative	creative	ADJ
bam-8776	4	14	commons	common	NOUN
bam-8776	4	15	attribution	attribution	NOUN
bam-8776	4	16	noncommercial	noncommercial	ADJ
bam-8776	4	17	license	license	NOUN
bam-8776	4	18	(	(	PUNCT
bam-8776	4	19	cc	cc	NOUN
bam-8776	4	20	by	by	ADP
bam-8776	4	21	-	-	PUNCT
bam-8776	4	22	nc	nc	PROPN
bam-8776	4	23	4.0	4.0	NUM
bam-8776	4	24	)	)	PUNCT
bam-8776	4	25	which	which	PRON
bam-8776	4	26	permits	permit	VERB
bam-8776	4	27	any	any	DET
bam-8776	4	28	noncommercial	noncommercial	ADJ
bam-8776	4	29	use	use	NOUN
bam-8776	4	30	,	,	PUNCT
bam-8776	4	31	distribution	distribution	NOUN
bam-8776	4	32	,	,	PUNCT
bam-8776	4	33	and	and	CCONJ
bam-8776	4	34	reproduction	reproduction	NOUN
bam-8776	4	35	in	in	ADP
bam-8776	4	36	any	any	DET
bam-8776	4	37	medium	medium	NOUN
bam-8776	4	38	,	,	PUNCT
bam-8776	4	39	provided	provide	VERB
bam-8776	4	40	the	the	DET
bam-8776	4	41	original	original	ADJ
bam-8776	4	42	author(s	author(s	NOUN
bam-8776	4	43	)	)	PUNCT
bam-8776	4	44	and	and	CCONJ
bam-8776	4	45	source	source	NOUN
bam-8776	4	46	are	be	AUX
bam-8776	4	47	credited	credit	VERB
bam-8776	4	48	.	.	PUNCT
bam-8776	5	1	abstract	abstract	ADJ
bam-8776	5	2	one	one	NUM
bam-8776	5	3	of	of	ADP
bam-8776	5	4	the	the	DET
bam-8776	5	5	most	most	ADV
bam-8776	5	6	serious	serious	ADJ
bam-8776	5	7	cancers	cancer	NOUN
bam-8776	5	8	among	among	ADP
bam-8776	5	9	women	woman	NOUN
bam-8776	5	10	is	be	AUX
bam-8776	5	11	breast	breast	NOUN
bam-8776	5	12	cancer	cancer	NOUN
bam-8776	5	13	.	.	PUNCT
bam-8776	6	1	this	this	DET
bam-8776	6	2	disease	disease	NOUN
bam-8776	6	3	is	be	AUX
bam-8776	6	4	the	the	DET
bam-8776	6	5	first	first	ADJ
bam-8776	6	6	reason	reason	NOUN
bam-8776	6	7	for	for	ADP
bam-8776	6	8	the	the	DET
bam-8776	6	9	death	death	NOUN
bam-8776	6	10	of	of	ADP
bam-8776	6	11	women	woman	NOUN
bam-8776	6	12	due	due	ADP
bam-8776	6	13	to	to	ADP
bam-8776	6	14	cancer	cancer	NOUN
bam-8776	6	15	.	.	PUNCT
bam-8776	7	1	increasing	increase	VERB
bam-8776	7	2	breast	breast	NOUN
bam-8776	7	3	cancer	cancer	NOUN
bam-8776	7	4	risk	risk	NOUN
bam-8776	7	5	may	may	AUX
bam-8776	7	6	associate	associate	VERB
bam-8776	7	7	with	with	ADP
bam-8776	7	8	many	many	ADJ
bam-8776	7	9	factors	factor	NOUN
bam-8776	7	10	including	include	VERB
bam-8776	7	11	genetic	genetic	ADJ
bam-8776	7	12	,	,	PUNCT
bam-8776	7	13	reproductive	reproductive	ADJ
bam-8776	7	14	factors	factor	NOUN
bam-8776	7	15	,	,	PUNCT
bam-8776	7	16	people	people	NOUN
bam-8776	7	17	's	's	PART
bam-8776	7	18	lifestyle	lifestyle	NOUN
bam-8776	7	19	,	,	PUNCT
bam-8776	7	20	metabolic	metabolic	NOUN
bam-8776	7	21	syndrome	syndrome	NOUN
bam-8776	7	22	(	(	PUNCT
bam-8776	7	23	ms	ms	NOUN
bam-8776	7	24	)	)	PUNCT
bam-8776	7	25	and	and	CCONJ
bam-8776	7	26	hormones	hormone	NOUN
bam-8776	7	27	.	.	PUNCT
bam-8776	8	1	ms	ms	PROPN
bam-8776	8	2	has	have	AUX
bam-8776	8	3	been	be	AUX
bam-8776	8	4	known	know	VERB
bam-8776	8	5	as	as	ADP
bam-8776	8	6	a	a	DET
bam-8776	8	7	risk	risk	NOUN
bam-8776	8	8	factor	factor	NOUN
bam-8776	8	9	for	for	ADP
bam-8776	8	10	prostate	prostate	NOUN
bam-8776	8	11	,	,	PUNCT
bam-8776	8	12	pancreatic	pancreatic	NOUN
bam-8776	8	13	,	,	PUNCT
bam-8776	8	14	breast	breast	NOUN
bam-8776	8	15	and	and	CCONJ
bam-8776	8	16	colorectal	colorectal	ADJ
bam-8776	8	17	cancers	cancer	NOUN
bam-8776	8	18	.	.	PUNCT
bam-8776	9	1	the	the	DET
bam-8776	9	2	purpose	purpose	NOUN
bam-8776	9	3	of	of	ADP
bam-8776	9	4	this	this	DET
bam-8776	9	5	review	review	NOUN
bam-8776	9	6	is	be	AUX
bam-8776	9	7	to	to	PART
bam-8776	9	8	identify	identify	VERB
bam-8776	9	9	the	the	DET
bam-8776	9	10	relationship	relationship	NOUN
bam-8776	9	11	between	between	ADP
bam-8776	9	12	ms	ms	PROPN
bam-8776	9	13	components	component	NOUN
bam-8776	9	14	and	and	CCONJ
bam-8776	9	15	breast	breast	NOUN
bam-8776	9	16	cancer	cancer	NOUN
bam-8776	9	17	individually	individually	ADV
bam-8776	9	18	.	.	PUNCT
bam-8776	10	1	this	this	DET
bam-8776	10	2	study	study	NOUN
bam-8776	10	3	was	be	AUX
bam-8776	10	4	performed	perform	VERB
bam-8776	10	5	by	by	ADP
bam-8776	10	6	researching	research	VERB
bam-8776	10	7	electronic	electronic	ADJ
bam-8776	10	8	database	database	NOUN
bam-8776	10	9	references	reference	NOUN
bam-8776	10	10	including	include	VERB
bam-8776	10	11	pubmed	pubmed	PROPN
bam-8776	10	12	,	,	PUNCT
bam-8776	10	13	google	google	PROPN
bam-8776	10	14	scholar	scholar	NOUN
bam-8776	10	15	,	,	PUNCT
bam-8776	10	16	cinahl	cinahl	PROPN
bam-8776	10	17	proquest	proquest	PROPN
bam-8776	10	18	,	,	PUNCT
bam-8776	10	19	and	and	CCONJ
bam-8776	10	20	web	web	NOUN
bam-8776	10	21	of	of	ADP
bam-8776	10	22	science	science	NOUN
bam-8776	10	23	through	through	ADP
bam-8776	10	24	2019	2019	NUM
bam-8776	10	25	.	.	PUNCT
bam-8776	11	1	the	the	DET
bam-8776	11	2	effect	effect	NOUN
bam-8776	11	3	of	of	ADP
bam-8776	11	4	ms	ms	NOUN
bam-8776	11	5	with	with	ADP
bam-8776	11	6	its	its	PRON
bam-8776	11	7	components	component	NOUN
bam-8776	11	8	and	and	CCONJ
bam-8776	11	9	breast	breast	NOUN
bam-8776	11	10	cancer	cancer	NOUN
bam-8776	11	11	was	be	AUX
bam-8776	11	12	reported	report	VERB
bam-8776	11	13	in	in	ADP
bam-8776	11	14	many	many	ADJ
bam-8776	11	15	studies	study	NOUN
bam-8776	11	16	.	.	PUNCT
bam-8776	12	1	nevertheless	nevertheless	ADV
bam-8776	12	2	,	,	PUNCT
bam-8776	12	3	a	a	DET
bam-8776	12	4	thorough	thorough	ADJ
bam-8776	12	5	understanding	understanding	NOUN
bam-8776	12	6	of	of	ADP
bam-8776	12	7	the	the	DET
bam-8776	12	8	mechanisms	mechanism	NOUN
bam-8776	12	9	involved	involve	VERB
bam-8776	12	10	remains	remain	VERB
bam-8776	12	11	a	a	DET
bam-8776	12	12	challenge	challenge	NOUN
bam-8776	12	13	.	.	PUNCT
bam-8776	13	1	however	however	ADV
bam-8776	13	2	,	,	PUNCT
bam-8776	13	3	one	one	PRON
bam-8776	13	4	can	can	AUX
bam-8776	13	5	take	take	VERB
bam-8776	13	6	several	several	ADJ
bam-8776	13	7	preventive	preventive	ADJ
bam-8776	13	8	measures	measure	NOUN
bam-8776	13	9	,	,	PUNCT
bam-8776	13	10	including	include	VERB
bam-8776	13	11	a	a	DET
bam-8776	13	12	proper	proper	ADJ
bam-8776	13	13	diet	diet	NOUN
bam-8776	13	14	,	,	PUNCT
bam-8776	13	15	which	which	PRON
bam-8776	13	16	is	be	AUX
bam-8776	13	17	one	one	NUM
bam-8776	13	18	of	of	ADP
bam-8776	13	19	the	the	DET
bam-8776	13	20	most	most	ADV
bam-8776	13	21	important	important	ADJ
bam-8776	13	22	determinants	determinant	NOUN
bam-8776	13	23	of	of	ADP
bam-8776	13	24	metabolic	metabolic	NOUN
bam-8776	13	25	status	status	NOUN
bam-8776	13	26	.	.	PUNCT
bam-8776	14	1	also	also	ADV
bam-8776	14	2	,	,	PUNCT
bam-8776	14	3	general	general	ADJ
bam-8776	14	4	preventive	preventive	ADJ
bam-8776	14	5	recommendations	recommendation	NOUN
bam-8776	14	6	are	be	AUX
bam-8776	14	7	including	include	VERB
bam-8776	14	8	reducing	reduce	VERB
bam-8776	14	9	alcohol	alcohol	NOUN
bam-8776	14	10	consumption	consumption	NOUN
bam-8776	14	11	,	,	PUNCT
bam-8776	14	12	red	red	ADJ
bam-8776	14	13	meat	meat	NOUN
bam-8776	14	14	and	and	CCONJ
bam-8776	14	15	total	total	ADJ
bam-8776	14	16	fat	fat	NOUN
bam-8776	14	17	in	in	ADP
bam-8776	14	18	the	the	DET
bam-8776	14	19	diet	diet	NOUN
bam-8776	14	20	.	.	PUNCT
bam-8776	15	1	moreover	moreover	ADV
bam-8776	15	2	,	,	PUNCT
bam-8776	15	3	increasing	increase	VERB
bam-8776	15	4	the	the	DET
bam-8776	15	5	consumption	consumption	NOUN
bam-8776	15	6	of	of	ADP
bam-8776	15	7	vegetable	vegetable	NOUN
bam-8776	15	8	and	and	CCONJ
bam-8776	15	9	fruit	fruit	NOUN
bam-8776	15	10	reduce	reduce	VERB
bam-8776	15	11	the	the	DET
bam-8776	15	12	proportion	proportion	NOUN
bam-8776	15	13	of	of	ADP
bam-8776	15	14	ms	ms	NOUN
bam-8776	15	15	patients	patient	NOUN
bam-8776	15	16	to	to	PART
bam-8776	15	17	improve	improve	VERB
bam-8776	15	18	the	the	DET
bam-8776	15	19	outcome	outcome	NOUN
bam-8776	15	20	of	of	ADP
bam-8776	15	21	breast	breast	NOUN
bam-8776	15	22	cancer	cancer	NOUN
bam-8776	15	23	patients	patient	NOUN
bam-8776	15	24	.	.	PUNCT
bam-8776	16	1	key	key	ADJ
bam-8776	16	2	words	word	NOUN
bam-8776	16	3	:	:	PUNCT
bam-8776	16	4	breast	breast	NOUN
bam-8776	16	5	cancer	cancer	NOUN
bam-8776	16	6	,	,	PUNCT
bam-8776	16	7	metabolic	metabolic	NOUN
bam-8776	16	8	syndrome	syndrome	NOUN
bam-8776	16	9	,	,	PUNCT
bam-8776	16	10	electronic	electronic	ADJ
bam-8776	16	11	database	database	NOUN
bam-8776	16	12	,	,	PUNCT
bam-8776	16	13	natural	natural	ADJ
bam-8776	16	14	products	product	NOUN
bam-8776	16	15	.	.	PUNCT
bam-8776	17	1	eur	eur	PROPN
bam-8776	17	2	j	j	PROPN
bam-8776	17	3	transl	transl	PROPN
bam-8776	17	4	myol	myol	ADV
bam-8776	17	5	30	30	NUM
bam-8776	17	6	(	(	PUNCT
bam-8776	17	7	3	3	NUM
bam-8776	17	8	):	):	PUNCT
bam-8776	17	9	xx1	xx1	PROPN
bam-8776	17	10	-	-	PUNCT
bam-8776	17	11	xx7	xx7	PROPN
bam-8776	17	12	,	,	PUNCT
bam-8776	17	13	2020	2020	NUM
bam-8776	17	14	breast	breast	NOUN
bam-8776	17	15	cancer	cancer	NOUN
bam-8776	17	16	is	be	AUX
bam-8776	17	17	one	one	NUM
bam-8776	17	18	of	of	ADP
bam-8776	17	19	the	the	DET
bam-8776	17	20	most	most	ADV
bam-8776	17	21	serious	serious	ADJ
bam-8776	17	22	diseases	disease	NOUN
bam-8776	17	23	among	among	ADP
bam-8776	17	24	women	woman	NOUN
bam-8776	17	25	in	in	ADP
bam-8776	17	26	the	the	DET
bam-8776	17	27	world	world	NOUN
bam-8776	17	28	.	.	PUNCT
bam-8776	18	1	this	this	DET
bam-8776	18	2	disease	disease	NOUN
bam-8776	18	3	is	be	AUX
bam-8776	18	4	the	the	DET
bam-8776	18	5	first	first	ADJ
bam-8776	18	6	reason	reason	NOUN
bam-8776	18	7	for	for	ADP
bam-8776	18	8	the	the	DET
bam-8776	18	9	death	death	NOUN
bam-8776	18	10	of	of	ADP
bam-8776	18	11	women	woman	NOUN
bam-8776	18	12	due	due	ADP
bam-8776	18	13	to	to	ADP
bam-8776	18	14	cancer	cancer	NOUN
bam-8776	18	15	.	.	PUNCT
bam-8776	19	1	increasing	increase	VERB
bam-8776	19	2	breast	breast	NOUN
bam-8776	19	3	cancer	cancer	NOUN
bam-8776	19	4	risk	risk	NOUN
bam-8776	19	5	may	may	AUX
bam-8776	19	6	be	be	AUX
bam-8776	19	7	associated	associate	VERB
bam-8776	19	8	with	with	ADP
bam-8776	19	9	many	many	ADJ
bam-8776	19	10	factors	factor	NOUN
bam-8776	19	11	including	include	VERB
bam-8776	19	12	genetic	genetic	ADJ
bam-8776	19	13	,	,	PUNCT
bam-8776	19	14	reproductive	reproductive	ADJ
bam-8776	19	15	and	and	CCONJ
bam-8776	19	16	hormonal	hormonal	ADJ
bam-8776	19	17	parameters	parameter	NOUN
bam-8776	19	18	,	,	PUNCT
bam-8776	19	19	metabolic	metabolic	NOUN
bam-8776	19	20	syndrome	syndrome	NOUN
bam-8776	19	21	(	(	PUNCT
bam-8776	19	22	ms	ms	NOUN
bam-8776	19	23	)	)	PUNCT
bam-8776	19	24	and	and	CCONJ
bam-8776	19	25	people	people	NOUN
bam-8776	19	26	lifestyle.1,2	lifestyle.1,2	PROPN
bam-8776	19	27	ms	ms	PROPN
bam-8776	19	28	is	be	AUX
bam-8776	19	29	a	a	DET
bam-8776	19	30	cluster	cluster	NOUN
bam-8776	19	31	of	of	ADP
bam-8776	19	32	metabolic	metabolic	NOUN
bam-8776	19	33	abnormality	abnormality	NOUN
bam-8776	19	34	that	that	PRON
bam-8776	19	35	happens	happen	VERB
bam-8776	19	36	to	to	ADP
bam-8776	19	37	people	people	NOUN
bam-8776	19	38	with	with	ADP
bam-8776	19	39	disordered	disordered	ADJ
bam-8776	19	40	sensitivity	sensitivity	NOUN
bam-8776	19	41	to	to	ADP
bam-8776	19	42	insulin.3	insulin.3	NOUN
bam-8776	19	43	it	it	PRON
bam-8776	19	44	is	be	AUX
bam-8776	19	45	described	describe	VERB
bam-8776	19	46	with	with	ADP
bam-8776	19	47	the	the	DET
bam-8776	19	48	existence	existence	NOUN
bam-8776	19	49	of	of	ADP
bam-8776	19	50	factors	factor	NOUN
bam-8776	19	51	including	include	VERB
bam-8776	19	52	the	the	DET
bam-8776	19	53	increase	increase	NOUN
bam-8776	19	54	of	of	ADP
bam-8776	19	55	triglycerides	triglyceride	NOUN
bam-8776	19	56	in	in	ADP
bam-8776	19	57	the	the	DET
bam-8776	19	58	blood	blood	NOUN
bam-8776	19	59	,	,	PUNCT
bam-8776	19	60	abdominal	abdominal	ADJ
bam-8776	19	61	obesity	obesity	NOUN
bam-8776	19	62	,	,	PUNCT
bam-8776	19	63	increasing	increase	VERB
bam-8776	19	64	fasting	fast	VERB
bam-8776	19	65	glucose	glucose	NOUN
bam-8776	19	66	and	and	CCONJ
bam-8776	19	67	high	high	ADJ
bam-8776	19	68	pressure	pressure	NOUN
bam-8776	19	69	of	of	ADP
bam-8776	19	70	blood.4	blood.4	PROPN
bam-8776	19	71	ms	ms	PROPN
bam-8776	19	72	is	be	AUX
bam-8776	19	73	known	know	VERB
bam-8776	19	74	as	as	ADP
bam-8776	19	75	a	a	DET
bam-8776	19	76	danger	danger	NOUN
bam-8776	19	77	for	for	ADP
bam-8776	19	78	many	many	ADJ
bam-8776	19	79	cancers	cancer	NOUN
bam-8776	19	80	such	such	ADJ
bam-8776	19	81	as	as	ADP
bam-8776	19	82	those	those	PRON
bam-8776	19	83	of	of	ADP
bam-8776	19	84	prostate	prostate	NOUN
bam-8776	19	85	,	,	PUNCT
bam-8776	19	86	pancreas	pancreas	NOUN
bam-8776	19	87	,	,	PUNCT
bam-8776	19	88	breast	breast	NOUN
bam-8776	19	89	and	and	CCONJ
bam-8776	19	90	colorectal	colorectal	ADJ
bam-8776	19	91	region.5	region.5	PROPN
bam-8776	19	92	-	-	PUNCT
bam-8776	19	93	10	10	NUM
bam-8776	19	94	studies	study	NOUN
bam-8776	19	95	show	show	VERB
bam-8776	19	96	that	that	SCONJ
bam-8776	19	97	,	,	PUNCT
bam-8776	19	98	in	in	ADP
bam-8776	19	99	women	woman	NOUN
bam-8776	19	100	age	age	NOUN
bam-8776	19	101	above	above	ADP
bam-8776	19	102	18	18	NUM
bam-8776	19	103	years	year	NOUN
bam-8776	19	104	,	,	PUNCT
bam-8776	19	105	there	there	PRON
bam-8776	19	106	is	be	VERB
bam-8776	19	107	a	a	DET
bam-8776	19	108	mild	mild	ADJ
bam-8776	19	109	positive	positive	ADJ
bam-8776	19	110	dependency	dependency	NOUN
bam-8776	19	111	between	between	ADP
bam-8776	19	112	breast	breast	NOUN
bam-8776	19	113	cancer	cancer	NOUN
bam-8776	19	114	and	and	CCONJ
bam-8776	19	115	ms.11	ms.11	NOUN
bam-8776	19	116	moreover	moreover	ADV
bam-8776	19	117	,	,	PUNCT
bam-8776	19	118	many	many	ADJ
bam-8776	19	119	of	of	ADP
bam-8776	19	120	these	these	DET
bam-8776	19	121	studies	study	NOUN
bam-8776	19	122	indicate	indicate	VERB
bam-8776	19	123	a	a	DET
bam-8776	19	124	positive	positive	ADJ
bam-8776	19	125	relationship	relationship	NOUN
bam-8776	19	126	with	with	ADP
bam-8776	19	127	diabetes	diabetes	NOUN
bam-8776	19	128	,	,	PUNCT
bam-8776	19	129	breast	breast	NOUN
bam-8776	19	130	cancer,12	cancer,12	PROPN
bam-8776	19	131	-	-	SYM
bam-8776	19	132	18	18	NUM
bam-8776	19	133	and	and	CCONJ
bam-8776	19	134	obesity.2,19,20	obesity.2,19,20	NOUN
bam-8776	19	135	additionally	additionally	ADV
bam-8776	19	136	,	,	PUNCT
bam-8776	19	137	some	some	DET
bam-8776	19	138	studies	study	NOUN
bam-8776	19	139	show	show	VERB
bam-8776	19	140	dyslipidemia	dyslipidemia	NOUN
bam-8776	19	141	and	and	CCONJ
bam-8776	19	142	hypertension	hypertension	NOUN
bam-8776	19	143	as	as	ADP
bam-8776	19	144	danger	danger	NOUN
bam-8776	19	145	agents	agent	NOUN
bam-8776	19	146	in	in	ADP
bam-8776	19	147	breast	breast	NOUN
bam-8776	19	148	cancer.11,21	cancer.11,21	NOUN
bam-8776	19	149	-	-	PUNCT
bam-8776	19	150	24	24	NUM
bam-8776	19	151	despite	despite	SCONJ
bam-8776	19	152	single	single	ADJ
bam-8776	19	153	ms	ms	PROPN
bam-8776	19	154	components	component	NOUN
bam-8776	19	155	can	can	AUX
bam-8776	19	156	not	not	PART
bam-8776	19	157	be	be	AUX
bam-8776	19	158	powerfully	powerfully	ADV
bam-8776	19	159	related	relate	VERB
bam-8776	19	160	to	to	ADP
bam-8776	19	161	the	the	DET
bam-8776	19	162	advancement	advancement	NOUN
bam-8776	19	163	of	of	ADP
bam-8776	19	164	breast	breast	NOUN
bam-8776	19	165	cancer	cancer	NOUN
bam-8776	19	166	,	,	PUNCT
bam-8776	19	167	their	their	PRON
bam-8776	19	168	mixture	mixture	NOUN
bam-8776	19	169	can	can	AUX
bam-8776	19	170	enhance	enhance	VERB
bam-8776	19	171	the	the	DET
bam-8776	19	172	venture.8,9	venture.8,9	ADJ
bam-8776	19	173	the	the	DET
bam-8776	19	174	main	main	ADJ
bam-8776	19	175	objective	objective	NOUN
bam-8776	19	176	of	of	ADP
bam-8776	19	177	this	this	DET
bam-8776	19	178	paper	paper	NOUN
bam-8776	19	179	is	be	AUX
bam-8776	19	180	to	to	PART
bam-8776	19	181	study	study	VERB
bam-8776	19	182	relationship	relationship	NOUN
bam-8776	19	183	among	among	ADP
bam-8776	19	184	the	the	DET
bam-8776	19	185	individual	individual	ADJ
bam-8776	19	186	ms	ms	PROPN
bam-8776	19	187	components	component	NOUN
bam-8776	19	188	and	and	CCONJ
bam-8776	19	189	breast	breast	NOUN
bam-8776	19	190	cancer	cancer	NOUN
bam-8776	19	191	.	.	PUNCT
bam-8776	20	1	definition	definition	NOUN
bam-8776	20	2	and	and	CCONJ
bam-8776	20	3	prevalence	prevalence	NOUN
bam-8776	20	4	of	of	ADP
bam-8776	20	5	metabolic	metabolic	NOUN
bam-8776	20	6	syndrome	syndrome	NOUN
bam-8776	20	7	the	the	DET
bam-8776	20	8	definition	definition	NOUN
bam-8776	20	9	of	of	ADP
bam-8776	20	10	ms	ms	PROPN
bam-8776	20	11	began	begin	VERB
bam-8776	20	12	from	from	ADP
bam-8776	20	13	2001,25	2001,25	PROPN
bam-8776	20	14	then	then	ADV
bam-8776	20	15	the	the	DET
bam-8776	20	16	concept	concept	NOUN
bam-8776	20	17	of	of	ADP
bam-8776	20	18	integrated	integrate	VERB
bam-8776	20	19	definition	definition	NOUN
bam-8776	20	20	has	have	AUX
bam-8776	20	21	been	be	AUX
bam-8776	20	22	fixed	fix	VERB
bam-8776	20	23	(	(	PUNCT
bam-8776	20	24	table	table	NOUN
bam-8776	20	25	1).4	1).4	NOUN
bam-8776	20	26	for	for	ADP
bam-8776	20	27	populations	population	NOUN
bam-8776	20	28	of	of	ADP
bam-8776	20	29	caucasian	caucasian	ADJ
bam-8776	20	30	,	,	PUNCT
bam-8776	20	31	in	in	ADP
bam-8776	20	32	men	man	NOUN
bam-8776	20	33	and	and	CCONJ
bam-8776	20	34	women	woman	NOUN
bam-8776	20	35	102	102	NUM
bam-8776	20	36	and	and	CCONJ
bam-8776	20	37	88	88	NUM
bam-8776	20	38	cm	cm	NOUN
bam-8776	20	39	waist	waist	NOUN
bam-8776	20	40	respectively	respectively	ADV
bam-8776	20	41	,	,	PUNCT
bam-8776	20	42	is	be	AUX
bam-8776	20	43	generally	generally	ADV
bam-8776	20	44	chosen	choose	VERB
bam-8776	20	45	as	as	ADP
bam-8776	20	46	an	an	DET
bam-8776	20	47	evidence	evidence	NOUN
bam-8776	20	48	of	of	ADP
bam-8776	20	49	abdominal	abdominal	ADJ
bam-8776	20	50	obesity	obesity	NOUN
bam-8776	20	51	.	.	PUNCT
bam-8776	21	1	diagnosis	diagnosis	NOUN
bam-8776	21	2	of	of	ADP
bam-8776	21	3	ms	ms	NOUN
bam-8776	21	4	complies	complie	NOUN
bam-8776	21	5	when	when	SCONJ
bam-8776	21	6	3	3	NUM
bam-8776	21	7	of	of	ADP
bam-8776	21	8	the	the	DET
bam-8776	21	9	5	5	NUM
bam-8776	21	10	criteria	criterion	NOUN
bam-8776	21	11	exist.4,25	exist.4,25	PROPN
bam-8776	21	12	the	the	DET
bam-8776	21	13	spread	spread	NOUN
bam-8776	21	14	of	of	ADP
bam-8776	21	15	ms	ms	NOUN
bam-8776	21	16	in	in	ADP
bam-8776	21	17	the	the	DET
bam-8776	21	18	west	west	NOUN
bam-8776	21	19	is	be	AUX
bam-8776	21	20	among	among	ADP
bam-8776	21	21	20	20	NUM
bam-8776	21	22	-	-	SYM
bam-8776	21	23	25	25	NUM
bam-8776	21	24	%	%	NOUN
bam-8776	21	25	of	of	ADP
bam-8776	21	26	adult	adult	NOUN
bam-8776	21	27	people	people	NOUN
bam-8776	21	28	,	,	PUNCT
bam-8776	21	29	while	while	SCONJ
bam-8776	21	30	in	in	ADP
bam-8776	21	31	old	old	ADJ
bam-8776	21	32	people	people	NOUN
bam-8776	21	33	it	it	PRON
bam-8776	21	34	ranges	range	VERB
bam-8776	21	35	from	from	ADP
bam-8776	21	36	40	40	NUM
bam-8776	21	37	to	to	ADP
bam-8776	21	38	45%26,27	45%26,27	PROPN
bam-8776	21	39	.	.	PUNCT
bam-8776	22	1	ms	ms	PROPN
bam-8776	22	2	also	also	ADV
bam-8776	22	3	increases	increase	VERB
bam-8776	22	4	risks	risk	NOUN
bam-8776	22	5	of	of	ADP
bam-8776	22	6	cardiovascular	cardiovascular	ADJ
bam-8776	22	7	diseases.28	diseases.28	NOUN
bam-8776	22	8	association	association	NOUN
bam-8776	22	9	of	of	ADP
bam-8776	22	10	breast	breast	NOUN
bam-8776	22	11	cancer	cancer	NOUN
bam-8776	22	12	and	and	CCONJ
bam-8776	22	13	diabetes	diabete	VERB
bam-8776	22	14	many	many	ADJ
bam-8776	22	15	clinical	clinical	ADJ
bam-8776	22	16	studies	study	NOUN
bam-8776	22	17	showed	show	VERB
bam-8776	22	18	diabetes	diabetes	NOUN
bam-8776	22	19	and	and	CCONJ
bam-8776	22	20	breast	breast	NOUN
bam-8776	22	21	cancer	cancer	NOUN
bam-8776	22	22	correlation	correlation	NOUN
bam-8776	22	23	.	.	PUNCT
bam-8776	23	1	in	in	ADP
bam-8776	23	2	one	one	NUM
bam-8776	23	3	study	study	NOUN
bam-8776	23	4	in	in	ADP
bam-8776	23	5	the	the	DET
bam-8776	23	6	united	united	PROPN
bam-8776	23	7	states	states	PROPN
bam-8776	23	8	1.2	1.2	NUM
bam-8776	23	9	million	million	NUM
bam-8776	23	10	patients	patient	NOUN
bam-8776	23	11	(	(	PUNCT
bam-8776	23	12	588321	588321	NUM
bam-8776	23	13	were	be	AUX
bam-8776	23	14	women	woman	NOUN
bam-8776	23	15	)	)	PUNCT
bam-8776	23	16	were	be	AUX
bam-8776	23	17	enrolled	enrol	VERB
bam-8776	23	18	and	and	CCONJ
bam-8776	23	19	studied	study	VERB
bam-8776	23	20	metabolic	metabolic	NOUN
bam-8776	23	21	syndrome	syndrome	NOUN
bam-8776	23	22	and	and	CCONJ
bam-8776	23	23	breast	breast	NOUN
bam-8776	23	24	cancer	cancer	NOUN
bam-8776	23	25	patients	patient	NOUN
bam-8776	23	26	eur	eur	PROPN
bam-8776	23	27	j	j	PROPN
bam-8776	23	28	transl	transl	PROPN
bam-8776	23	29	myol	myol	ADV
bam-8776	23	30	30	30	NUM
bam-8776	23	31	(	(	PUNCT
bam-8776	23	32	3	3	NUM
bam-8776	23	33	):	):	PUNCT
bam-8776	23	34	xx1	xx1	PROPN
bam-8776	23	35	-	-	PUNCT
bam-8776	23	36	xx7	xx7	PROPN
bam-8776	23	37	,	,	PUNCT
bam-8776	23	38	2020	2020	NUM
bam-8776	23	39	2	2	NUM
bam-8776	23	40	for	for	ADP
bam-8776	23	41	6	6	NUM
bam-8776	23	42	years	year	NOUN
bam-8776	23	43	(	(	PUNCT
bam-8776	23	44	19821988	19821988	NUM
bam-8776	23	45	)	)	PUNCT
bam-8776	23	46	.	.	PUNCT
bam-8776	24	1	it	it	PRON
bam-8776	24	2	was	be	AUX
bam-8776	24	3	shown	show	VERB
bam-8776	24	4	that	that	SCONJ
bam-8776	24	5	diabetic	diabetic	ADJ
bam-8776	24	6	women	woman	NOUN
bam-8776	24	7	with	with	ADP
bam-8776	24	8	breast	breast	NOUN
bam-8776	24	9	cancer	cancer	NOUN
bam-8776	24	10	died	die	VERB
bam-8776	24	11	more	more	ADJ
bam-8776	24	12	than	than	ADP
bam-8776	24	13	women	woman	NOUN
bam-8776	24	14	without	without	ADP
bam-8776	24	15	diabetes.29	diabetes.29	NOUN
bam-8776	24	16	some	some	DET
bam-8776	24	17	meta	meta	ADJ
bam-8776	24	18	-	-	PUNCT
bam-8776	24	19	analyses	analysis	NOUN
bam-8776	24	20	have	have	AUX
bam-8776	24	21	investigated	investigate	VERB
bam-8776	24	22	this	this	DET
bam-8776	24	23	relation	relation	NOUN
bam-8776	24	24	in	in	ADP
bam-8776	24	25	details13,30	details13,30	PROPN
bam-8776	24	26	-	-	PUNCT
bam-8776	24	27	32	32	NUM
bam-8776	24	28	.	.	PUNCT
bam-8776	25	1	much	much	ADJ
bam-8776	25	2	research	research	NOUN
bam-8776	25	3	confirmed	confirm	VERB
bam-8776	25	4	the	the	DET
bam-8776	25	5	role	role	NOUN
bam-8776	25	6	of	of	ADP
bam-8776	25	7	diabetes	diabetes	NOUN
bam-8776	25	8	on	on	ADP
bam-8776	25	9	breast	breast	NOUN
bam-8776	25	10	cancer	cancer	NOUN
bam-8776	25	11	level	level	NOUN
bam-8776	25	12	,	,	PUNCT
bam-8776	25	13	increasing	increase	VERB
bam-8776	25	14	hospitalization	hospitalization	NOUN
bam-8776	25	15	and	and	CCONJ
bam-8776	25	16	decreasing	decrease	VERB
bam-8776	25	17	illness	illness	NOUN
bam-8776	25	18	-	-	PUNCT
bam-8776	25	19	free	free	ADJ
bam-8776	25	20	duration.33	duration.33	PROPN
bam-8776	25	21	-	-	SYM
bam-8776	25	22	35	35	NUM
bam-8776	25	23	insulin	insulin	NOUN
bam-8776	25	24	resistance	resistance	NOUN
bam-8776	25	25	of	of	ADP
bam-8776	25	26	type	type	NOUN
bam-8776	25	27	2	2	NUM
bam-8776	25	28	diabetes	diabetes	NOUN
bam-8776	25	29	may	may	AUX
bam-8776	25	30	cause	cause	VERB
bam-8776	25	31	hyperglycemia	hyperglycemia	NOUN
bam-8776	25	32	that	that	PRON
bam-8776	25	33	support	support	VERB
bam-8776	25	34	cell	cell	NOUN
bam-8776	25	35	differentiation	differentiation	NOUN
bam-8776	25	36	and	and	CCONJ
bam-8776	25	37	proliferation	proliferation	NOUN
bam-8776	25	38	.	.	PUNCT
bam-8776	26	1	hyperinsulinemia	hyperinsulinemia	NOUN
bam-8776	26	2	can	can	AUX
bam-8776	26	3	increase	increase	VERB
bam-8776	26	4	mitogenicity	mitogenicity	NOUN
bam-8776	26	5	.	.	PUNCT
bam-8776	27	1	the	the	DET
bam-8776	27	2	increase	increase	NOUN
bam-8776	27	3	of	of	ADP
bam-8776	27	4	circulating	circulate	VERB
bam-8776	27	5	estrogens	estrogen	NOUN
bam-8776	27	6	may	may	AUX
bam-8776	27	7	favor	favor	VERB
bam-8776	27	8	breast	breast	NOUN
bam-8776	27	9	cancer	cancer	NOUN
bam-8776	27	10	development.30	development.30	VERB
bam-8776	27	11	insulin	insulin	NOUN
bam-8776	27	12	can	can	AUX
bam-8776	27	13	have	have	VERB
bam-8776	27	14	direct	direct	ADJ
bam-8776	27	15	effects	effect	NOUN
bam-8776	27	16	on	on	ADP
bam-8776	27	17	epithelial	epithelial	ADJ
bam-8776	27	18	cells	cell	NOUN
bam-8776	27	19	and	and	CCONJ
bam-8776	27	20	thus	thus	ADV
bam-8776	27	21	supporting	support	VERB
bam-8776	27	22	tumorigenesis.36,37	tumorigenesis.36,37	ADP
bam-8776	27	23	insulin	insulin	NOUN
bam-8776	27	24	receptor	receptor	NOUN
bam-8776	27	25	is	be	AUX
bam-8776	27	26	more	more	ADV
bam-8776	27	27	concentrated	concentrated	ADJ
bam-8776	27	28	in	in	ADP
bam-8776	27	29	breast	breast	NOUN
bam-8776	27	30	cancer	cancer	NOUN
bam-8776	27	31	tissue	tissue	NOUN
bam-8776	27	32	than	than	SCONJ
bam-8776	27	33	in	in	ADP
bam-8776	27	34	healthy	healthy	ADJ
bam-8776	27	35	tissue.38	tissue.38	PROPN
bam-8776	27	36	insulin	insulin	NOUN
bam-8776	27	37	can	can	AUX
bam-8776	27	38	act	act	VERB
bam-8776	27	39	via	via	ADP
bam-8776	27	40	an	an	DET
bam-8776	27	41	insulin	insulin	NOUN
bam-8776	27	42	-	-	PUNCT
bam-8776	27	43	like	like	ADJ
bam-8776	27	44	growth	growth	NOUN
bam-8776	27	45	factor	factor	NOUN
bam-8776	27	46	(	(	PUNCT
bam-8776	27	47	igf	igf	NOUN
bam-8776	27	48	)	)	PUNCT
bam-8776	27	49	system	system	NOUN
bam-8776	27	50	that	that	PRON
bam-8776	27	51	is	be	AUX
bam-8776	27	52	a	a	DET
bam-8776	27	53	main	main	ADJ
bam-8776	27	54	breast	breast	NOUN
bam-8776	27	55	cancer	cancer	NOUN
bam-8776	27	56	pathway	pathway	NOUN
bam-8776	27	57	.	.	PUNCT
bam-8776	28	1	increased	increase	VERB
bam-8776	28	2	of	of	ADP
bam-8776	28	3	igf-1	igf-1	NOUN
bam-8776	28	4	level	level	NOUN
bam-8776	28	5	and	and	CCONJ
bam-8776	28	6	binding	binding	NOUN
bam-8776	28	7	of	of	ADP
bam-8776	28	8	insulin	insulin	NOUN
bam-8776	28	9	-	-	PUNCT
bam-8776	28	10	like	like	ADJ
bam-8776	28	11	growth	growth	NOUN
bam-8776	28	12	factor	factor	NOUN
bam-8776	28	13	protein	protein	NOUN
bam-8776	28	14	3	3	NUM
bam-8776	28	15	(	(	PUNCT
bam-8776	28	16	igfbp3	igfbp3	NOUN
bam-8776	28	17	)	)	PUNCT
bam-8776	28	18	level	level	NOUN
bam-8776	28	19	may	may	AUX
bam-8776	28	20	increase	increase	VERB
bam-8776	28	21	risk	risk	NOUN
bam-8776	28	22	of	of	ADP
bam-8776	28	23	breast	breast	NOUN
bam-8776	28	24	cancer.39,40	cancer.39,40	VERB
bam-8776	28	25	much	much	ADJ
bam-8776	28	26	research	research	NOUN
bam-8776	28	27	investigated	investigate	VERB
bam-8776	28	28	the	the	DET
bam-8776	28	29	relationship	relationship	NOUN
bam-8776	28	30	between	between	ADP
bam-8776	28	31	therapy	therapy	NOUN
bam-8776	28	32	for	for	ADP
bam-8776	28	33	type	type	NOUN
bam-8776	28	34	2	2	NUM
bam-8776	28	35	diabetes	diabetes	NOUN
bam-8776	28	36	and	and	CCONJ
bam-8776	28	37	breast	breast	NOUN
bam-8776	28	38	cancer	cancer	NOUN
bam-8776	28	39	.	.	PUNCT
bam-8776	29	1	metformin	metformin	NOUN
bam-8776	29	2	is	be	AUX
bam-8776	29	3	a	a	DET
bam-8776	29	4	biguanide	biguanide	NOUN
bam-8776	29	5	medicine	medicine	NOUN
bam-8776	29	6	cause	cause	VERB
bam-8776	29	7	to	to	PART
bam-8776	29	8	decrease	decrease	VERB
bam-8776	29	9	hyperinsulinemia	hyperinsulinemia	NOUN
bam-8776	29	10	and	and	CCONJ
bam-8776	29	11	hyperglycemia	hyperglycemia	NOUN
bam-8776	29	12	by	by	ADP
bam-8776	29	13	increasing	increase	VERB
bam-8776	29	14	muscle	muscle	NOUN
bam-8776	29	15	glucose	glucose	NOUN
bam-8776	29	16	absorption	absorption	NOUN
bam-8776	29	17	.	.	PUNCT
bam-8776	30	1	it	it	PRON
bam-8776	30	2	is	be	AUX
bam-8776	30	3	thought	think	VERB
bam-8776	30	4	metformin	metformin	PROPN
bam-8776	30	5	independent	independent	ADJ
bam-8776	30	6	of	of	ADP
bam-8776	30	7	insulin	insulin	NOUN
bam-8776	30	8	has	have	VERB
bam-8776	30	9	a	a	DET
bam-8776	30	10	desirable	desirable	ADJ
bam-8776	30	11	effect	effect	NOUN
bam-8776	30	12	on	on	ADP
bam-8776	30	13	breast	breast	NOUN
bam-8776	30	14	cancer	cancer	NOUN
bam-8776	30	15	prevention	prevention	NOUN
bam-8776	30	16	and	and	CCONJ
bam-8776	30	17	treatment.41,42	treatment.41,42	NOUN
bam-8776	30	18	in	in	ADP
bam-8776	30	19	2018	2018	NUM
bam-8776	30	20	tang	tang	NOUN
bam-8776	30	21	et	et	PROPN
bam-8776	30	22	al	al	PROPN
bam-8776	30	23	investigated	investigate	VERB
bam-8776	30	24	12	12	NUM
bam-8776	30	25	articles	article	NOUN
bam-8776	30	26	about	about	ADP
bam-8776	30	27	metformin	metformin	NOUN
bam-8776	30	28	and	and	CCONJ
bam-8776	30	29	breast	breast	NOUN
bam-8776	30	30	cancer	cancer	NOUN
bam-8776	30	31	relationship	relationship	NOUN
bam-8776	30	32	in	in	ADP
bam-8776	30	33	a	a	DET
bam-8776	30	34	systematic	systematic	ADJ
bam-8776	30	35	review	review	NOUN
bam-8776	30	36	.	.	PUNCT
bam-8776	31	1	they	they	PRON
bam-8776	31	2	showed	show	VERB
bam-8776	31	3	non	non	ADJ
bam-8776	31	4	statistically	statistically	ADV
bam-8776	31	5	significant	significant	ADJ
bam-8776	31	6	improvement	improvement	NOUN
bam-8776	31	7	of	of	ADP
bam-8776	31	8	t2d	t2d	NOUN
bam-8776	31	9	and	and	CCONJ
bam-8776	31	10	breast	breast	NOUN
bam-8776	31	11	cancer	cancer	NOUN
bam-8776	31	12	patients	patient	NOUN
bam-8776	31	13	with	with	ADP
bam-8776	31	14	metformin.43	metformin.43	PROPN
bam-8776	31	15	the	the	DET
bam-8776	31	16	multivariate	multivariate	NOUN
bam-8776	31	17	investigation	investigation	NOUN
bam-8776	31	18	was	be	AUX
bam-8776	31	19	performed	perform	VERB
bam-8776	31	20	by	by	ADP
bam-8776	31	21	bosco	bosco	PROPN
bam-8776	31	22	et	et	PROPN
bam-8776	31	23	al	al	PROPN
bam-8776	31	24	.	.	PROPN
bam-8776	31	25	showed	show	VERB
bam-8776	31	26	metformin	metformin	NOUN
bam-8776	31	27	used	use	VERB
bam-8776	31	28	for	for	ADP
bam-8776	31	29	less	less	ADJ
bam-8776	31	30	than	than	ADP
bam-8776	31	31	one	one	NUM
bam-8776	31	32	year	year	NOUN
bam-8776	31	33	may	may	AUX
bam-8776	31	34	decrease	decrease	VERB
bam-8776	31	35	breast	breast	NOUN
bam-8776	31	36	cancer	cancer	NOUN
bam-8776	31	37	incidence42	incidence42	NOUN
bam-8776	31	38	.	.	PUNCT
bam-8776	32	1	research	research	NOUN
bam-8776	32	2	in	in	ADP
bam-8776	32	3	2018	2018	NUM
bam-8776	32	4	evaluated	evaluate	VERB
bam-8776	32	5	the	the	DET
bam-8776	32	6	breast	breast	NOUN
bam-8776	32	7	cancer	cancer	NOUN
bam-8776	32	8	risk	risk	NOUN
bam-8776	32	9	for	for	ADP
bam-8776	32	10	aged	aged	ADJ
bam-8776	32	11	women	woman	NOUN
bam-8776	32	12	treated	treat	VERB
bam-8776	32	13	with	with	ADP
bam-8776	32	14	metformin	metformin	NOUN
bam-8776	32	15	or	or	CCONJ
bam-8776	32	16	sulfonylureas	sulfonylurea	NOUN
bam-8776	32	17	.	.	PUNCT
bam-8776	33	1	no	no	DET
bam-8776	33	2	reduction	reduction	NOUN
bam-8776	33	3	of	of	ADP
bam-8776	33	4	breast	breast	NOUN
bam-8776	33	5	cancer	cancer	NOUN
bam-8776	33	6	risk	risk	NOUN
bam-8776	33	7	was	be	AUX
bam-8776	33	8	showed	show	VERB
bam-8776	33	9	adding	add	VERB
bam-8776	33	10	metformin	metformin	NOUN
bam-8776	33	11	to	to	ADP
bam-8776	33	12	the	the	DET
bam-8776	33	13	clinical	clinical	ADJ
bam-8776	33	14	alternative.44	alternative.44	NOUN
bam-8776	33	15	on	on	ADP
bam-8776	33	16	the	the	DET
bam-8776	33	17	other	other	ADJ
bam-8776	33	18	hand	hand	NOUN
bam-8776	33	19	,	,	PUNCT
bam-8776	33	20	clinical	clinical	ADJ
bam-8776	33	21	trials	trial	NOUN
bam-8776	33	22	show	show	VERB
bam-8776	33	23	metformin	metformin	NOUN
bam-8776	33	24	efficacy	efficacy	NOUN
bam-8776	33	25	when	when	SCONJ
bam-8776	33	26	used	use	VERB
bam-8776	33	27	before	before	ADP
bam-8776	33	28	breast	breast	NOUN
bam-8776	33	29	cancer	cancer	NOUN
bam-8776	33	30	surgery.45	surgery.45	ADV
bam-8776	33	31	recently	recently	ADV
bam-8776	33	32	,	,	PUNCT
bam-8776	33	33	relation	relation	NOUN
bam-8776	33	34	between	between	ADP
bam-8776	33	35	ppar	ppar	NOUN
bam-8776	33	36	γ	γ	X
bam-8776	33	37	(	(	PUNCT
bam-8776	33	38	a	a	DET
bam-8776	33	39	nuclear	nuclear	ADJ
bam-8776	33	40	hormone	hormone	NOUN
bam-8776	33	41	receptor	receptor	NOUN
bam-8776	33	42	)	)	PUNCT
bam-8776	33	43	and	and	CCONJ
bam-8776	33	44	breast	breast	NOUN
bam-8776	33	45	cancer	cancer	NOUN
bam-8776	33	46	have	have	AUX
bam-8776	33	47	been	be	AUX
bam-8776	33	48	shown	show	VERB
bam-8776	33	49	.	.	PUNCT
bam-8776	34	1	reducing	reduce	VERB
bam-8776	34	2	ppar	ppar	NOUN
bam-8776	34	3	γ	γ	NOUN
bam-8776	34	4	expression	expression	NOUN
bam-8776	34	5	causes	cause	VERB
bam-8776	34	6	higher	high	ADJ
bam-8776	34	7	tumor	tumor	NOUN
bam-8776	34	8	grade	grade	NOUN
bam-8776	34	9	and	and	CCONJ
bam-8776	34	10	development	development	NOUN
bam-8776	34	11	of	of	ADP
bam-8776	34	12	the	the	DET
bam-8776	34	13	disease.46	disease.46	PROPN
bam-8776	34	14	but	but	CCONJ
bam-8776	34	15	in	in	ADP
bam-8776	34	16	one	one	NUM
bam-8776	34	17	study	study	NOUN
bam-8776	34	18	with	with	ADP
bam-8776	34	19	22	22	NUM
bam-8776	34	20	patients	patient	NOUN
bam-8776	34	21	,	,	PUNCT
bam-8776	34	22	a	a	DET
bam-8776	34	23	ppar	ppar	NOUN
bam-8776	34	24	γ	γ	X
bam-8776	34	25	agonist	agonist	NOUN
bam-8776	34	26	didi	didi	NOUN
bam-8776	34	27	not	not	PART
bam-8776	34	28	induced	induce	VERB
bam-8776	34	29	any	any	DET
bam-8776	34	30	reaction	reaction	NOUN
bam-8776	34	31	in	in	ADP
bam-8776	34	32	patients.47	patients.47	PROPN
bam-8776	34	33	in	in	ADP
bam-8776	34	34	contrast	contrast	NOUN
bam-8776	34	35	,	,	PUNCT
bam-8776	34	36	using	use	VERB
bam-8776	34	37	long	long	ADJ
bam-8776	34	38	term	term	NOUN
bam-8776	34	39	of	of	ADP
bam-8776	34	40	insulin	insulin	NOUN
bam-8776	34	41	glargine	glargine	NOUN
bam-8776	34	42	may	may	AUX
bam-8776	34	43	increase	increase	VERB
bam-8776	34	44	breast	breast	NOUN
bam-8776	34	45	cancer	cancer	NOUN
bam-8776	34	46	risk.48	risk.48	PROPN
bam-8776	34	47	in	in	ADP
bam-8776	34	48	summary	summary	NOUN
bam-8776	34	49	,	,	PUNCT
bam-8776	34	50	managements	management	NOUN
bam-8776	34	51	of	of	ADP
bam-8776	34	52	diabetes	diabetes	NOUN
bam-8776	34	53	can	can	AUX
bam-8776	34	54	have	have	VERB
bam-8776	34	55	the	the	DET
bam-8776	34	56	same	same	ADJ
bam-8776	34	57	impact	impact	NOUN
bam-8776	34	58	as	as	ADP
bam-8776	34	59	diabetes	diabetes	NOUN
bam-8776	34	60	itself	itself	PRON
bam-8776	34	61	,	,	PUNCT
bam-8776	34	62	thus	thus	ADV
bam-8776	34	63	randomized	randomize	VERB
bam-8776	34	64	controlled	control	VERB
bam-8776	34	65	trials	trial	NOUN
bam-8776	34	66	are	be	AUX
bam-8776	34	67	needed	need	VERB
bam-8776	34	68	.	.	PUNCT
bam-8776	35	1	in	in	ADP
bam-8776	35	2	summary	summary	NOUN
bam-8776	35	3	,	,	PUNCT
bam-8776	35	4	published	publish	VERB
bam-8776	35	5	data	datum	NOUN
bam-8776	35	6	demonstrate	demonstrate	VERB
bam-8776	35	7	that	that	DET
bam-8776	35	8	type	type	NOUN
bam-8776	35	9	2	2	NUM
bam-8776	35	10	diabetes	diabetes	NOUN
bam-8776	35	11	increase	increase	VERB
bam-8776	35	12	breast	breast	NOUN
bam-8776	35	13	cancer	cancer	NOUN
bam-8776	35	14	risk.49	risk.49	NOUN
bam-8776	35	15	better	well	ADV
bam-8776	35	16	ndersatnding	ndersatnde	VERB
bam-8776	35	17	of	of	ADP
bam-8776	35	18	the	the	DET
bam-8776	35	19	involved	involve	VERB
bam-8776	35	20	mechanisms	mechanism	NOUN
bam-8776	35	21	may	may	AUX
bam-8776	35	22	open	open	VERB
bam-8776	35	23	the	the	DET
bam-8776	35	24	way	way	NOUN
bam-8776	35	25	to	to	PART
bam-8776	35	26	find	find	VERB
bam-8776	35	27	new	new	ADJ
bam-8776	35	28	drugs	drug	NOUN
bam-8776	35	29	that	that	PRON
bam-8776	35	30	may	may	AUX
bam-8776	35	31	be	be	AUX
bam-8776	35	32	useful	useful	ADJ
bam-8776	35	33	to	to	PART
bam-8776	35	34	establish	establish	VERB
bam-8776	35	35	stronger	strong	ADJ
bam-8776	35	36	preventive	preventive	ADJ
bam-8776	35	37	measures	measure	NOUN
bam-8776	35	38	.	.	PUNCT
bam-8776	36	1	obesity	obesity	NOUN
bam-8776	36	2	and	and	CCONJ
bam-8776	36	3	breast	breast	NOUN
bam-8776	36	4	cancer	cancer	NOUN
bam-8776	36	5	according	accord	VERB
bam-8776	36	6	to	to	ADP
bam-8776	36	7	several	several	ADJ
bam-8776	36	8	epidemiological	epidemiological	ADJ
bam-8776	36	9	studies	study	NOUN
bam-8776	36	10	,	,	PUNCT
bam-8776	36	11	obesity	obesity	NOUN
bam-8776	36	12	before	before	SCONJ
bam-8776	36	13	menopause	menopause	NOUN
bam-8776	36	14	protects	protect	VERB
bam-8776	36	15	for	for	ADP
bam-8776	36	16	breast	breast	NOUN
bam-8776	36	17	cancer50	cancer50	NOUN
bam-8776	36	18	.	.	PUNCT
bam-8776	37	1	on	on	ADP
bam-8776	37	2	the	the	DET
bam-8776	37	3	contrary	contrary	NOUN
bam-8776	37	4	,	,	PUNCT
bam-8776	37	5	obesity	obesity	NOUN
bam-8776	37	6	after	after	SCONJ
bam-8776	37	7	menopause	menopause	NOUN
bam-8776	37	8	may	may	AUX
bam-8776	37	9	increase	increase	VERB
bam-8776	37	10	breast	breast	NOUN
bam-8776	37	11	cancer	cancer	NOUN
bam-8776	37	12	risks49,51	risks49,51	PROPN
bam-8776	37	13	.	.	PUNCT
bam-8776	38	1	in	in	ADP
bam-8776	38	2	particular	particular	ADJ
bam-8776	38	3	,	,	PUNCT
bam-8776	38	4	triple	triple	ADJ
bam-8776	38	5	-	-	PUNCT
bam-8776	38	6	negative	negative	ADJ
bam-8776	38	7	breast	breast	NOUN
bam-8776	38	8	cancer.52,53	cancer.52,53	NOUN
bam-8776	38	9	indeed	indeed	ADV
bam-8776	38	10	,	,	PUNCT
bam-8776	38	11	adipokines	adipokine	NOUN
bam-8776	38	12	and	and	CCONJ
bam-8776	38	13	breast	breast	NOUN
bam-8776	38	14	cancer	cancer	NOUN
bam-8776	38	15	relations	relation	NOUN
bam-8776	38	16	have	have	AUX
bam-8776	38	17	been	be	AUX
bam-8776	38	18	studied	study	VERB
bam-8776	38	19	.	.	PUNCT
bam-8776	39	1	leptin	leptin	NOUN
bam-8776	39	2	levels	level	NOUN
bam-8776	39	3	and	and	CCONJ
bam-8776	39	4	obesity	obesity	NOUN
bam-8776	39	5	levels	level	NOUN
bam-8776	39	6	have	have	VERB
bam-8776	39	7	positive	positive	ADJ
bam-8776	39	8	effect	effect	NOUN
bam-8776	39	9	on	on	ADP
bam-8776	39	10	each	each	DET
bam-8776	39	11	other	other	ADJ
bam-8776	39	12	,	,	PUNCT
bam-8776	39	13	while	while	SCONJ
bam-8776	39	14	lower	low	ADJ
bam-8776	39	15	leptin	leptin	NOUN
bam-8776	39	16	levels	level	NOUN
bam-8776	39	17	are	be	AUX
bam-8776	39	18	associated	associate	VERB
bam-8776	39	19	with	with	ADP
bam-8776	39	20	increased	increase	VERB
bam-8776	39	21	obesity	obesity	NOUN
bam-8776	39	22	.	.	PUNCT
bam-8776	40	1	one	one	NUM
bam-8776	40	2	study	study	NOUN
bam-8776	40	3	has	have	AUX
bam-8776	40	4	shown	show	VERB
bam-8776	40	5	that	that	SCONJ
bam-8776	40	6	leptin	leptin	NOUN
bam-8776	40	7	and	and	CCONJ
bam-8776	40	8	its	its	PRON
bam-8776	40	9	receptor	receptor	NOUN
bam-8776	40	10	expression	expression	NOUN
bam-8776	40	11	in	in	ADP
bam-8776	40	12	adipose	adipose	ADJ
bam-8776	40	13	tissue	tissue	NOUN
bam-8776	40	14	were	be	AUX
bam-8776	40	15	similar	similar	ADJ
bam-8776	40	16	to	to	ADP
bam-8776	40	17	that	that	PRON
bam-8776	40	18	of	of	ADP
bam-8776	40	19	obesity	obesity	NOUN
bam-8776	40	20	in	in	ADP
bam-8776	40	21	breast	breast	NOUN
bam-8776	40	22	cancer.54	cancer.54	PROPN
bam-8776	40	23	-	-	SYM
bam-8776	40	24	56	56	NUM
bam-8776	40	25	breast	breast	NOUN
bam-8776	40	26	cancer	cancer	NOUN
bam-8776	40	27	and	and	CCONJ
bam-8776	40	28	hypertension	hypertension	NOUN
bam-8776	40	29	recent	recent	ADJ
bam-8776	40	30	studies	study	NOUN
bam-8776	40	31	have	have	AUX
bam-8776	40	32	shown	show	VERB
bam-8776	40	33	that	that	SCONJ
bam-8776	40	34	increased	increase	VERB
bam-8776	40	35	blood	blood	NOUN
bam-8776	40	36	pressure	pressure	NOUN
bam-8776	40	37	(	(	PUNCT
bam-8776	40	38	hypertension	hypertension	NOUN
bam-8776	40	39	)	)	PUNCT
bam-8776	40	40	is	be	AUX
bam-8776	40	41	a	a	DET
bam-8776	40	42	risk	risk	NOUN
bam-8776	40	43	for	for	ADP
bam-8776	40	44	breast	breast	NOUN
bam-8776	40	45	cancer,24,57,58	cancer,24,57,58	NOUN
bam-8776	40	46	but	but	CCONJ
bam-8776	40	47	there	there	PRON
bam-8776	40	48	are	be	VERB
bam-8776	40	49	contradictory	contradictory	ADJ
bam-8776	40	50	findings.56,58,59	findings.56,58,59	NOUN
bam-8776	40	51	one	one	NUM
bam-8776	40	52	study	study	NOUN
bam-8776	40	53	found	find	VERB
bam-8776	40	54	that	that	SCONJ
bam-8776	40	55	diuretics	diuretic	NOUN
bam-8776	40	56	increased	increase	VERB
bam-8776	40	57	breast	breast	NOUN
bam-8776	40	58	cancer	cancer	NOUN
bam-8776	40	59	risk	risk	NOUN
bam-8776	40	60	in	in	ADP
bam-8776	40	61	hypertension.60	hypertension.60	PROPN
bam-8776	40	62	in	in	ADP
bam-8776	40	63	another	another	DET
bam-8776	40	64	study	study	NOUN
bam-8776	40	65	,	,	PUNCT
bam-8776	40	66	li	li	PROPN
bam-8776	40	67	ci	ci	PROPN
bam-8776	40	68	et	et	PROPN
bam-8776	40	69	al	al	PROPN
bam-8776	40	70	.	.	PROPN
bam-8776	40	71	claims	claim	VERB
bam-8776	40	72	that	that	SCONJ
bam-8776	40	73	there	there	PRON
bam-8776	40	74	was	be	VERB
bam-8776	40	75	low	low	ADJ
bam-8776	40	76	statistical	statistical	ADJ
bam-8776	40	77	correlation	correlation	NOUN
bam-8776	40	78	between	between	ADP
bam-8776	40	79	these	these	DET
bam-8776	40	80	two	two	NUM
bam-8776	40	81	events61	events61	NOUN
bam-8776	40	82	high	high	ADJ
bam-8776	40	83	blood	blood	NOUN
bam-8776	40	84	pressure	pressure	NOUN
bam-8776	40	85	during	during	ADP
bam-8776	40	86	pregnancy	pregnancy	NOUN
bam-8776	40	87	or	or	CCONJ
bam-8776	40	88	pre	pre	ADJ
bam-8776	40	89	-	-	ADJ
bam-8776	40	90	eclampsia	eclampsia	NOUN
bam-8776	40	91	seem	seem	VERB
bam-8776	40	92	to	to	PART
bam-8776	40	93	be	be	AUX
bam-8776	40	94	breast	breast	NOUN
bam-8776	40	95	cancer	cancer	NOUN
bam-8776	40	96	risks	risk	NOUN
bam-8776	40	97	,	,	PUNCT
bam-8776	40	98	but	but	CCONJ
bam-8776	40	99	another	another	DET
bam-8776	40	100	study	study	NOUN
bam-8776	40	101	found	find	VERB
bam-8776	40	102	that	that	SCONJ
bam-8776	40	103	that	that	DET
bam-8776	40	104	high	high	ADJ
bam-8776	40	105	blood	blood	NOUN
bam-8776	40	106	pressure	pressure	NOUN
bam-8776	40	107	(	(	PUNCT
bam-8776	40	108	pre	pre	ADJ
bam-8776	40	109	-	-	NOUN
bam-8776	40	110	eclampsia	eclampsia	NOUN
bam-8776	40	111	)	)	PUNCT
bam-8776	40	112	reduces	reduce	VERB
bam-8776	40	113	the	the	DET
bam-8776	40	114	chance	chance	NOUN
bam-8776	40	115	of	of	ADP
bam-8776	40	116	breast	breast	NOUN
bam-8776	40	117	cancer	cancer	NOUN
bam-8776	40	118	risk	risk	NOUN
bam-8776	40	119	of	of	ADP
bam-8776	40	120	20	20	NUM
bam-8776	40	121	-	-	SYM
bam-8776	40	122	30	30	NUM
bam-8776	40	123	%	%	NOUN
bam-8776	40	124	,	,	PUNCT
bam-8776	40	125	through	through	ADP
bam-8776	40	126	a	a	DET
bam-8776	40	127	lower	low	ADJ
bam-8776	40	128	concentration	concentration	NOUN
bam-8776	40	129	of	of	ADP
bam-8776	40	130	insulin	insulin	NOUN
bam-8776	40	131	-	-	PUNCT
bam-8776	40	132	like	like	ADJ
bam-8776	40	133	growth	growth	NOUN
bam-8776	40	134	factor	factor	NOUN
bam-8776	40	135	and	and	CCONJ
bam-8776	40	136	estrogen	estrogen	NOUN
bam-8776	40	137	and	and	CCONJ
bam-8776	40	138	a	a	DET
bam-8776	40	139	higher	high	ADJ
bam-8776	40	140	amount	amount	NOUN
bam-8776	40	141	of	of	ADP
bam-8776	40	142	androgens	androgen	NOUN
bam-8776	40	143	and	and	CCONJ
bam-8776	40	144	human	human	ADJ
bam-8776	40	145	chorionic	chorionic	ADJ
bam-8776	40	146	gonadotropin	gonadotropin	NOUN
bam-8776	40	147	in	in	ADP
bam-8776	40	148	women	woman	NOUN
bam-8776	40	149	with	with	ADP
bam-8776	40	150	pre	pre	ADJ
bam-8776	40	151	-	-	ADJ
bam-8776	40	152	eclampsia.62	eclampsia.62	ADJ
bam-8776	40	153	anyhow	anyhow	ADV
bam-8776	40	154	,	,	PUNCT
bam-8776	40	155	the	the	DET
bam-8776	40	156	relationship	relationship	NOUN
bam-8776	40	157	between	between	ADP
bam-8776	40	158	hypertension	hypertension	NOUN
bam-8776	40	159	,	,	PUNCT
bam-8776	40	160	utilization	utilization	NOUN
bam-8776	40	161	of	of	ADP
bam-8776	40	162	relevant	relevant	ADJ
bam-8776	40	163	drugs	drug	NOUN
bam-8776	40	164	and	and	CCONJ
bam-8776	40	165	breast	breast	NOUN
bam-8776	40	166	cancer	cancer	NOUN
bam-8776	40	167	continues	continue	VERB
bam-8776	40	168	to	to	PART
bam-8776	40	169	be	be	AUX
bam-8776	40	170	very	very	ADV
bam-8776	40	171	controversial	controversial	ADJ
bam-8776	40	172	.	.	PUNCT
bam-8776	41	1	table	table	NOUN
bam-8776	41	2	1	1	NUM
bam-8776	41	3	:	:	PUNCT
bam-8776	41	4	criteria	criterion	NOUN
bam-8776	41	5	for	for	ADP
bam-8776	41	6	clinical	clinical	ADJ
bam-8776	41	7	diagnosis	diagnosis	NOUN
bam-8776	41	8	of	of	ADP
bam-8776	41	9	metabolic	metabolic	ADJ
bam-8776	41	10	syndrome4	syndrome4	PROPN
bam-8776	41	11	measure	measure	NOUN
bam-8776	41	12	categorical	categorical	ADJ
bam-8776	41	13	cut	cut	NOUN
bam-8776	41	14	points	point	NOUN
bam-8776	41	15	elevated	elevate	VERB
bam-8776	41	16	waist	waist	NOUN
bam-8776	41	17	circumference	circumference	NOUN
bam-8776	41	18	populationand	populationand	VERB
bam-8776	41	19	country	country	NOUN
bam-8776	41	20	-	-	PUNCT
bam-8776	41	21	specific	specific	ADJ
bam-8776	41	22	definitions	definition	NOUN
bam-8776	41	23	elevated	elevate	VERB
bam-8776	41	24	triglycerides	triglyceride	NOUN
bam-8776	41	25	(	(	PUNCT
bam-8776	41	26	drug	drug	NOUN
bam-8776	41	27	treatment	treatment	NOUN
bam-8776	41	28	for	for	ADP
bam-8776	41	29	elevated	elevated	ADJ
bam-8776	41	30	triglycerides	triglyceride	NOUN
bam-8776	41	31	is	be	AUX
bam-8776	41	32	an	an	DET
bam-8776	41	33	alternate	alternate	ADJ
bam-8776	41	34	indicator	indicator	NOUN
bam-8776	41	35	)	)	PUNCT
bam-8776	42	1	≥150	≥150	NOUN
bam-8776	42	2	mg	mg	PROPN
bam-8776	42	3	/	/	SYM
bam-8776	42	4	dl	dl	PROPN
bam-8776	42	5	(	(	PUNCT
bam-8776	42	6	1.7	1.7	NUM
bam-8776	42	7	mmol	mmol	NOUN
bam-8776	42	8	/	/	SYM
bam-8776	42	9	l	l	NOUN
bam-8776	42	10	)	)	PUNCT
bam-8776	42	11	reduced	reduce	VERB
bam-8776	42	12	hdl	hdl	NOUN
bam-8776	42	13	-	-	PUNCT
bam-8776	42	14	cholesterol	cholesterol	NOUN
bam-8776	42	15	(	(	PUNCT
bam-8776	42	16	drug	drug	NOUN
bam-8776	42	17	treatment	treatment	NOUN
bam-8776	42	18	for	for	ADP
bam-8776	42	19	reduced	reduced	ADJ
bam-8776	42	20	hdlcholesterol	hdlcholesterol	NOUN
bam-8776	42	21	is	be	AUX
bam-8776	42	22	an	an	DET
bam-8776	42	23	alternate	alternate	ADJ
bam-8776	42	24	indicator	indicator	NOUN
bam-8776	42	25	)	)	PUNCT
bam-8776	42	26	≤40	≤40	ADJ
bam-8776	42	27	mg	mg	PROPN
bam-8776	42	28	/	/	SYM
bam-8776	42	29	dl	dl	PROPN
bam-8776	42	30	(	(	PUNCT
bam-8776	42	31	1.0	1.0	NUM
bam-8776	42	32	mmol	mmol	NOUN
bam-8776	42	33	/	/	SYM
bam-8776	42	34	l	l	NOUN
bam-8776	42	35	)	)	PUNCT
bam-8776	42	36	in	in	ADP
bam-8776	42	37	males	male	NOUN
bam-8776	42	38	;	;	PUNCT
bam-8776	42	39	≤	≤	NUM
bam-8776	42	40	50	50	NUM
bam-8776	42	41	mg	mg	PROPN
bam-8776	42	42	/	/	SYM
bam-8776	42	43	dl	dl	PROPN
bam-8776	42	44	(	(	PUNCT
bam-8776	42	45	1.3	1.3	NUM
bam-8776	42	46	mmol	mmol	NOUN
bam-8776	42	47	/	/	SYM
bam-8776	42	48	l	l	NOUN
bam-8776	42	49	)	)	PUNCT
bam-8776	42	50	in	in	ADP
bam-8776	42	51	females	female	NOUN
bam-8776	42	52	elevated	elevate	VERB
bam-8776	42	53	blood	blood	NOUN
bam-8776	42	54	pressure	pressure	NOUN
bam-8776	42	55	(	(	PUNCT
bam-8776	42	56	antihypertensive	antihypertensive	ADJ
bam-8776	42	57	drug	drug	NOUN
bam-8776	42	58	treatment	treatment	NOUN
bam-8776	42	59	in	in	ADP
bam-8776	42	60	a	a	DET
bam-8776	42	61	patient	patient	NOUN
bam-8776	42	62	with	with	ADP
bam-8776	42	63	a	a	DET
bam-8776	42	64	history	history	NOUN
bam-8776	42	65	of	of	ADP
bam-8776	42	66	hypertension	hypertension	NOUN
bam-8776	42	67	is	be	AUX
bam-8776	42	68	an	an	DET
bam-8776	42	69	alternate	alternate	ADJ
bam-8776	42	70	indicator	indicator	NOUN
bam-8776	42	71	)	)	PUNCT
bam-8776	42	72	systolic	systolic	ADJ
bam-8776	42	73	≥130	≥130	NOUN
bam-8776	42	74	and/or	and/or	CCONJ
bam-8776	42	75	diastolic	diastolic	VERB
bam-8776	42	76	≥85	≥85	NOUN
bam-8776	42	77	mm	mm	PROPN
bam-8776	42	78	hg	hg	NOUN
bam-8776	42	79	elevated	elevate	VERB
bam-8776	42	80	fasting	fasting	NOUN
bam-8776	42	81	glucose	glucose	NOUN
bam-8776	42	82	(	(	PUNCT
bam-8776	42	83	drug	drug	NOUN
bam-8776	42	84	treatment	treatment	NOUN
bam-8776	42	85	for	for	ADP
bam-8776	42	86	elevated	elevated	ADJ
bam-8776	42	87	glucose	glucose	NOUN
bam-8776	42	88	is	be	AUX
bam-8776	42	89	an	an	DET
bam-8776	42	90	alternate	alternate	ADJ
bam-8776	42	91	indicator	indicator	NOUN
bam-8776	42	92	)	)	PUNCT
bam-8776	42	93	≥	≥	NOUN
bam-8776	42	94	100	100	NUM
bam-8776	42	95	mg	mg	PROPN
bam-8776	42	96	/	/	SYM
bam-8776	42	97	dl	dl	PROPN
bam-8776	42	98	metabolic	metabolic	PROPN
bam-8776	42	99	syndrome	syndrome	PROPN
bam-8776	42	100	and	and	CCONJ
bam-8776	42	101	breast	breast	NOUN
bam-8776	42	102	cancer	cancer	NOUN
bam-8776	42	103	patients	patient	NOUN
bam-8776	42	104	eur	eur	PROPN
bam-8776	42	105	j	j	PROPN
bam-8776	42	106	transl	transl	PROPN
bam-8776	42	107	myol	myol	ADV
bam-8776	42	108	30	30	NUM
bam-8776	42	109	(	(	PUNCT
bam-8776	42	110	3	3	NUM
bam-8776	42	111	):	):	PUNCT
bam-8776	42	112	xx1	xx1	PROPN
bam-8776	42	113	-	-	PUNCT
bam-8776	42	114	xx7	xx7	PROPN
bam-8776	42	115	,	,	PUNCT
bam-8776	42	116	2020	2020	NUM
bam-8776	42	117	3	3	NUM
bam-8776	42	118	breast	breast	NOUN
bam-8776	42	119	cancer	cancer	NOUN
bam-8776	42	120	and	and	CCONJ
bam-8776	42	121	dyslipidemia	dyslipidemia	NOUN
bam-8776	42	122	dyslipidemia	dyslipidemia	NOUN
bam-8776	42	123	is	be	AUX
bam-8776	42	124	another	another	DET
bam-8776	42	125	widely	widely	ADV
bam-8776	42	126	discussed	discuss	VERB
bam-8776	42	127	risk	risk	NOUN
bam-8776	42	128	factor	factor	NOUN
bam-8776	42	129	.	.	PUNCT
bam-8776	43	1	low	low	ADJ
bam-8776	43	2	hdl	hdl	PROPN
bam-8776	43	3	-	-	PUNCT
bam-8776	43	4	cholesterol	cholesterol	NOUN
bam-8776	43	5	is	be	AUX
bam-8776	43	6	a	a	DET
bam-8776	43	7	risk	risk	NOUN
bam-8776	43	8	factor	factor	NOUN
bam-8776	43	9	for	for	ADP
bam-8776	43	10	cardiovascular	cardiovascular	ADJ
bam-8776	43	11	illness	illness	NOUN
bam-8776	43	12	,	,	PUNCT
bam-8776	43	13	but	but	CCONJ
bam-8776	43	14	may	may	AUX
bam-8776	43	15	cause	cause	VERB
bam-8776	43	16	cancer	cancer	NOUN
bam-8776	43	17	in	in	ADP
bam-8776	43	18	other	other	ADJ
bam-8776	43	19	parts	part	NOUN
bam-8776	43	20	of	of	ADP
bam-8776	43	21	the	the	DET
bam-8776	43	22	body,63	body,63	ADJ
bam-8776	43	23	but	but	CCONJ
bam-8776	43	24	because	because	SCONJ
bam-8776	43	25	of	of	ADP
bam-8776	43	26	differences	difference	NOUN
bam-8776	43	27	in	in	ADP
bam-8776	43	28	the	the	DET
bam-8776	43	29	populations	population	NOUN
bam-8776	43	30	and	and	CCONJ
bam-8776	43	31	methods	method	NOUN
bam-8776	43	32	of	of	ADP
bam-8776	43	33	analysis	analysis	NOUN
bam-8776	43	34	,	,	PUNCT
bam-8776	43	35	conclusions	conclusion	NOUN
bam-8776	43	36	are	be	AUX
bam-8776	43	37	mixed.64	mixed.64	NOUN
bam-8776	43	38	-	-	SYM
bam-8776	43	39	66	66	NUM
bam-8776	43	40	kim	kim	PROPN
bam-8776	43	41	et	et	PROPN
bam-8776	43	42	al	al	PROPN
bam-8776	43	43	.	.	PROPN
bam-8776	43	44	have	have	AUX
bam-8776	43	45	shown	show	VERB
bam-8776	43	46	that	that	SCONJ
bam-8776	43	47	hdl	hdl	PROPN
bam-8776	43	48	has	have	VERB
bam-8776	43	49	a	a	DET
bam-8776	43	50	protective	protective	ADJ
bam-8776	43	51	effect	effect	NOUN
bam-8776	43	52	on	on	ADP
bam-8776	43	53	some	some	DET
bam-8776	43	54	postmenopausal	postmenopausal	ADJ
bam-8776	43	55	women	woman	NOUN
bam-8776	43	56	with	with	ADP
bam-8776	43	57	breast	breast	NOUN
bam-8776	43	58	cancer,67	cancer,67	NOUN
bam-8776	43	59	but	but	CCONJ
bam-8776	43	60	kucharska	kucharska	VERB
bam-8776	43	61	et	et	PROPN
bam-8776	43	62	al	al	PROPN
bam-8776	43	63	.	.	PROPN
bam-8776	44	1	in	in	ADP
bam-8776	44	2	a	a	DET
bam-8776	44	3	prospective	prospective	ADJ
bam-8776	44	4	study	study	NOUN
bam-8776	44	5	of	of	ADP
bam-8776	44	6	15.792	15.792	NUM
bam-8776	44	7	men	man	NOUN
bam-8776	44	8	and	and	CCONJ
bam-8776	44	9	women	woman	NOUN
bam-8776	44	10	found	find	VERB
bam-8776	44	11	that	that	SCONJ
bam-8776	44	12	there	there	PRON
bam-8776	44	13	was	be	VERB
bam-8776	44	14	only	only	ADV
bam-8776	44	15	a	a	DET
bam-8776	44	16	moderate	moderate	ADJ
bam-8776	44	17	dependence	dependence	NOUN
bam-8776	44	18	of	of	ADP
bam-8776	44	19	breast	breast	NOUN
bam-8776	44	20	cancer	cancer	NOUN
bam-8776	44	21	increased	increase	VERB
bam-8776	44	22	risk	risk	NOUN
bam-8776	44	23	and	and	CCONJ
bam-8776	44	24	low	low	ADJ
bam-8776	44	25	premenopausal	premenopausal	ADJ
bam-8776	44	26	hdl	hdl	NOUN
bam-8776	44	27	-	-	PUNCT
bam-8776	44	28	cholesterol	cholesterol	NOUN
bam-8776	44	29	free	free	ADJ
bam-8776	44	30	,	,	PUNCT
bam-8776	44	31	number	number	NOUN
bam-8776	44	32	of	of	ADP
bam-8776	44	33	live	live	ADJ
bam-8776	44	34	births	birth	NOUN
bam-8776	44	35	,	,	PUNCT
bam-8776	44	36	race	race	NOUN
bam-8776	44	37	,	,	PUNCT
bam-8776	44	38	age	age	NOUN
bam-8776	44	39	,	,	PUNCT
bam-8776	44	40	age	age	NOUN
bam-8776	44	41	at	at	ADP
bam-8776	44	42	menarche	menarche	NOUN
bam-8776	44	43	,	,	PUNCT
bam-8776	44	44	smoking	smoking	NOUN
bam-8776	44	45	status	status	NOUN
bam-8776	44	46	and	and	CCONJ
bam-8776	44	47	bmi.68	bmi.68	VERB
bam-8776	44	48	all	all	DET
bam-8776	44	49	cancer	cancer	NOUN
bam-8776	44	50	cells	cell	NOUN
bam-8776	44	51	need	need	VERB
bam-8776	44	52	fatty	fatty	NOUN
bam-8776	44	53	acids	acid	NOUN
bam-8776	44	54	(	(	PUNCT
bam-8776	44	55	fa	fa	NOUN
bam-8776	44	56	)	)	PUNCT
bam-8776	44	57	to	to	PART
bam-8776	44	58	grow	grow	VERB
bam-8776	44	59	and	and	CCONJ
bam-8776	44	60	survive	survive	VERB
bam-8776	44	61	and	and	CCONJ
bam-8776	44	62	obstruction	obstruction	NOUN
bam-8776	44	63	of	of	ADP
bam-8776	44	64	de	de	X
bam-8776	44	65	novo	novo	PROPN
bam-8776	44	66	fa	fa	PROPN
bam-8776	44	67	synthesis	synthesis	NOUN
bam-8776	44	68	in	in	ADP
bam-8776	44	69	rat	rat	NOUN
bam-8776	44	70	models	model	NOUN
bam-8776	44	71	has	have	AUX
bam-8776	44	72	resulted	result	VERB
bam-8776	44	73	in	in	ADP
bam-8776	44	74	anticancer	anticancer	NOUN
bam-8776	44	75	effects.56	effects.56	ADJ
bam-8776	44	76	in	in	ADP
bam-8776	44	77	summary	summary	NOUN
bam-8776	44	78	,	,	PUNCT
bam-8776	44	79	lipids	lipid	NOUN
bam-8776	44	80	and	and	CCONJ
bam-8776	44	81	lipoproteins	lipoprotein	NOUN
bam-8776	44	82	have	have	VERB
bam-8776	44	83	an	an	DET
bam-8776	44	84	impact	impact	NOUN
bam-8776	44	85	on	on	ADP
bam-8776	44	86	cardiovascular	cardiovascular	ADJ
bam-8776	44	87	disease	disease	NOUN
bam-8776	44	88	and	and	CCONJ
bam-8776	44	89	may	may	AUX
bam-8776	44	90	have	have	VERB
bam-8776	44	91	also	also	ADV
bam-8776	44	92	an	an	DET
bam-8776	44	93	impact	impact	NOUN
bam-8776	44	94	in	in	ADP
bam-8776	44	95	breast	breast	NOUN
bam-8776	44	96	cancer	cancer	NOUN
bam-8776	44	97	being	be	AUX
bam-8776	44	98	active	active	ADJ
bam-8776	44	99	molecules	molecule	NOUN
bam-8776	44	100	with	with	ADP
bam-8776	44	101	high	high	ADJ
bam-8776	44	102	effects	effect	NOUN
bam-8776	44	103	rather	rather	ADV
bam-8776	44	104	than	than	ADP
bam-8776	44	105	idle	idle	ADJ
bam-8776	44	106	means	mean	NOUN
bam-8776	44	107	of	of	ADP
bam-8776	44	108	energy	energy	NOUN
bam-8776	44	109	storage	storage	NOUN
bam-8776	44	110	.	.	PUNCT
bam-8776	45	1	changes	change	NOUN
bam-8776	45	2	in	in	ADP
bam-8776	45	3	lifestyle	lifestyle	NOUN
bam-8776	45	4	,	,	PUNCT
bam-8776	45	5	as	as	SCONJ
bam-8776	45	6	advised	advise	VERB
bam-8776	45	7	for	for	ADP
bam-8776	45	8	cardiovascular	cardiovascular	ADJ
bam-8776	45	9	disease	disease	NOUN
bam-8776	45	10	prevention	prevention	NOUN
bam-8776	45	11	,	,	PUNCT
bam-8776	45	12	may	may	AUX
bam-8776	45	13	be	be	AUX
bam-8776	45	14	important	important	ADJ
bam-8776	45	15	to	to	PART
bam-8776	45	16	prevent	prevent	VERB
bam-8776	45	17	also	also	ADV
bam-8776	45	18	breast	breast	NOUN
bam-8776	45	19	cancer	cancer	NOUN
bam-8776	45	20	deaths	death	NOUN
bam-8776	45	21	.	.	PUNCT
bam-8776	46	1	breast	breast	NOUN
bam-8776	46	2	cancer	cancer	NOUN
bam-8776	46	3	and	and	CCONJ
bam-8776	46	4	metabolic	metabolic	NOUN
bam-8776	46	5	syndrome	syndrome	NOUN
bam-8776	46	6	ms	ms	PROPN
bam-8776	46	7	is	be	AUX
bam-8776	46	8	a	a	DET
bam-8776	46	9	mixture	mixture	NOUN
bam-8776	46	10	of	of	ADP
bam-8776	46	11	metabolic	metabolic	NOUN
bam-8776	46	12	disturbances	disturbance	NOUN
bam-8776	46	13	such	such	ADJ
bam-8776	46	14	as	as	ADP
bam-8776	46	15	insulin	insulin	NOUN
bam-8776	46	16	resistance	resistance	NOUN
bam-8776	46	17	,	,	PUNCT
bam-8776	46	18	dyslipidemia	dyslipidemia	NOUN
bam-8776	46	19	,	,	PUNCT
bam-8776	46	20	hypertension	hypertension	NOUN
bam-8776	46	21	,	,	PUNCT
bam-8776	46	22	visceral	visceral	ADJ
bam-8776	46	23	obesity	obesity	NOUN
bam-8776	46	24	,	,	PUNCT
bam-8776	46	25	and	and	CCONJ
bam-8776	46	26	raised	raise	VERB
bam-8776	46	27	blood	blood	NOUN
bam-8776	46	28	sugar	sugar	NOUN
bam-8776	46	29	.	.	PUNCT
bam-8776	47	1	as	as	ADP
bam-8776	47	2	a	a	DET
bam-8776	47	3	unique	unique	ADJ
bam-8776	47	4	medical	medical	ADJ
bam-8776	47	5	risk	risk	NOUN
bam-8776	47	6	,	,	PUNCT
bam-8776	47	7	ms	ms	PROPN
bam-8776	47	8	has	have	AUX
bam-8776	47	9	been	be	AUX
bam-8776	47	10	studied	study	VERB
bam-8776	47	11	with	with	ADP
bam-8776	47	12	breast	breast	NOUN
bam-8776	47	13	cancer.56,69	cancer.56,69	NOUN
bam-8776	47	14	-	-	PUNCT
bam-8776	47	15	71	71	NUM
bam-8776	47	16	the	the	DET
bam-8776	47	17	odds	odd	NOUN
bam-8776	47	18	ratios	ratio	NOUN
bam-8776	47	19	of	of	ADP
bam-8776	47	20	breast	breast	NOUN
bam-8776	47	21	cancer	cancer	NOUN
bam-8776	47	22	after	after	SCONJ
bam-8776	47	23	menopausal	menopausal	NOUN
bam-8776	47	24	were	be	AUX
bam-8776	47	25	1.33	1.33	NUM
bam-8776	47	26	(	(	PUNCT
bam-8776	47	27	95	95	NUM
bam-8776	47	28	%	%	NOUN
bam-8776	47	29	ci	ci	NOUN
bam-8776	47	30	1.091.62	1.091.62	NUM
bam-8776	47	31	)	)	PUNCT
bam-8776	47	32	to	to	ADP
bam-8776	47	33	diabetes	diabetes	NOUN
bam-8776	47	34	,	,	PUNCT
bam-8776	47	35	1.19	1.19	NUM
bam-8776	47	36	(	(	PUNCT
bam-8776	47	37	95	95	NUM
bam-8776	47	38	%	%	NOUN
bam-8776	47	39	ci	ci	NOUN
bam-8776	47	40	1.07	1.07	NUM
bam-8776	47	41	-	-	SYM
bam-8776	47	42	1.33	1.33	NUM
bam-8776	47	43	)	)	PUNCT
bam-8776	47	44	to	to	ADP
bam-8776	47	45	hypertension	hypertension	NOUN
bam-8776	47	46	,	,	PUNCT
bam-8776	47	47	1.08	1.08	NUM
bam-8776	47	48	(	(	PUNCT
bam-8776	47	49	95	95	NUM
bam-8776	47	50	%	%	NOUN
bam-8776	47	51	ci	ci	NOUN
bam-8776	47	52	0.95	0.95	NUM
bam-8776	47	53	-	-	PUNCT
bam-8776	47	54	1.22	1.22	NUM
bam-8776	47	55	)	)	PUNCT
bam-8776	47	56	to	to	ADP
bam-8776	47	57	hyperlipidemia	hyperlipidemia	NOUN
bam-8776	47	58	,	,	PUNCT
bam-8776	47	59	1.26	1.26	NUM
bam-8776	47	60	(	(	PUNCT
bam-8776	47	61	95	95	NUM
bam-8776	47	62	%	%	NOUN
bam-8776	47	63	ci	ci	NOUN
bam-8776	47	64	1.11	1.11	NUM
bam-8776	47	65	-	-	SYM
bam-8776	47	66	1.44	1.44	NUM
bam-8776	47	67	)	)	PUNCT
bam-8776	47	68	to	to	PART
bam-8776	47	69	bmi	bmi	VERB
bam-8776	47	70	≥30	≥30	PROPN
bam-8776	47	71	kg	kg	PROPN
bam-8776	47	72	/	/	SYM
bam-8776	47	73	m2	m2	PROPN
bam-8776	47	74	,	,	PUNCT
bam-8776	47	75	and	and	CCONJ
bam-8776	47	76	1.22	1.22	NUM
bam-8776	47	77	(	(	PUNCT
bam-8776	47	78	95	95	NUM
bam-8776	47	79	%	%	NOUN
bam-8776	47	80	ci	ci	NOUN
bam-8776	47	81	1.09	1.09	NUM
bam-8776	47	82	-	-	SYM
bam-8776	47	83	1.36	1.36	NUM
bam-8776	47	84	)	)	PUNCT
bam-8776	47	85	to	to	ADP
bam-8776	47	86	waist	waist	NOUN
bam-8776	47	87	perimeter	perimeter	NOUN
bam-8776	47	88	≥88	≥88	PROPN
bam-8776	47	89	cm	cm	NOUN
bam-8776	47	90	.	.	PUNCT
bam-8776	48	1	in	in	ADP
bam-8776	48	2	women	woman	NOUN
bam-8776	48	3	with	with	ADP
bam-8776	48	4	metabolic	metabolic	NOUN
bam-8776	48	5	syndrome	syndrome	NOUN
bam-8776	48	6	,	,	PUNCT
bam-8776	48	7	the	the	DET
bam-8776	48	8	risk	risk	NOUN
bam-8776	48	9	of	of	ADP
bam-8776	48	10	breast	breast	NOUN
bam-8776	48	11	cancer	cancer	NOUN
bam-8776	48	12	after	after	ADP
bam-8776	48	13	menopausal	menopausal	NOUN
bam-8776	48	14	is	be	AUX
bam-8776	48	15	significantly	significantly	ADV
bam-8776	48	16	increased	increase	VERB
bam-8776	48	17	(	(	PUNCT
bam-8776	48	18	or	or	CCONJ
bam-8776	48	19	1.75	1.75	NUM
bam-8776	48	20	,	,	PUNCT
bam-8776	48	21	95	95	NUM
bam-8776	48	22	%	%	NOUN
bam-8776	48	23	ci	ci	NOUN
bam-8776	48	24	1.37	1.37	NUM
bam-8776	48	25	-	-	SYM
bam-8776	48	26	2.22	2.22	NUM
bam-8776	48	27	)	)	PUNCT
bam-8776	48	28	,	,	PUNCT
bam-8776	48	29	which	which	PRON
bam-8776	48	30	is	be	AUX
bam-8776	48	31	higher	high	ADJ
bam-8776	48	32	at	at	ADP
bam-8776	48	33	an	an	DET
bam-8776	48	34	older	old	ADJ
bam-8776	48	35	age	age	NOUN
bam-8776	48	36	(	(	PUNCT
bam-8776	48	37	or	or	CCONJ
bam-8776	48	38	3.04	3.04	NUM
bam-8776	48	39	,	,	PUNCT
bam-8776	48	40	95	95	NUM
bam-8776	48	41	%	%	NOUN
bam-8776	48	42	ci	ci	NOUN
bam-8776	48	43	1.75	1.75	NUM
bam-8776	48	44	-	-	SYM
bam-8776	48	45	5.29	5.29	NUM
bam-8776	48	46	,	,	PUNCT
bam-8776	48	47	at	at	SCONJ
bam-8776	48	48	age	age	NOUN
bam-8776	48	49	≥70	≥70	NOUN
bam-8776	48	50	years).5	years).5	PROPN
bam-8776	48	51	metabolic	metabolic	PROPN
bam-8776	48	52	syndrome	syndrome	PROPN
bam-8776	48	53	presents	present	VERB
bam-8776	48	54	many	many	ADJ
bam-8776	48	55	changes	change	NOUN
bam-8776	48	56	in	in	ADP
bam-8776	48	57	the	the	DET
bam-8776	48	58	body	body	NOUN
bam-8776	48	59	's	's	PART
bam-8776	48	60	metabolism	metabolism	NOUN
bam-8776	48	61	.	.	PUNCT
bam-8776	49	1	below	below	ADV
bam-8776	49	2	,	,	PUNCT
bam-8776	49	3	we	we	PRON
bam-8776	49	4	examine	examine	VERB
bam-8776	49	5	the	the	DET
bam-8776	49	6	possible	possible	ADJ
bam-8776	49	7	mechanisms	mechanism	NOUN
bam-8776	49	8	increasing	increase	VERB
bam-8776	49	9	the	the	DET
bam-8776	49	10	risk	risk	NOUN
bam-8776	49	11	of	of	ADP
bam-8776	49	12	breast	breast	NOUN
bam-8776	49	13	cancer	cancer	NOUN
bam-8776	49	14	.	.	PUNCT
bam-8776	50	1	one	one	NUM
bam-8776	50	2	of	of	ADP
bam-8776	50	3	the	the	DET
bam-8776	50	4	molecules	molecule	NOUN
bam-8776	50	5	presumed	presume	VERB
bam-8776	50	6	to	to	PART
bam-8776	50	7	mediated	mediate	VERB
bam-8776	50	8	the	the	DET
bam-8776	50	9	metabolic	metabolic	NOUN
bam-8776	50	10	syndrome	syndrome	NOUN
bam-8776	50	11	risk	risk	NOUN
bam-8776	50	12	is	be	AUX
bam-8776	50	13	the	the	DET
bam-8776	50	14	plasminogen	plasminogen	NOUN
bam-8776	50	15	activator	activator	NOUN
bam-8776	50	16	inhibitor-1	inhibitor-1	NUM
bam-8776	50	17	(	(	PUNCT
bam-8776	50	18	pai-1	pai-1	NUM
bam-8776	50	19	)	)	PUNCT
bam-8776	50	20	.	.	PUNCT
bam-8776	51	1	this	this	DET
bam-8776	51	2	protein	protein	NOUN
bam-8776	51	3	is	be	AUX
bam-8776	51	4	known	know	VERB
bam-8776	51	5	as	as	ADP
bam-8776	51	6	a	a	DET
bam-8776	51	7	physiological	physiological	ADJ
bam-8776	51	8	inhibitor	inhibitor	NOUN
bam-8776	51	9	of	of	ADP
bam-8776	51	10	urokinase	urokinase	NOUN
bam-8776	51	11	(	(	PUNCT
bam-8776	51	12	upa	upa	NOUN
bam-8776	51	13	)	)	PUNCT
bam-8776	51	14	.	.	PUNCT
bam-8776	52	1	on	on	ADP
bam-8776	52	2	the	the	DET
bam-8776	52	3	other	other	ADJ
bam-8776	52	4	hand	hand	NOUN
bam-8776	52	5	,	,	PUNCT
bam-8776	52	6	increased	increase	VERB
bam-8776	52	7	levels	level	NOUN
bam-8776	52	8	of	of	ADP
bam-8776	52	9	pai-1	pai-1	PRON
bam-8776	52	10	are	be	AUX
bam-8776	52	11	paradoxically	paradoxically	ADV
bam-8776	52	12	associated	associate	VERB
bam-8776	52	13	with	with	ADP
bam-8776	52	14	poor	poor	ADJ
bam-8776	52	15	prognosis	prognosis	NOUN
bam-8776	52	16	in	in	ADP
bam-8776	52	17	breast	breast	NOUN
bam-8776	52	18	cancer.72	cancer.72	NOUN
bam-8776	52	19	in	in	ADP
bam-8776	52	20	fact	fact	NOUN
bam-8776	52	21	,	,	PUNCT
bam-8776	52	22	stern	stern	PROPN
bam-8776	52	23	introduced	introduce	VERB
bam-8776	52	24	the	the	DET
bam-8776	52	25	hypothesis	hypothesis	NOUN
bam-8776	52	26	of	of	ADP
bam-8776	52	27	a	a	DET
bam-8776	52	28	"	"	PUNCT
bam-8776	52	29	common	common	ADJ
bam-8776	52	30	soil	soil	NOUN
bam-8776	52	31	"	"	PUNCT
bam-8776	52	32	affected	affect	VERB
bam-8776	52	33	by	by	ADP
bam-8776	52	34	metabolic	metabolic	NOUN
bam-8776	52	35	syndrome	syndrome	NOUN
bam-8776	52	36	,	,	PUNCT
bam-8776	52	37	defined	define	VERB
bam-8776	52	38	as	as	ADP
bam-8776	52	39	chronic	chronic	ADJ
bam-8776	52	40	inflammation	inflammation	NOUN
bam-8776	52	41	and	and	CCONJ
bam-8776	52	42	insulin	insulin	NOUN
bam-8776	52	43	resistance	resistance	NOUN
bam-8776	52	44	,	,	PUNCT
bam-8776	52	45	that	that	PRON
bam-8776	52	46	is	be	AUX
bam-8776	52	47	suspected	suspect	VERB
bam-8776	52	48	to	to	PART
bam-8776	52	49	be	be	AUX
bam-8776	52	50	related	relate	VERB
bam-8776	52	51	to	to	ADP
bam-8776	52	52	breast	breast	NOUN
bam-8776	52	53	cancer.73	cancer.73	NOUN
bam-8776	52	54	further	further	ADJ
bam-8776	52	55	evidence	evidence	NOUN
bam-8776	52	56	is	be	AUX
bam-8776	52	57	presented	present	VERB
bam-8776	52	58	in	in	ADP
bam-8776	52	59	figure	figure	NOUN
bam-8776	52	60	1.27	1.27	NUM
bam-8776	52	61	the	the	DET
bam-8776	52	62	reason	reason	NOUN
bam-8776	52	63	for	for	ADP
bam-8776	52	64	high	high	ADJ
bam-8776	52	65	levels	level	NOUN
bam-8776	52	66	of	of	ADP
bam-8776	52	67	insulin	insulin	NOUN
bam-8776	52	68	in	in	ADP
bam-8776	52	69	cancer	cancer	NOUN
bam-8776	52	70	progression	progression	NOUN
bam-8776	52	71	,	,	PUNCT
bam-8776	52	72	as	as	ADV
bam-8776	52	73	well	well	ADV
bam-8776	52	74	as	as	ADP
bam-8776	52	75	mortality	mortality	NOUN
bam-8776	52	76	,	,	PUNCT
bam-8776	52	77	is	be	AUX
bam-8776	52	78	that	that	SCONJ
bam-8776	52	79	insulin	insulin	NOUN
bam-8776	52	80	appears	appear	VERB
bam-8776	52	81	to	to	PART
bam-8776	52	82	have	have	VERB
bam-8776	52	83	mitogenic	mitogenic	ADJ
bam-8776	52	84	,	,	PUNCT
bam-8776	52	85	anti	anti	ADJ
bam-8776	52	86	-	-	ADJ
bam-8776	52	87	apoptotic	apoptotic	ADJ
bam-8776	52	88	and	and	CCONJ
bam-8776	52	89	angiogenic	angiogenic	ADJ
bam-8776	52	90	properties.74	properties.74	NOUN
bam-8776	52	91	moreover	moreover	ADV
bam-8776	52	92	,	,	PUNCT
bam-8776	52	93	researchers	researcher	NOUN
bam-8776	52	94	have	have	AUX
bam-8776	52	95	found	find	VERB
bam-8776	52	96	insulin	insulin	NOUN
bam-8776	52	97	to	to	PART
bam-8776	52	98	incite	incite	VERB
bam-8776	52	99	the	the	DET
bam-8776	52	100	synthesis	synthesis	NOUN
bam-8776	52	101	of	of	ADP
bam-8776	52	102	insulin	insulin	NOUN
bam-8776	52	103	-	-	PUNCT
bam-8776	52	104	like	like	ADJ
bam-8776	52	105	growth	growth	NOUN
bam-8776	52	106	factor	factor	NOUN
bam-8776	52	107	1	1	NUM
bam-8776	52	108	(	(	PUNCT
bam-8776	52	109	igf1	igf1	PROPN
bam-8776	52	110	)	)	PUNCT
bam-8776	52	111	and	and	CCONJ
bam-8776	52	112	to	to	ADP
bam-8776	52	113	poor	poor	ADJ
bam-8776	52	114	link	link	NOUN
bam-8776	52	115	to	to	ADP
bam-8776	52	116	the	the	DET
bam-8776	52	117	igf-1	igf-1	NOUN
bam-8776	52	118	receptor	receptor	NOUN
bam-8776	52	119	.	.	PUNCT
bam-8776	53	1	commonly	commonly	ADV
bam-8776	53	2	,	,	PUNCT
bam-8776	53	3	insulin	insulin	NOUN
bam-8776	53	4	-	-	PUNCT
bam-8776	53	5	igf-1	igf-1	NOUN
bam-8776	53	6	signaling	signal	VERB
bam-8776	53	7	is	be	AUX
bam-8776	53	8	up	up	ADV
bam-8776	53	9	-	-	PUNCT
bam-8776	53	10	regulated	regulate	VERB
bam-8776	53	11	in	in	ADP
bam-8776	53	12	tumor	tumor	NOUN
bam-8776	53	13	cells	cell	NOUN
bam-8776	53	14	,	,	PUNCT
bam-8776	53	15	as	as	SCONJ
bam-8776	53	16	it	it	PRON
bam-8776	53	17	is	be	AUX
bam-8776	53	18	up	up	ADV
bam-8776	53	19	-	-	PUNCT
bam-8776	53	20	regulated	regulate	VERB
bam-8776	53	21	in	in	ADP
bam-8776	53	22	obesity	obesity	NOUN
bam-8776	53	23	,	,	PUNCT
bam-8776	53	24	leading	lead	VERB
bam-8776	53	25	to	to	ADP
bam-8776	53	26	activation	activation	NOUN
bam-8776	53	27	of	of	ADP
bam-8776	53	28	the	the	DET
bam-8776	53	29	oncogenic	oncogenic	ADJ
bam-8776	53	30	ras	ras	NOUN
bam-8776	53	31	-	-	NOUN
bam-8776	53	32	mapk	mapk	NOUN
bam-8776	53	33	and	and	CCONJ
bam-8776	53	34	pi3k	pi3k	PROPN
bam-8776	53	35	-	-	PUNCT
bam-8776	53	36	akt	akt	PROPN
bam-8776	53	37	pathways	pathway	NOUN
bam-8776	53	38	(	(	PUNCT
bam-8776	53	39	mapk	mapk	PROPN
bam-8776	53	40	mitogen	mitogen	NOUN
bam-8776	53	41	-	-	PUNCT
bam-8776	53	42	activated	activate	VERB
bam-8776	53	43	protein	protein	NOUN
bam-8776	53	44	kinase	kinase	NOUN
bam-8776	53	45	,	,	PUNCT
bam-8776	53	46	pi3k	pi3k	PROPN
bam-8776	53	47	phosphoinositide	phosphoinositide	NOUN
bam-8776	53	48	3	3	NUM
bam-8776	53	49	-	-	PUNCT
bam-8776	53	50	kinase	kinase	NOUN
bam-8776	53	51	)	)	PUNCT
bam-8776	53	52	.	.	PUNCT
bam-8776	54	1	additional	additional	ADJ
bam-8776	54	2	,	,	PUNCT
bam-8776	54	3	the	the	DET
bam-8776	54	4	akt	akt	PROPN
bam-8776	54	5	pathway	pathway	NOUN
bam-8776	54	6	stimulates	stimulate	VERB
bam-8776	54	7	the	the	DET
bam-8776	54	8	rapamycin	rapamycin	NOUN
bam-8776	54	9	mammalian	mammalian	ADJ
bam-8776	54	10	target	target	NOUN
bam-8776	54	11	rapamycin	rapamycin	NOUN
bam-8776	54	12	(	(	PUNCT
bam-8776	54	13	mtor	mtor	PROPN
bam-8776	54	14	)	)	PUNCT
bam-8776	54	15	,	,	PUNCT
bam-8776	54	16	all	all	DET
bam-8776	54	17	together	together	ADV
bam-8776	54	18	known	know	VERB
bam-8776	54	19	mechanisms	mechanism	NOUN
bam-8776	54	20	of	of	ADP
bam-8776	54	21	the	the	DET
bam-8776	54	22	tumor	tumor	NOUN
bam-8776	54	23	cell	cell	NOUN
bam-8776	54	24	growth.27,75	growth.27,75	NOUN
bam-8776	54	25	in	in	ADP
bam-8776	54	26	breast	breast	NOUN
bam-8776	54	27	cancer	cancer	NOUN
bam-8776	54	28	,	,	PUNCT
bam-8776	54	29	adipose	adipose	ADJ
bam-8776	54	30	tissue	tissue	NOUN
bam-8776	54	31	is	be	AUX
bam-8776	54	32	a	a	DET
bam-8776	54	33	major	major	ADJ
bam-8776	54	34	part	part	NOUN
bam-8776	54	35	of	of	ADP
bam-8776	54	36	the	the	DET
bam-8776	54	37	tumor	tumor	NOUN
bam-8776	54	38	.	.	PUNCT
bam-8776	55	1	due	due	ADP
bam-8776	55	2	to	to	ADP
bam-8776	55	3	the	the	DET
bam-8776	55	4	interaction	interaction	NOUN
bam-8776	55	5	between	between	ADP
bam-8776	55	6	cancer	cancer	NOUN
bam-8776	55	7	cells	cell	NOUN
bam-8776	55	8	and	and	CCONJ
bam-8776	55	9	the	the	DET
bam-8776	55	10	adipose	adipose	NOUN
bam-8776	55	11	surrounding	surround	VERB
bam-8776	55	12	fat	fat	NOUN
bam-8776	55	13	,	,	PUNCT
bam-8776	55	14	it	it	PRON
bam-8776	55	15	is	be	AUX
bam-8776	55	16	known	know	VERB
bam-8776	55	17	as	as	ADP
bam-8776	55	18	cancer	cancer	NOUN
bam-8776	55	19	-	-	PUNCT
bam-8776	55	20	associated	associate	VERB
bam-8776	55	21	fat	fat	NOUN
bam-8776	55	22	(	(	PUNCT
bam-8776	55	23	caa	caa	NOUN
bam-8776	55	24	)	)	PUNCT
bam-8776	55	25	that	that	SCONJ
bam-8776	55	26	by	by	ADP
bam-8776	55	27	its	its	PRON
bam-8776	55	28	own	own	ADJ
bam-8776	55	29	secretion	secretion	NOUN
bam-8776	55	30	sustain	sustain	VERB
bam-8776	55	31	tumor	tumor	PROPN
bam-8776	55	32	growth.27	growth.27	PROPN
bam-8776	55	33	direct	direct	ADJ
bam-8776	55	34	contact	contact	NOUN
bam-8776	55	35	of	of	ADP
bam-8776	55	36	these	these	DET
bam-8776	55	37	two	two	NUM
bam-8776	55	38	cells	cell	NOUN
bam-8776	55	39	destroys	destroy	VERB
bam-8776	55	40	differentiation	differentiation	NOUN
bam-8776	55	41	markers	marker	NOUN
bam-8776	55	42	and	and	CCONJ
bam-8776	55	43	enhances	enhance	VERB
bam-8776	55	44	expression	expression	NOUN
bam-8776	55	45	of	of	ADP
bam-8776	55	46	inflammatory	inflammatory	ADJ
bam-8776	55	47	cytokines	cytokine	NOUN
bam-8776	55	48	including	include	VERB
bam-8776	55	49	il-6	il-6	PRON
bam-8776	55	50	and	and	CCONJ
bam-8776	55	51	plasminogen	plasminogen	NOUN
bam-8776	55	52	activator	activator	NOUN
bam-8776	55	53	type	type	NOUN
bam-8776	55	54	1	1	NUM
bam-8776	55	55	inhibitor	inhibitor	NOUN
bam-8776	55	56	(	(	PUNCT
bam-8776	55	57	pai-1).76	pai-1).76	PROPN
bam-8776	55	58	reduction	reduction	NOUN
bam-8776	55	59	of	of	ADP
bam-8776	55	60	fat	fat	ADJ
bam-8776	55	61	tissue	tissue	NOUN
bam-8776	55	62	,	,	PUNCT
bam-8776	55	63	especially	especially	ADV
bam-8776	55	64	visceral	visceral	ADJ
bam-8776	55	65	,	,	PUNCT
bam-8776	55	66	may	may	AUX
bam-8776	55	67	reduce	reduce	VERB
bam-8776	55	68	ms	ms	NOUN
bam-8776	55	69	features	feature	NOUN
bam-8776	55	70	.	.	PUNCT
bam-8776	56	1	so	so	ADV
bam-8776	56	2	,	,	PUNCT
bam-8776	56	3	weight	weight	NOUN
bam-8776	56	4	loss	loss	NOUN
bam-8776	56	5	obtained	obtain	VERB
bam-8776	56	6	with	with	ADP
bam-8776	56	7	regular	regular	ADJ
bam-8776	56	8	exercise	exercise	NOUN
bam-8776	56	9	seems	seem	VERB
bam-8776	56	10	to	to	PART
bam-8776	56	11	decrease	decrease	VERB
bam-8776	56	12	chronic	chronic	ADJ
bam-8776	56	13	inflammation	inflammation	NOUN
bam-8776	56	14	and	and	CCONJ
bam-8776	56	15	insulin	insulin	NOUN
bam-8776	56	16	resistance.77	resistance.77	NOUN
bam-8776	56	17	the	the	DET
bam-8776	56	18	achievement	achievement	NOUN
bam-8776	56	19	of	of	ADP
bam-8776	56	20	these	these	DET
bam-8776	56	21	goals	goal	NOUN
bam-8776	56	22	were	be	AUX
bam-8776	56	23	recently	recently	ADV
bam-8776	56	24	investigated.77	investigated.77	ADV
bam-8776	56	25	these	these	DET
bam-8776	56	26	studies	study	NOUN
bam-8776	56	27	show	show	VERB
bam-8776	56	28	that	that	SCONJ
bam-8776	56	29	weight	weight	NOUN
bam-8776	56	30	loss	loss	NOUN
bam-8776	56	31	decreases	decrease	VERB
bam-8776	56	32	markers	marker	NOUN
bam-8776	56	33	of	of	ADP
bam-8776	56	34	cancer	cancer	NOUN
bam-8776	56	35	progression	progression	NOUN
bam-8776	56	36	and	and	CCONJ
bam-8776	56	37	the	the	DET
bam-8776	56	38	progression	progression	NOUN
bam-8776	56	39	of	of	ADP
bam-8776	56	40	the	the	DET
bam-8776	56	41	tumor.27,78,79	tumor.27,78,79	NOUN
bam-8776	56	42	another	another	DET
bam-8776	56	43	option	option	NOUN
bam-8776	56	44	for	for	ADP
bam-8776	56	45	breast	breast	NOUN
bam-8776	56	46	cancer	cancer	NOUN
bam-8776	56	47	prevention	prevention	NOUN
bam-8776	56	48	and	and	CCONJ
bam-8776	56	49	for	for	ADP
bam-8776	56	50	improvement	improvement	NOUN
bam-8776	56	51	of	of	ADP
bam-8776	56	52	its	its	PRON
bam-8776	56	53	prognosis	prognosis	NOUN
bam-8776	56	54	is	be	AUX
bam-8776	56	55	the	the	DET
bam-8776	56	56	mediterranean	mediterranean	PROPN
bam-8776	56	57	diet.80,81	diet.80,81	NOUN
bam-8776	56	58	together	together	ADV
bam-8776	56	59	with	with	ADP
bam-8776	56	60	other	other	ADJ
bam-8776	56	61	food	food	NOUN
bam-8776	56	62	supplements	supplement	NOUN
bam-8776	56	63	,	,	PUNCT
bam-8776	56	64	mediterranean	mediterranean	PROPN
bam-8776	56	65	diet	diet	PROPN
bam-8776	56	66	was	be	AUX
bam-8776	56	67	reported	report	VERB
bam-8776	56	68	to	to	PART
bam-8776	56	69	be	be	AUX
bam-8776	56	70	effective	effective	ADJ
bam-8776	56	71	also	also	ADV
bam-8776	56	72	in	in	ADP
bam-8776	56	73	pediatrics	pediatric	NOUN
bam-8776	56	74	periods.82	periods.82	NOUN
bam-8776	56	75	-	-	PUNCT
bam-8776	56	76	84	84	NUM
bam-8776	56	77	conclusions	conclusion	NOUN
bam-8776	56	78	in	in	ADP
bam-8776	56	79	this	this	DET
bam-8776	56	80	short	short	ADJ
bam-8776	56	81	review	review	NOUN
bam-8776	56	82	,	,	PUNCT
bam-8776	56	83	we	we	PRON
bam-8776	56	84	examined	examine	VERB
bam-8776	56	85	the	the	DET
bam-8776	56	86	components	component	NOUN
bam-8776	56	87	of	of	ADP
bam-8776	56	88	the	the	DET
bam-8776	56	89	metabolic	metabolic	NOUN
bam-8776	56	90	syndrome	syndrome	NOUN
bam-8776	56	91	in	in	ADP
bam-8776	56	92	relation	relation	NOUN
bam-8776	56	93	to	to	ADP
bam-8776	56	94	breast	breast	NOUN
bam-8776	56	95	cancer	cancer	NOUN
bam-8776	56	96	,	,	PUNCT
bam-8776	56	97	as	as	SCONJ
bam-8776	56	98	they	they	PRON
bam-8776	56	99	are	be	AUX
bam-8776	56	100	reported	report	VERB
bam-8776	56	101	in	in	ADP
bam-8776	56	102	many	many	ADJ
bam-8776	56	103	studies	study	NOUN
bam-8776	56	104	.	.	PUNCT
bam-8776	57	1	nevertheless	nevertheless	ADV
bam-8776	57	2	,	,	PUNCT
bam-8776	57	3	a	a	DET
bam-8776	57	4	thorough	thorough	ADJ
bam-8776	57	5	understanding	understanding	NOUN
bam-8776	57	6	of	of	ADP
bam-8776	57	7	the	the	DET
bam-8776	57	8	mechanisms	mechanism	NOUN
bam-8776	57	9	involved	involve	VERB
bam-8776	57	10	remains	remain	VERB
bam-8776	57	11	a	a	DET
bam-8776	57	12	challenge	challenge	NOUN
bam-8776	57	13	.	.	PUNCT
bam-8776	58	1	among	among	ADP
bam-8776	58	2	a	a	DET
bam-8776	58	3	number	number	NOUN
bam-8776	58	4	of	of	ADP
bam-8776	58	5	preventive	preventive	ADJ
bam-8776	58	6	measures	measure	NOUN
bam-8776	58	7	,	,	PUNCT
bam-8776	58	8	proper	proper	ADJ
bam-8776	58	9	diet	diet	NOUN
bam-8776	58	10	,	,	PUNCT
bam-8776	58	11	that	that	PRON
bam-8776	58	12	seems	seem	VERB
bam-8776	58	13	to	to	PART
bam-8776	58	14	be	be	AUX
bam-8776	58	15	one	one	NUM
bam-8776	58	16	of	of	ADP
bam-8776	58	17	the	the	DET
bam-8776	58	18	most	most	ADJ
bam-8776	58	19	effectives	effective	NOUN
bam-8776	58	20	fig	fig	VERB
bam-8776	58	21	1	1	NUM
bam-8776	58	22	.	.	PUNCT
bam-8776	59	1	the	the	DET
bam-8776	59	2	diagram	diagram	NOUN
bam-8776	59	3	of	of	ADP
bam-8776	59	4	the	the	DET
bam-8776	59	5	connection	connection	NOUN
bam-8776	59	6	between	between	ADP
bam-8776	59	7	metabolic	metabolic	NOUN
bam-8776	59	8	syndrome	syndrome	NOUN
bam-8776	59	9	and	and	CCONJ
bam-8776	59	10	breast	breast	NOUN
bam-8776	59	11	cancer27	cancer27	NOUN
bam-8776	59	12	metabolic	metabolic	NOUN
bam-8776	59	13	syndrome	syndrome	PROPN
bam-8776	59	14	and	and	CCONJ
bam-8776	59	15	breast	breast	NOUN
bam-8776	59	16	cancer	cancer	NOUN
bam-8776	59	17	patients	patient	NOUN
bam-8776	59	18	eur	eur	PROPN
bam-8776	59	19	j	j	PROPN
bam-8776	59	20	transl	transl	PROPN
bam-8776	59	21	myol	myol	ADV
bam-8776	59	22	30	30	NUM
bam-8776	59	23	(	(	PUNCT
bam-8776	59	24	3	3	NUM
bam-8776	59	25	):	):	PUNCT
bam-8776	59	26	xx1	xx1	PROPN
bam-8776	59	27	-	-	PUNCT
bam-8776	59	28	xx7	xx7	PROPN
bam-8776	59	29	,	,	PUNCT
bam-8776	59	30	2020	2020	NUM
bam-8776	59	31	4	4	NUM
bam-8776	59	32	determinants	determinant	NOUN
bam-8776	59	33	of	of	ADP
bam-8776	59	34	metabolic	metabolic	NOUN
bam-8776	59	35	status	status	NOUN
bam-8776	59	36	,	,	PUNCT
bam-8776	59	37	ought	ought	AUX
bam-8776	59	38	to	to	PART
bam-8776	59	39	be	be	AUX
bam-8776	59	40	considered	consider	VERB
bam-8776	59	41	.	.	PUNCT
bam-8776	60	1	general	general	ADJ
bam-8776	60	2	preventive	preventive	ADJ
bam-8776	60	3	recommendations	recommendation	NOUN
bam-8776	60	4	are	be	AUX
bam-8776	60	5	to	to	PART
bam-8776	60	6	reduce	reduce	VERB
bam-8776	60	7	alcohol	alcohol	NOUN
bam-8776	60	8	,	,	PUNCT
bam-8776	60	9	red	red	ADJ
bam-8776	60	10	meat	meat	NOUN
bam-8776	60	11	and	and	CCONJ
bam-8776	60	12	total	total	ADJ
bam-8776	60	13	fat	fat	NOUN
bam-8776	60	14	in	in	ADP
bam-8776	60	15	the	the	DET
bam-8776	60	16	diet	diet	NOUN
bam-8776	60	17	,	,	PUNCT
bam-8776	60	18	while	while	SCONJ
bam-8776	60	19	increasing	increase	VERB
bam-8776	60	20	consumption	consumption	NOUN
bam-8776	60	21	of	of	ADP
bam-8776	60	22	vegetables	vegetable	NOUN
bam-8776	60	23	and	and	CCONJ
bam-8776	60	24	fruits	fruit	NOUN
bam-8776	60	25	.	.	PUNCT
bam-8776	61	1	these	these	DET
bam-8776	61	2	measures	measure	NOUN
bam-8776	61	3	will	will	AUX
bam-8776	61	4	reduce	reduce	VERB
bam-8776	61	5	thenumber	thenumber	NOUN
bam-8776	61	6	of	of	ADP
bam-8776	61	7	ms	ms	NOUN
bam-8776	61	8	patients	patient	NOUN
bam-8776	61	9	,	,	PUNCT
bam-8776	61	10	thus	thus	ADV
bam-8776	61	11	improving	improve	VERB
bam-8776	61	12	outcomes	outcome	NOUN
bam-8776	61	13	of	of	ADP
bam-8776	61	14	breast	breast	NOUN
bam-8776	61	15	cancer.53,56	cancer.53,56	NOUN
bam-8776	61	16	list	list	NOUN
bam-8776	61	17	of	of	ADP
bam-8776	61	18	acronyms	acronym	NOUN
bam-8776	61	19	ms	ms	PROPN
bam-8776	61	20	metabolic	metabolic	PROPN
bam-8776	61	21	syndrome	syndrome	PROPN
bam-8776	61	22	pparγ	pparγ	PROPN
bam-8776	61	23	peroxisome	peroxisome	PROPN
bam-8776	61	24	proliferator	proliferator	PROPN
bam-8776	61	25	–	–	PUNCT
bam-8776	61	26	activated	activate	VERB
bam-8776	61	27	receptor	receptor	NOUN
bam-8776	61	28	γ	γ	X
bam-8776	61	29	fa	fa	PROPN
bam-8776	61	30	fatty	fatty	NOUN
bam-8776	61	31	acids	acid	NOUN
bam-8776	61	32	bmi	bmi	NOUN
bam-8776	61	33	body	body	PROPN
bam-8776	61	34	mass	mass	PROPN
bam-8776	61	35	index	index	NOUN
bam-8776	61	36	pai-1	pai-1	NUM
bam-8776	61	37	plasminogen	plasminogen	NOUN
bam-8776	61	38	activator	activator	NOUN
bam-8776	61	39	inhibitor-1	inhibitor-1	NUM
bam-8776	61	40	mapk	mapk	NOUN
bam-8776	61	41	mitogen	mitogen	NOUN
bam-8776	61	42	-	-	PUNCT
bam-8776	61	43	activated	activate	VERB
bam-8776	61	44	protein	protein	NOUN
bam-8776	61	45	kinase	kinase	NOUN
bam-8776	61	46	pi3k	pi3k	PROPN
bam-8776	61	47	phosphoinositide	phosphoinositide	NOUN
bam-8776	61	48	3	3	NUM
bam-8776	61	49	-	-	PUNCT
bam-8776	61	50	kinase	kinase	PROPN
bam-8776	61	51	caa	caa	PROPN
bam-8776	61	52	cancer	cancer	NOUN
bam-8776	61	53	-	-	PUNCT
bam-8776	61	54	associated	associate	VERB
bam-8776	61	55	adipocytes	adipocyte	NOUN
bam-8776	61	56	.	.	PUNCT
bam-8776	62	1	authors	author	NOUN
bam-8776	62	2	contributions	contribution	VERB
bam-8776	62	3	de	de	ADP
bam-8776	62	4	,	,	PUNCT
bam-8776	62	5	nkh	nkh	ADV
bam-8776	62	6	,	,	PUNCT
bam-8776	62	7	agh	agh	INTJ
bam-8776	62	8	,	,	PUNCT
bam-8776	62	9	hs	hs	PROPN
bam-8776	62	10	,	,	PUNCT
bam-8776	62	11	ah	ah	INTJ
bam-8776	62	12	drafted	draft	VERB
bam-8776	62	13	the	the	DET
bam-8776	62	14	manuscript	manuscript	NOUN
bam-8776	62	15	and	and	CCONJ
bam-8776	62	16	were	be	AUX
bam-8776	62	17	responsible	responsible	ADJ
bam-8776	62	18	for	for	ADP
bam-8776	62	19	literature	literature	NOUN
bam-8776	62	20	review	review	NOUN
bam-8776	62	21	,	,	PUNCT
bam-8776	62	22	participated	participate	VERB
bam-8776	62	23	in	in	ADP
bam-8776	62	24	the	the	DET
bam-8776	62	25	conception	conception	NOUN
bam-8776	62	26	and	and	CCONJ
bam-8776	62	27	design	design	NOUN
bam-8776	62	28	of	of	ADP
bam-8776	62	29	the	the	DET
bam-8776	62	30	work	work	NOUN
bam-8776	62	31	,	,	PUNCT
bam-8776	62	32	and	and	CCONJ
bam-8776	62	33	approved	approve	VERB
bam-8776	62	34	the	the	DET
bam-8776	62	35	final	final	ADJ
bam-8776	62	36	typescript	typescript	NOUN
bam-8776	62	37	.	.	PUNCT
bam-8776	63	1	acknowledgments	acknowledgment	NOUN
bam-8776	63	2	none	none	NOUN
bam-8776	63	3	.	.	PUNCT
bam-8776	64	1	funding	fund	VERB
bam-8776	64	2	no	no	DET
bam-8776	64	3	funding	funding	NOUN
bam-8776	64	4	was	be	AUX
bam-8776	64	5	obtained	obtain	VERB
bam-8776	64	6	for	for	ADP
bam-8776	64	7	this	this	DET
bam-8776	64	8	study	study	NOUN
bam-8776	64	9	.	.	PUNCT
bam-8776	65	1	conflict	conflict	NOUN
bam-8776	65	2	of	of	ADP
bam-8776	65	3	interest	interest	NOUN
bam-8776	65	4	the	the	DET
bam-8776	65	5	authors	author	NOUN
bam-8776	65	6	have	have	VERB
bam-8776	65	7	no	no	DET
bam-8776	65	8	conflicts	conflict	NOUN
bam-8776	65	9	to	to	PART
bam-8776	65	10	disclose	disclose	VERB
bam-8776	65	11	.	.	PUNCT
bam-8776	66	1	ethical	ethical	ADJ
bam-8776	66	2	publication	publication	NOUN
bam-8776	66	3	statement	statement	NOUN
bam-8776	66	4	we	we	PRON
bam-8776	66	5	confirm	confirm	VERB
bam-8776	66	6	that	that	SCONJ
bam-8776	66	7	we	we	PRON
bam-8776	66	8	have	have	AUX
bam-8776	66	9	read	read	VERB
bam-8776	66	10	the	the	DET
bam-8776	66	11	journal	journal	NOUN
bam-8776	66	12	’s	’s	PART
bam-8776	66	13	position	position	NOUN
bam-8776	66	14	on	on	ADP
bam-8776	66	15	issues	issue	NOUN
bam-8776	66	16	involved	involve	VERB
bam-8776	66	17	in	in	ADP
bam-8776	66	18	ethical	ethical	ADJ
bam-8776	66	19	publication	publication	NOUN
bam-8776	66	20	and	and	CCONJ
bam-8776	66	21	affirm	affirm	NOUN
bam-8776	66	22	that	that	SCONJ
bam-8776	66	23	this	this	DET
bam-8776	66	24	report	report	NOUN
bam-8776	66	25	is	be	AUX
bam-8776	66	26	consistent	consistent	ADJ
bam-8776	66	27	with	with	ADP
bam-8776	66	28	those	those	DET
bam-8776	66	29	guidelines	guideline	NOUN
bam-8776	66	30	.	.	PUNCT
bam-8776	67	1	corresponding	correspond	VERB
bam-8776	67	2	author	author	NOUN
bam-8776	67	3	alireza	alireza	PROPN
bam-8776	67	4	hejrati	hejrati	PROPN
bam-8776	67	5	,	,	PUNCT
bam-8776	67	6	department	department	NOUN
bam-8776	67	7	of	of	ADP
bam-8776	67	8	internal	internal	ADJ
bam-8776	67	9	medicine	medicine	NOUN
bam-8776	67	10	,	,	PUNCT
bam-8776	67	11	school	school	NOUN
bam-8776	67	12	of	of	ADP
bam-8776	67	13	medicine	medicine	NOUN
bam-8776	67	14	,	,	PUNCT
bam-8776	67	15	hazrat	hazrat	NOUN
bam-8776	67	16	-	-	PUNCT
bam-8776	67	17	e	e	NOUN
bam-8776	67	18	rasool	rasool	NOUN
bam-8776	67	19	hospital	hospital	NOUN
bam-8776	67	20	,	,	PUNCT
bam-8776	67	21	iran	iran	PROPN
bam-8776	67	22	university	university	PROPN
bam-8776	67	23	of	of	ADP
bam-8776	67	24	medical	medical	ADJ
bam-8776	67	25	sciences	sciences	PROPN
bam-8776	67	26	.	.	PUNCT
bam-8776	68	1	tehran	tehran	PROPN
bam-8776	68	2	,	,	PUNCT
bam-8776	68	3	iran	iran	PROPN
bam-8776	68	4	.	.	PUNCT
bam-8776	69	1	tel	tel	ADP
bam-8776	69	2	:	:	PUNCT
bam-8776	69	3	+98	+98	ADJ
bam-8776	69	4	21	21	NUM
bam-8776	69	5	64352474	64352474	NUM
bam-8776	69	6	.	.	PUNCT
bam-8776	70	1	orcid	orcid	NOUN
bam-8776	71	1	i	i	PRON
bam-8776	71	2	d	d	NOUN
bam-8776	71	3	:	:	PUNCT
bam-8776	71	4	0000	0000	NUM
bam-8776	71	5	-	-	PUNCT
bam-8776	71	6	0003	0003	NUM
bam-8776	71	7	-	-	PUNCT
bam-8776	71	8	0087	0087	NUM
bam-8776	71	9	-	-	PUNCT
bam-8776	71	10	8385	8385	NUM
bam-8776	71	11	email	email	NOUN
bam-8776	71	12	:	:	PUNCT
bam-8776	71	13	hejrati.a@iums.ac.ir	hejrati.a@iums.ac.ir	PROPN
bam-8776	71	14	e	e	X
bam-8776	71	15	-	-	NOUN
bam-8776	71	16	mails	mail	NOUN
bam-8776	71	17	of	of	ADP
bam-8776	71	18	co	co	NOUN
bam-8776	71	19	-	-	NOUN
bam-8776	71	20	authors	author	NOUN
bam-8776	71	21	delaram	delaram	VERB
bam-8776	71	22	eskandari	eskandari	ADJ
bam-8776	71	23	:	:	PUNCT
bam-8776	71	24	eskandari.d@iums.ac.ir	eskandari.d@iums.ac.ir	NUM
bam-8776	71	25	orcid	orcid	NOUN
bam-8776	71	26	i	i	PRON
bam-8776	71	27	d	d	NOUN
bam-8776	71	28	:	:	PUNCT
bam-8776	71	29	0000	0000	NUM
bam-8776	71	30	-	-	PUNCT
bam-8776	71	31	0003	0003	NUM
bam-8776	71	32	-	-	PUNCT
bam-8776	71	33	2524	2524	NUM
bam-8776	71	34	-	-	SYM
bam-8776	71	35	2367	2367	NUM
bam-8776	71	36	niloofar	niloofar	ADJ
bam-8776	71	37	khodabandehloo	khodabandehloo	NOUN
bam-8776	71	38	:	:	PUNCT
bam-8776	71	39	khodabandehloo.n@iums.ac.ir	khodabandehloo.n@iums.ac.ir	VERB
bam-8776	71	40	orcid	orcid	NOUN
bam-8776	71	41	i	i	PRON
bam-8776	71	42	d	d	NOUN
bam-8776	71	43	:	:	PUNCT
bam-8776	71	44	0000	0000	NUM
bam-8776	71	45	-	-	PUNCT
bam-8776	71	46	0002	0002	NUM
bam-8776	71	47	-	-	PUNCT
bam-8776	71	48	0307	0307	NUM
bam-8776	71	49	-	-	PUNCT
bam-8776	71	50	6014	6014	NUM
bam-8776	71	51	abbas	abbas	PROPN
bam-8776	71	52	gholami	gholami	NOUN
bam-8776	71	53	:	:	PUNCT
bam-8776	71	54	gholami.ab@iums.ac.ir	gholami.ab@iums.ac.ir	VERB
bam-8776	71	55	orcid	orcid	PROPN
bam-8776	72	1	i	i	PRON
bam-8776	72	2	d	d	NOUN
bam-8776	72	3	:	:	PUNCT
bam-8776	72	4	0000	0000	NUM
bam-8776	72	5	-	-	PUNCT
bam-8776	72	6	0002	0002	NUM
bam-8776	72	7	-	-	PUNCT
bam-8776	72	8	7033	7033	NUM
bam-8776	72	9	-	-	PUNCT
bam-8776	72	10	7624	7624	NUM
bam-8776	72	11	hosein	hosein	PROPN
bam-8776	72	12	samadanifard	samadanifard	PROPN
bam-8776	72	13	:	:	PUNCT
bam-8776	73	1	dr_samadanifard@yahoo.com	dr_samadanifard@yahoo.com	PROPN
bam-8776	73	2	orcid	orcid	NOUN
bam-8776	73	3	i	i	PRON
bam-8776	73	4	d	d	NOUN
bam-8776	73	5	:	:	PUNCT
bam-8776	73	6	0000	0000	NUM
bam-8776	73	7	-	-	PUNCT
bam-8776	73	8	0002	0002	NUM
bam-8776	73	9	-	-	PUNCT
bam-8776	73	10	8015	8015	NUM
bam-8776	73	11	-	-	SYM
bam-8776	73	12	3466	3466	NUM
bam-8776	73	13	references	reference	NOUN
bam-8776	73	14	1	1	NUM
bam-8776	73	15	.	.	PUNCT
bam-8776	73	16	ferlay	ferlay	PROPN
bam-8776	73	17	j	j	PROPN
bam-8776	73	18	,	,	PUNCT
bam-8776	73	19	soerjomataram	soerjomataram	PROPN
bam-8776	73	20	i	i	PROPN
bam-8776	73	21	,	,	PUNCT
bam-8776	73	22	dikshit	dikshit	PROPN
bam-8776	73	23	r	r	PROPN
bam-8776	73	24	,	,	PUNCT
bam-8776	73	25	et	et	PROPN
bam-8776	73	26	al	al	PROPN
bam-8776	73	27	.	.	PUNCT
bam-8776	74	1	cancer	cancer	NOUN
bam-8776	74	2	incidence	incidence	NOUN
bam-8776	74	3	and	and	CCONJ
bam-8776	74	4	mortality	mortality	NOUN
bam-8776	74	5	worldwide	worldwide	ADV
bam-8776	74	6	:	:	PUNCT
bam-8776	74	7	sources	source	NOUN
bam-8776	74	8	,	,	PUNCT
bam-8776	74	9	methods	method	NOUN
bam-8776	74	10	and	and	CCONJ
bam-8776	74	11	major	major	ADJ
bam-8776	74	12	patterns	pattern	NOUN
bam-8776	74	13	in	in	ADP
bam-8776	74	14	globocan	globocan	PROPN
bam-8776	74	15	2012	2012	NUM
bam-8776	74	16	.	.	PUNCT
bam-8776	75	1	int	int	PROPN
bam-8776	75	2	j	j	PROPN
bam-8776	75	3	cancer	cancer	NOUN
bam-8776	75	4	2015;136	2015;136	NUM
bam-8776	75	5	:	:	PUNCT
bam-8776	75	6	e359	e359	NUM
bam-8776	75	7	-	-	SYM
bam-8776	75	8	86	86	NUM
bam-8776	75	9	.	.	PUNCT
bam-8776	76	1	2	2	NUM
bam-8776	76	2	.	.	PUNCT
bam-8776	76	3	wani	wani	PROPN
bam-8776	76	4	b	b	PROPN
bam-8776	76	5	,	,	PUNCT
bam-8776	76	6	aziz	aziz	PROPN
bam-8776	76	7	sa	sa	PROPN
bam-8776	76	8	,	,	PUNCT
bam-8776	76	9	ganaie	ganaie	PROPN
bam-8776	76	10	ma	ma	PROPN
bam-8776	76	11	,	,	PUNCT
bam-8776	76	12	mir	mir	PROPN
bam-8776	76	13	mh	mh	PROPN
bam-8776	76	14	.	.	PROPN
bam-8776	76	15	metabolic	metabolic	PROPN
bam-8776	76	16	syndrome	syndrome	PROPN
bam-8776	76	17	and	and	CCONJ
bam-8776	76	18	breast	breast	NOUN
bam-8776	76	19	cancer	cancer	NOUN
bam-8776	76	20	risk	risk	NOUN
bam-8776	76	21	.	.	PUNCT
bam-8776	77	1	indian	indian	PROPN
bam-8776	77	2	j	j	PROPN
bam-8776	77	3	med	me	VERB
bam-8776	77	4	paediatr	paediatr	NOUN
bam-8776	77	5	oncol	oncol	ADJ
bam-8776	77	6	2017;38:434–439	2017;38:434–439	NOUN
bam-8776	77	7	.	.	PUNCT
bam-8776	78	1	3	3	X
bam-8776	78	2	.	.	X
bam-8776	78	3	riccardi	riccardi	VERB
bam-8776	78	4	g	g	PROPN
bam-8776	78	5	,	,	PUNCT
bam-8776	78	6	rivellese	rivellese	ADJ
bam-8776	78	7	a.	a.	NOUN
bam-8776	78	8	dietary	dietary	ADJ
bam-8776	78	9	treatment	treatment	NOUN
bam-8776	78	10	of	of	ADP
bam-8776	78	11	the	the	DET
bam-8776	78	12	metabolic	metabolic	NOUN
bam-8776	78	13	syndrome	syndrome	NOUN
bam-8776	78	14	the	the	DET
bam-8776	78	15	optimal	optimal	ADJ
bam-8776	78	16	diet	diet	NOUN
bam-8776	78	17	.	.	PUNCT
bam-8776	79	1	br	br	PROPN
bam-8776	79	2	j	j	PROPN
bam-8776	79	3	nutr	nutr	PROPN
bam-8776	79	4	2000	2000	NUM
bam-8776	79	5	;	;	PUNCT
bam-8776	79	6	83	83	NUM
bam-8776	79	7	:	:	PUNCT
bam-8776	79	8	s143	s143	PROPN
bam-8776	79	9	-	-	PUNCT
bam-8776	79	10	8	8	NUM
bam-8776	79	11	.	.	NOUN
bam-8776	79	12	4	4	NUM
bam-8776	79	13	.	.	X
bam-8776	79	14	alberti	alberti	PROPN
bam-8776	79	15	kg	kg	PROPN
bam-8776	79	16	,	,	PUNCT
bam-8776	79	17	eckel	eckel	PROPN
bam-8776	79	18	rh	rh	PROPN
bam-8776	79	19	,	,	PUNCT
bam-8776	79	20	grundy	grundy	PROPN
bam-8776	79	21	sm	sm	PROPN
bam-8776	79	22	,	,	PUNCT
bam-8776	79	23	et	et	PROPN
bam-8776	79	24	al	al	PROPN
bam-8776	79	25	.	.	PUNCT
bam-8776	79	26	harmonizing	harmonize	VERB
bam-8776	79	27	the	the	DET
bam-8776	79	28	metabolic	metabolic	NOUN
bam-8776	79	29	syndrome	syndrome	NOUN
bam-8776	79	30	:	:	PUNCT
bam-8776	79	31	a	a	DET
bam-8776	79	32	joint	joint	ADJ
bam-8776	79	33	interim	interim	ADJ
bam-8776	79	34	statement	statement	NOUN
bam-8776	79	35	of	of	ADP
bam-8776	79	36	the	the	DET
bam-8776	79	37	international	international	ADJ
bam-8776	79	38	diabetes	diabetes	PROPN
bam-8776	79	39	federation	federation	PROPN
bam-8776	79	40	task	task	PROPN
bam-8776	79	41	force	force	NOUN
bam-8776	79	42	on	on	ADP
bam-8776	79	43	epidemiology	epidemiology	NOUN
bam-8776	79	44	and	and	CCONJ
bam-8776	79	45	prevention	prevention	NOUN
bam-8776	79	46	;	;	PUNCT
bam-8776	79	47	national	national	ADJ
bam-8776	79	48	heart	heart	NOUN
bam-8776	79	49	,	,	PUNCT
bam-8776	79	50	lung	lung	NOUN
bam-8776	79	51	,	,	PUNCT
bam-8776	79	52	and	and	CCONJ
bam-8776	79	53	blood	blood	NOUN
bam-8776	79	54	institute	institute	NOUN
bam-8776	79	55	;	;	PUNCT
bam-8776	79	56	american	american	PROPN
bam-8776	79	57	heart	heart	PROPN
bam-8776	79	58	association	association	PROPN
bam-8776	79	59	;	;	PUNCT
bam-8776	79	60	world	world	NOUN
bam-8776	79	61	heart	heart	PROPN
bam-8776	79	62	federation	federation	PROPN
bam-8776	79	63	;	;	PUNCT
bam-8776	79	64	international	international	ADJ
bam-8776	79	65	atherosclerosis	atherosclerosis	NOUN
bam-8776	79	66	society	society	NOUN
bam-8776	79	67	;	;	PUNCT
bam-8776	79	68	and	and	CCONJ
bam-8776	79	69	international	international	ADJ
bam-8776	79	70	association	association	NOUN
bam-8776	79	71	for	for	ADP
bam-8776	79	72	the	the	DET
bam-8776	79	73	study	study	NOUN
bam-8776	79	74	of	of	ADP
bam-8776	79	75	obesity	obesity	NOUN
bam-8776	79	76	.	.	PUNCT
bam-8776	80	1	circulation	circulation	NOUN
bam-8776	80	2	2009;120:1640	2009;120:1640	NUM
bam-8776	80	3	-	-	SYM
bam-8776	80	4	5	5	NUM
bam-8776	80	5	.	.	NOUN
bam-8776	80	6	5	5	NUM
bam-8776	80	7	.	.	NUM
bam-8776	80	8	esposito	esposito	PROPN
bam-8776	81	1	k	k	PROPN
bam-8776	81	2	,	,	PUNCT
bam-8776	81	3	chiodini	chiodini	NOUN
bam-8776	81	4	p	p	NOUN
bam-8776	81	5	,	,	PUNCT
bam-8776	81	6	capuano	capuano	PROPN
bam-8776	81	7	a	a	PROPN
bam-8776	81	8	,	,	PUNCT
bam-8776	81	9	et	et	PROPN
bam-8776	81	10	al	al	PROPN
bam-8776	81	11	.	.	PROPN
bam-8776	81	12	metabolic	metabolic	PROPN
bam-8776	81	13	syndrome	syndrome	PROPN
bam-8776	81	14	and	and	CCONJ
bam-8776	81	15	postmenopausal	postmenopausal	ADJ
bam-8776	81	16	breast	breast	NOUN
bam-8776	81	17	cancer	cancer	NOUN
bam-8776	81	18	:	:	PUNCT
bam-8776	81	19	systematic	systematic	ADJ
bam-8776	81	20	review	review	NOUN
bam-8776	81	21	and	and	CCONJ
bam-8776	81	22	meta	meta	ADJ
bam-8776	81	23	-	-	PUNCT
bam-8776	81	24	analysis	analysis	NOUN
bam-8776	81	25	.	.	PUNCT
bam-8776	82	1	menopause	menopause	NOUN
bam-8776	82	2	2013;20:1301	2013;20:1301	NUM
bam-8776	82	3	-	-	SYM
bam-8776	82	4	9	9	NUM
bam-8776	82	5	.	.	NOUN
bam-8776	82	6	6	6	NUM
bam-8776	82	7	.	.	NUM
bam-8776	82	8	esposito	esposito	PROPN
bam-8776	83	1	k	k	PROPN
bam-8776	83	2	,	,	PUNCT
bam-8776	83	3	chiodini	chiodini	NOUN
bam-8776	83	4	p	p	NOUN
bam-8776	83	5	,	,	PUNCT
bam-8776	83	6	capuano	capuano	PROPN
bam-8776	83	7	a	a	PROPN
bam-8776	83	8	,	,	PUNCT
bam-8776	83	9	et	et	PROPN
bam-8776	83	10	al	al	PROPN
bam-8776	83	11	.	.	PROPN
bam-8776	83	12	effect	effect	NOUN
bam-8776	83	13	of	of	ADP
bam-8776	83	14	metabolic	metabolic	NOUN
bam-8776	83	15	syndrome	syndrome	NOUN
bam-8776	83	16	and	and	CCONJ
bam-8776	83	17	its	its	PRON
bam-8776	83	18	components	component	NOUN
bam-8776	83	19	on	on	ADP
bam-8776	83	20	prostate	prostate	NOUN
bam-8776	83	21	cancer	cancer	NOUN
bam-8776	83	22	risk	risk	NOUN
bam-8776	83	23	:	:	PUNCT
bam-8776	83	24	meta	meta	ADJ
bam-8776	83	25	-	-	PUNCT
bam-8776	83	26	analysis	analysis	NOUN
bam-8776	83	27	.	.	PUNCT
bam-8776	84	1	j	j	PROPN
bam-8776	84	2	endocrinol	endocrinol	NOUN
bam-8776	84	3	invest	invest	VERB
bam-8776	84	4	2013;36:132	2013;36:132	NOUN
bam-8776	84	5	-	-	SYM
bam-8776	84	6	9	9	NUM
bam-8776	84	7	.	.	NOUN
bam-8776	84	8	7	7	NUM
bam-8776	84	9	.	.	NUM
bam-8776	84	10	esposito	esposito	PROPN
bam-8776	85	1	k	k	PROPN
bam-8776	85	2	,	,	PUNCT
bam-8776	85	3	chiodini	chiodini	NOUN
bam-8776	85	4	p	p	NOUN
bam-8776	85	5	,	,	PUNCT
bam-8776	85	6	capuano	capuano	PROPN
bam-8776	85	7	a	a	PROPN
bam-8776	85	8	,	,	PUNCT
bam-8776	85	9	et	et	PROPN
bam-8776	85	10	al	al	PROPN
bam-8776	85	11	.	.	PROPN
bam-8776	85	12	colorectal	colorectal	ADJ
bam-8776	85	13	cancer	cancer	NOUN
bam-8776	85	14	association	association	NOUN
bam-8776	85	15	with	with	ADP
bam-8776	85	16	metabolic	metabolic	NOUN
bam-8776	85	17	syndrome	syndrome	NOUN
bam-8776	85	18	and	and	CCONJ
bam-8776	85	19	its	its	PRON
bam-8776	85	20	components	component	NOUN
bam-8776	85	21	:	:	PUNCT
bam-8776	85	22	a	a	DET
bam-8776	85	23	systematic	systematic	ADJ
bam-8776	85	24	review	review	NOUN
bam-8776	85	25	with	with	ADP
bam-8776	85	26	meta	meta	ADJ
bam-8776	85	27	-	-	PUNCT
bam-8776	85	28	analysis	analysis	NOUN
bam-8776	85	29	:	:	PUNCT
bam-8776	85	30	endocrine	endocrine	PROPN
bam-8776	85	31	2013;44:634	2013;44:634	PROPN
bam-8776	85	32	-	-	PUNCT
bam-8776	85	33	47	47	NUM
bam-8776	85	34	.	.	PUNCT
bam-8776	85	35	8	8	NUM
bam-8776	85	36	.	.	X
bam-8776	85	37	osaki	osaki	PROPN
bam-8776	85	38	y	y	PROPN
bam-8776	85	39	,	,	PUNCT
bam-8776	85	40	taniguchi	taniguchi	PROPN
bam-8776	85	41	s	s	PROPN
bam-8776	85	42	-	-	PUNCT
bam-8776	85	43	i	i	PROPN
bam-8776	85	44	,	,	PUNCT
bam-8776	85	45	tahara	tahara	NOUN
bam-8776	85	46	a	a	X
bam-8776	85	47	,	,	PUNCT
bam-8776	85	48	okamoto	okamoto	PROPN
bam-8776	85	49	m	m	PROPN
bam-8776	85	50	,	,	PUNCT
bam-8776	85	51	kishimoto	kishimoto	PROPN
bam-8776	85	52	t.	t.	PROPN
bam-8776	85	53	metabolic	metabolic	PROPN
bam-8776	85	54	syndrome	syndrome	NOUN
bam-8776	85	55	and	and	CCONJ
bam-8776	85	56	incidence	incidence	NOUN
bam-8776	85	57	of	of	ADP
bam-8776	85	58	liver	liver	NOUN
bam-8776	85	59	and	and	CCONJ
bam-8776	85	60	breast	breast	NOUN
bam-8776	85	61	cancers	cancer	NOUN
bam-8776	85	62	in	in	ADP
bam-8776	85	63	japan	japan	PROPN
bam-8776	85	64	.	.	PUNCT
bam-8776	86	1	cancer	cancer	NOUN
bam-8776	86	2	epidemiol	epidemiol	PROPN
bam-8776	86	3	2012;36:141	2012;36:141	PROPN
bam-8776	86	4	-	-	SYM
bam-8776	86	5	7	7	NUM
bam-8776	86	6	.	.	NOUN
bam-8776	86	7	9	9	NUM
bam-8776	86	8	.	.	X
bam-8776	86	9	rosato	rosato	PROPN
bam-8776	86	10	v	v	NOUN
bam-8776	86	11	,	,	PUNCT
bam-8776	86	12	bosetti	bosetti	ADJ
bam-8776	86	13	c	c	NOUN
bam-8776	86	14	,	,	PUNCT
bam-8776	86	15	talamini	talamini	PROPN
bam-8776	86	16	r	r	NOUN
bam-8776	86	17	,	,	PUNCT
bam-8776	86	18	et	et	PROPN
bam-8776	86	19	al	al	PROPN
bam-8776	86	20	.	.	PROPN
bam-8776	86	21	metabolic	metabolic	PROPN
bam-8776	86	22	syndrome	syndrome	NOUN
bam-8776	86	23	and	and	CCONJ
bam-8776	86	24	the	the	DET
bam-8776	86	25	risk	risk	NOUN
bam-8776	86	26	of	of	ADP
bam-8776	86	27	breast	breast	NOUN
bam-8776	86	28	cancer	cancer	NOUN
bam-8776	86	29	in	in	ADP
bam-8776	86	30	postmenopausal	postmenopausal	ADJ
bam-8776	86	31	women	woman	NOUN
bam-8776	86	32	.	.	PUNCT
bam-8776	87	1	ann	ann	PROPN
bam-8776	87	2	oncol	oncol	PROPN
bam-8776	87	3	2011;22:2687	2011;22:2687	PROPN
bam-8776	87	4	-	-	SYM
bam-8776	87	5	92	92	NUM
bam-8776	87	6	.	.	PUNCT
bam-8776	88	1	10	10	NUM
bam-8776	88	2	.	.	PUNCT
bam-8776	88	3	rosato	rosato	PROPN
bam-8776	88	4	v	v	ADP
bam-8776	88	5	,	,	PUNCT
bam-8776	88	6	tavani	tavani	X
bam-8776	88	7	a	a	PRON
bam-8776	88	8	,	,	PUNCT
bam-8776	88	9	bosetti	bosetti	ADJ
bam-8776	88	10	c	c	NOUN
bam-8776	88	11	,	,	PUNCT
bam-8776	88	12	et	et	PROPN
bam-8776	88	13	al	al	PROPN
bam-8776	88	14	.	.	PROPN
bam-8776	88	15	metabolic	metabolic	PROPN
bam-8776	88	16	syndrome	syndrome	PROPN
bam-8776	88	17	and	and	CCONJ
bam-8776	88	18	pancreatic	pancreatic	ADJ
bam-8776	88	19	cancer	cancer	NOUN
bam-8776	88	20	risk	risk	NOUN
bam-8776	88	21	:	:	PUNCT
bam-8776	88	22	a	a	DET
bam-8776	88	23	case	case	NOUN
bam-8776	88	24	-	-	PUNCT
bam-8776	88	25	control	control	NOUN
bam-8776	88	26	study	study	NOUN
bam-8776	88	27	in	in	ADP
bam-8776	88	28	italy	italy	PROPN
bam-8776	88	29	and	and	CCONJ
bam-8776	88	30	meta	meta	ADJ
bam-8776	88	31	-	-	PUNCT
bam-8776	88	32	analysis	analysis	NOUN
bam-8776	88	33	.	.	PUNCT
bam-8776	89	1	metabolism	metabolism	NOUN
bam-8776	89	2	2011;60:1372	2011;60:1372	NUM
bam-8776	89	3	-	-	SYM
bam-8776	89	4	8	8	NUM
bam-8776	89	5	.	.	PUNCT
bam-8776	89	6	11	11	NUM
bam-8776	89	7	.	.	PUNCT
bam-8776	90	1	bhandari	bhandari	PROPN
bam-8776	90	2	r	r	PROPN
bam-8776	90	3	,	,	PUNCT
bam-8776	90	4	kelley	kelley	PROPN
bam-8776	90	5	ga	ga	PROPN
bam-8776	90	6	,	,	PUNCT
bam-8776	90	7	hartley	hartley	PROPN
bam-8776	90	8	ta	ta	PROPN
bam-8776	90	9	,	,	PUNCT
bam-8776	90	10	rockett	rockett	PROPN
bam-8776	90	11	ir	ir	PROPN
bam-8776	90	12	.	.	PROPN
bam-8776	90	13	metabolic	metabolic	PROPN
bam-8776	90	14	syndrome	syndrome	PROPN
bam-8776	90	15	is	be	AUX
bam-8776	90	16	associated	associate	VERB
bam-8776	90	17	with	with	ADP
bam-8776	90	18	increased	increase	VERB
bam-8776	90	19	breast	breast	NOUN
bam-8776	90	20	cancer	cancer	NOUN
bam-8776	90	21	risk	risk	NOUN
bam-8776	90	22	:	:	PUNCT
bam-8776	90	23	a	a	DET
bam-8776	90	24	systematic	systematic	ADJ
bam-8776	90	25	review	review	NOUN
bam-8776	90	26	with	with	ADP
bam-8776	90	27	metaanalysis	metaanalysis	NOUN
bam-8776	90	28	.	.	PUNCT
bam-8776	91	1	int	int	PROPN
bam-8776	91	2	j	j	PROPN
bam-8776	91	3	breast	breast	NOUN
bam-8776	91	4	cancer	cancer	NOUN
bam-8776	91	5	2014;2014:189384	2014;2014:189384	NUM
bam-8776	91	6	.	.	PUNCT
bam-8776	91	7	12	12	NUM
bam-8776	91	8	.	.	PUNCT
bam-8776	92	1	michels	michels	PROPN
bam-8776	92	2	kb	kb	PROPN
bam-8776	92	3	,	,	PUNCT
bam-8776	92	4	solomon	solomon	PROPN
bam-8776	92	5	cg	cg	PROPN
bam-8776	92	6	,	,	PUNCT
bam-8776	92	7	hu	hu	PROPN
bam-8776	93	1	fb	fb	INTJ
bam-8776	93	2	,	,	PUNCT
bam-8776	93	3	et	et	PROPN
bam-8776	93	4	al	al	PROPN
bam-8776	93	5	.	.	PROPN
bam-8776	93	6	type	type	NOUN
bam-8776	93	7	2	2	NUM
bam-8776	93	8	diabetes	diabetes	NOUN
bam-8776	93	9	and	and	CCONJ
bam-8776	93	10	subsequent	subsequent	ADJ
bam-8776	93	11	incidence	incidence	NOUN
bam-8776	93	12	of	of	ADP
bam-8776	93	13	breast	breast	NOUN
bam-8776	93	14	cancer	cancer	NOUN
bam-8776	93	15	in	in	ADP
bam-8776	93	16	the	the	DET
bam-8776	93	17	nurses	nurse	NOUN
bam-8776	93	18	’	'	PUNCT
bam-8776	93	19	health	health	NOUN
bam-8776	93	20	study	study	NOUN
bam-8776	93	21	.	.	PUNCT
bam-8776	94	1	diabetes	diabetes	NOUN
bam-8776	94	2	care	care	VERB
bam-8776	94	3	2003;26:1752	2003;26:1752	NUM
bam-8776	94	4	-	-	SYM
bam-8776	94	5	8	8	NUM
bam-8776	94	6	.	.	NOUN
bam-8776	95	1	13	13	NUM
bam-8776	95	2	.	.	PUNCT
bam-8776	96	1	larsson	larsson	PROPN
bam-8776	96	2	sc	sc	PROPN
bam-8776	96	3	,	,	PUNCT
bam-8776	96	4	mantzoros	mantzoros	PROPN
bam-8776	96	5	cs	cs	PROPN
bam-8776	96	6	,	,	PUNCT
bam-8776	96	7	wolk	wolk	NOUN
bam-8776	96	8	a.	a.	NOUN
bam-8776	96	9	diabetes	diabetes	PROPN
bam-8776	96	10	mellitus	mellitus	NOUN
bam-8776	96	11	and	and	CCONJ
bam-8776	96	12	risk	risk	NOUN
bam-8776	96	13	of	of	ADP
bam-8776	96	14	breast	breast	NOUN
bam-8776	96	15	cancer	cancer	NOUN
bam-8776	96	16	:	:	PUNCT
bam-8776	96	17	a	a	DET
bam-8776	96	18	meta‐analysis	meta‐analysis	NOUN
bam-8776	96	19	.	.	PUNCT
bam-8776	97	1	int	int	PROPN
bam-8776	97	2	j	j	PROPN
bam-8776	97	3	cancer	cancer	NOUN
bam-8776	97	4	2007;121:856	2007;121:856	NUM
bam-8776	97	5	-	-	SYM
bam-8776	97	6	62	62	NUM
bam-8776	97	7	.	.	PUNCT
bam-8776	97	8	14	14	NUM
bam-8776	97	9	.	.	PUNCT
bam-8776	98	1	goodman	goodman	PROPN
bam-8776	98	2	mt	mt	PROPN
bam-8776	98	3	,	,	PUNCT
bam-8776	98	4	cologne	cologne	PROPN
bam-8776	98	5	jb	jb	PROPN
bam-8776	98	6	,	,	PUNCT
bam-8776	98	7	moriwaki	moriwaki	PROPN
bam-8776	98	8	h	h	PROPN
bam-8776	98	9	,	,	PUNCT
bam-8776	98	10	et	et	PROPN
bam-8776	98	11	al	al	PROPN
bam-8776	98	12	.	.	PUNCT
bam-8776	98	13	risk	risk	NOUN
bam-8776	98	14	factors	factor	NOUN
bam-8776	98	15	for	for	ADP
bam-8776	98	16	primary	primary	ADJ
bam-8776	98	17	breast	breast	NOUN
bam-8776	98	18	cancer	cancer	NOUN
bam-8776	98	19	in	in	ADP
bam-8776	98	20	japan	japan	PROPN
bam-8776	98	21	:	:	PUNCT
bam-8776	98	22	8	8	NUM
bam-8776	98	23	-	-	PUNCT
bam-8776	98	24	year	year	NOUN
bam-8776	98	25	follow	follow	NOUN
bam-8776	98	26	-	-	PUNCT
bam-8776	98	27	up	up	NOUN
bam-8776	98	28	of	of	ADP
bam-8776	98	29	atomic	atomic	ADJ
bam-8776	98	30	bomb	bomb	NOUN
bam-8776	98	31	survivors	survivor	NOUN
bam-8776	98	32	.	.	PUNCT
bam-8776	99	1	prev	prev	PROPN
bam-8776	99	2	med	med	ADJ
bam-8776	99	3	1997;26:144	1997;26:144	PROPN
bam-8776	99	4	-	-	SYM
bam-8776	99	5	53	53	NUM
bam-8776	99	6	.	.	NOUN
bam-8776	99	7	15	15	NUM
bam-8776	99	8	.	.	NOUN
bam-8776	100	1	weiderpass	weiderpass	PROPN
bam-8776	100	2	e	e	NOUN
bam-8776	100	3	,	,	PUNCT
bam-8776	100	4	gridley	gridley	PROPN
bam-8776	100	5	g	g	PROPN
bam-8776	100	6	,	,	PUNCT
bam-8776	100	7	persson	persson	PROPN
bam-8776	100	8	i	i	PROPN
bam-8776	100	9	,	,	PUNCT
bam-8776	100	10	et	et	PROPN
bam-8776	100	11	al	al	PROPN
bam-8776	100	12	.	.	PROPN
bam-8776	100	13	risk	risk	NOUN
bam-8776	100	14	of	of	ADP
bam-8776	100	15	endometrial	endometrial	ADJ
bam-8776	100	16	and	and	CCONJ
bam-8776	100	17	breast	breast	NOUN
bam-8776	100	18	cancer	cancer	NOUN
bam-8776	100	19	in	in	ADP
bam-8776	100	20	patients	patient	NOUN
bam-8776	100	21	with	with	ADP
bam-8776	100	22	diabetes	diabetes	NOUN
bam-8776	100	23	mellitus	mellitus	NOUN
bam-8776	100	24	.	.	PUNCT
bam-8776	101	1	int	int	PROPN
bam-8776	101	2	j	j	PROPN
bam-8776	101	3	can	can	AUX
bam-8776	101	4	1997;71:360	1997;71:360	NUM
bam-8776	101	5	-	-	SYM
bam-8776	101	6	3	3	NUM
bam-8776	101	7	.	.	NOUN
bam-8776	101	8	16	16	NUM
bam-8776	101	9	.	.	PUNCT
bam-8776	101	10	wideroff	wideroff	PROPN
bam-8776	101	11	l	l	PROPN
bam-8776	101	12	,	,	PUNCT
bam-8776	101	13	gridley	gridley	PROPN
bam-8776	101	14	g	g	PROPN
bam-8776	101	15	,	,	PUNCT
bam-8776	101	16	chow	chow	PROPN
bam-8776	101	17	w	w	PROPN
bam-8776	101	18	-	-	PUNCT
bam-8776	101	19	h	h	NOUN
bam-8776	101	20	,	,	PUNCT
bam-8776	101	21	et	et	PROPN
bam-8776	101	22	al	al	PROPN
bam-8776	101	23	.	.	PUNCT
bam-8776	102	1	cancer	cancer	NOUN
bam-8776	102	2	incidence	incidence	NOUN
bam-8776	102	3	in	in	ADP
bam-8776	102	4	a	a	DET
bam-8776	102	5	population	population	NOUN
bam-8776	102	6	-	-	PUNCT
bam-8776	102	7	based	base	VERB
bam-8776	102	8	cohort	cohort	NOUN
bam-8776	102	9	of	of	ADP
bam-8776	102	10	patients	patient	NOUN
bam-8776	102	11	mailto:hejrati.a@iums.ac.ir	mailto:hejrati.a@iums.ac.ir	ADJ
bam-8776	102	12	https://orcid.org/0000-0003-2524-2367	https://orcid.org/0000-0003-2524-2367	NOUN
bam-8776	102	13	https://orcid.org/0000-0002-8015-3466	https://orcid.org/0000-0002-8015-3466	PROPN
bam-8776	102	14	https://www.ncbi.nlm.nih.gov/pubmed/?term=cancer+incidence+and+mortality+worldwide%3a+sources%2c+methods+and+major+patterns+in+globocan+2012.+international+journal+of+cancer	https://www.ncbi.nlm.nih.gov/pubmed/?term=cancer+incidence+and+mortality+worldwide%3a+sources%2c+methods+and+major+patterns+in+globocan+2012.+international+journal+of+cancer	NOUN
bam-8776	102	15	.	.	PUNCT
bam-8776	103	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=dietary+treatment+of+the+metabolic+syndrome%e2%80%94the+optimal+diet.+british+journal+of+nutrition	https://www.ncbi.nlm.nih.gov/pubmed/?term=dietary+treatment+of+the+metabolic+syndrome%e2%80%94the+optimal+diet.+british+journal+of+nutrition	PROPN
bam-8776	103	2	.	.	PUNCT
bam-8776	104	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=harmonizing+the+metabolic+syndrome%3a+a+joint+interim+statement+of+the+international+diabetes+federation+task+force+on+epidemiology+and+prevention%3b+national+heart%2c+lung%2c+and+blood+institute%3b+american+heart+association%3b+world+heart+federation%3b+international+atherosclerosis+society%3b+and+international+association+for+the+study+of+obesity.+circulation	https://www.ncbi.nlm.nih.gov/pubmed/?term=harmonizing+the+metabolic+syndrome%3a+a+joint+interim+statement+of+the+international+diabetes+federation+task+force+on+epidemiology+and+prevention%3b+national+heart%2c+lung%2c+and+blood+institute%3b+american+heart+association%3b+world+heart+federation%3b+international+atherosclerosis+society%3b+and+international+association+for+the+study+of+obesity.+circulation	NOUN
bam-8776	104	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+postmenopausal+breast+cancer%3a+systematic+review+and+meta-analysis.+menopause	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+postmenopausal+breast+cancer%3a+systematic+review+and+meta-analysis.+menopause	NOUN
bam-8776	104	3	.	.	PUNCT
bam-8776	105	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=effect+of+metabolic+syndrome+and+its+components+on+prostate+cancer+risk%3a+meta-analysis.+journal+of+endocrinological+investigation	https://www.ncbi.nlm.nih.gov/pubmed/?term=effect+of+metabolic+syndrome+and+its+components+on+prostate+cancer+risk%3a+meta-analysis.+journal+of+endocrinological+investigation	NOUN
bam-8776	105	2	.	.	PUNCT
bam-8776	106	1	https://www.ncbi.nlm.nih.gov/pubmed/23546613	https://www.ncbi.nlm.nih.gov/pubmed/23546613	NUM
bam-8776	106	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+incidence+of+liver+and+breast+cancers+in+japan.+cancer+epidemiology	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+incidence+of+liver+and+breast+cancers+in+japan.+cancer+epidemiology	NOUN
bam-8776	106	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+pancreatic+cancer+risk%3a+a+case-control+study+in+italy+and+meta-analysis.+metabolism	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+pancreatic+cancer+risk%3a+a+case-control+study+in+italy+and+meta-analysis.+metabolism	NOUN
bam-8776	106	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=diabetes+mellitus+and+risk+of+breast+cancer%3a+a+meta%e2%80%90analysis.+international+journal+of+cancer	https://www.ncbi.nlm.nih.gov/pubmed/?term=diabetes+mellitus+and+risk+of+breast+cancer%3a+a+meta%e2%80%90analysis.+international+journal+of+cancer	NOUN
bam-8776	106	5	metabolic	metabolic	NOUN
bam-8776	106	6	syndrome	syndrome	NOUN
bam-8776	106	7	and	and	CCONJ
bam-8776	106	8	breast	breast	NOUN
bam-8776	106	9	cancer	cancer	NOUN
bam-8776	106	10	patients	patient	NOUN
bam-8776	106	11	eur	eur	PROPN
bam-8776	106	12	j	j	PROPN
bam-8776	106	13	transl	transl	PROPN
bam-8776	106	14	myol	myol	ADV
bam-8776	106	15	30	30	NUM
bam-8776	106	16	(	(	PUNCT
bam-8776	106	17	3	3	NUM
bam-8776	106	18	):	):	PUNCT
bam-8776	106	19	xx1	xx1	PROPN
bam-8776	106	20	-	-	PUNCT
bam-8776	106	21	xx7	xx7	PROPN
bam-8776	106	22	,	,	PUNCT
bam-8776	106	23	2020	2020	NUM
bam-8776	106	24	5	5	NUM
bam-8776	106	25	hospitalized	hospitalize	VERB
bam-8776	106	26	with	with	ADP
bam-8776	106	27	diabetes	diabetes	NOUN
bam-8776	106	28	mellitus	mellitus	NOUN
bam-8776	106	29	in	in	ADP
bam-8776	106	30	denmark	denmark	PROPN
bam-8776	106	31	.	.	PUNCT
bam-8776	107	1	j	j	PROPN
bam-8776	107	2	nation	nation	NOUN
bam-8776	107	3	can	can	AUX
bam-8776	107	4	instit	instit	VERB
bam-8776	107	5	1997;89:1360	1997;89:1360	NUM
bam-8776	107	6	-	-	SYM
bam-8776	107	7	5	5	NUM
bam-8776	107	8	.	.	NUM
bam-8776	107	9	17	17	NUM
bam-8776	107	10	.	.	PUNCT
bam-8776	108	1	jee	jee	PROPN
bam-8776	108	2	sh	sh	PROPN
bam-8776	108	3	,	,	PUNCT
bam-8776	108	4	ohrr	ohrr	NOUN
bam-8776	108	5	h	h	PROPN
bam-8776	108	6	,	,	PUNCT
bam-8776	108	7	sull	sull	PROPN
bam-8776	108	8	jw	jw	PROPN
bam-8776	108	9	,	,	PUNCT
bam-8776	108	10	et	et	PROPN
bam-8776	108	11	al	al	PROPN
bam-8776	108	12	.	.	PUNCT
bam-8776	108	13	fasting	fast	VERB
bam-8776	108	14	serum	serum	NOUN
bam-8776	108	15	glucose	glucose	NOUN
bam-8776	108	16	level	level	NOUN
bam-8776	108	17	and	and	CCONJ
bam-8776	108	18	cancer	cancer	NOUN
bam-8776	108	19	risk	risk	NOUN
bam-8776	108	20	in	in	ADP
bam-8776	108	21	korean	korean	ADJ
bam-8776	108	22	men	man	NOUN
bam-8776	108	23	and	and	CCONJ
bam-8776	108	24	women	woman	NOUN
bam-8776	108	25	.	.	PUNCT
bam-8776	109	1	jama	jama	PROPN
bam-8776	109	2	2005;293:194	2005;293:194	NUM
bam-8776	109	3	-	-	SYM
bam-8776	109	4	202	202	NUM
bam-8776	109	5	.	.	NOUN
bam-8776	109	6	18	18	NUM
bam-8776	109	7	.	.	PUNCT
bam-8776	110	1	boyle	boyle	PROPN
bam-8776	110	2	p	p	PROPN
bam-8776	110	3	,	,	PUNCT
bam-8776	110	4	boniol	boniol	PROPN
bam-8776	110	5	m	m	PROPN
bam-8776	110	6	,	,	PUNCT
bam-8776	110	7	koechlin	koechlin	PROPN
bam-8776	110	8	a	a	PROPN
bam-8776	110	9	,	,	PUNCT
bam-8776	110	10	et	et	PROPN
bam-8776	110	11	al	al	PROPN
bam-8776	110	12	.	.	PROPN
bam-8776	111	1	diabetes	diabetes	NOUN
bam-8776	111	2	and	and	CCONJ
bam-8776	111	3	breast	breast	NOUN
bam-8776	111	4	cancer	cancer	NOUN
bam-8776	111	5	risk	risk	NOUN
bam-8776	111	6	:	:	PUNCT
bam-8776	111	7	a	a	DET
bam-8776	111	8	meta	meta	ADJ
bam-8776	111	9	-	-	PUNCT
bam-8776	111	10	analysis	analysis	NOUN
bam-8776	111	11	.	.	PUNCT
bam-8776	112	1	br	br	PROPN
bam-8776	112	2	j	j	PROPN
bam-8776	112	3	cancer	cancer	PROPN
bam-8776	112	4	2012;107:1608	2012;107:1608	PROPN
bam-8776	112	5	-	-	SYM
bam-8776	112	6	17	17	NUM
bam-8776	112	7	.	.	PUNCT
bam-8776	112	8	19	19	NUM
bam-8776	112	9	.	.	PUNCT
bam-8776	113	1	van	van	PROPN
bam-8776	113	2	den	den	PROPN
bam-8776	113	3	brandt	brandt	PROPN
bam-8776	113	4	pa	pa	PROPN
bam-8776	113	5	,	,	PUNCT
bam-8776	113	6	spiegelman	spiegelman	NOUN
bam-8776	113	7	d	d	PROPN
bam-8776	113	8	,	,	PUNCT
bam-8776	113	9	yaun	yaun	PROPN
bam-8776	113	10	s	s	PROPN
bam-8776	113	11	-	-	PUNCT
bam-8776	113	12	s	s	PROPN
bam-8776	113	13	,	,	PUNCT
bam-8776	113	14	et	et	PROPN
bam-8776	113	15	al	al	PROPN
bam-8776	113	16	.	.	PROPN
bam-8776	113	17	pooled	pool	VERB
bam-8776	113	18	analysis	analysis	NOUN
bam-8776	113	19	of	of	ADP
bam-8776	113	20	prospective	prospective	ADJ
bam-8776	113	21	cohort	cohort	NOUN
bam-8776	113	22	studies	study	NOUN
bam-8776	113	23	on	on	ADP
bam-8776	113	24	height	height	NOUN
bam-8776	113	25	,	,	PUNCT
bam-8776	113	26	weight	weight	NOUN
bam-8776	113	27	,	,	PUNCT
bam-8776	113	28	and	and	CCONJ
bam-8776	113	29	breast	breast	NOUN
bam-8776	113	30	cancer	cancer	NOUN
bam-8776	113	31	risk	risk	NOUN
bam-8776	113	32	.	.	PUNCT
bam-8776	114	1	am	be	AUX
bam-8776	114	2	j	j	PROPN
bam-8776	114	3	epidemiol	epidemiol	PROPN
bam-8776	114	4	2000;152:514	2000;152:514	PROPN
bam-8776	114	5	-	-	SYM
bam-8776	114	6	27	27	NUM
bam-8776	114	7	.	.	PUNCT
bam-8776	115	1	20	20	NUM
bam-8776	115	2	.	.	PUNCT
bam-8776	116	1	morimoto	morimoto	PROPN
bam-8776	116	2	lm	lm	PROPN
bam-8776	116	3	,	,	PUNCT
bam-8776	116	4	white	white	PROPN
bam-8776	116	5	e	e	PROPN
bam-8776	116	6	,	,	PUNCT
bam-8776	116	7	chen	chen	PROPN
bam-8776	116	8	z	z	PROPN
bam-8776	116	9	,	,	PUNCT
bam-8776	116	10	et	et	PROPN
bam-8776	116	11	al	al	PROPN
bam-8776	116	12	.	.	PUNCT
bam-8776	116	13	obesity	obesity	NOUN
bam-8776	116	14	,	,	PUNCT
bam-8776	116	15	body	body	NOUN
bam-8776	116	16	size	size	NOUN
bam-8776	116	17	,	,	PUNCT
bam-8776	116	18	and	and	CCONJ
bam-8776	116	19	risk	risk	NOUN
bam-8776	116	20	of	of	ADP
bam-8776	116	21	postmenopausal	postmenopausal	ADJ
bam-8776	116	22	breast	breast	NOUN
bam-8776	116	23	cancer	cancer	NOUN
bam-8776	116	24	:	:	PUNCT
bam-8776	116	25	the	the	DET
bam-8776	116	26	women	woman	NOUN
bam-8776	116	27	's	's	PART
bam-8776	116	28	health	health	NOUN
bam-8776	116	29	initiative	initiative	NOUN
bam-8776	116	30	(	(	PUNCT
bam-8776	116	31	united	united	PROPN
bam-8776	116	32	states	states	PROPN
bam-8776	116	33	)	)	PUNCT
bam-8776	116	34	.	.	PUNCT
bam-8776	117	1	cancer	cancer	NOUN
bam-8776	117	2	causes	cause	VERB
bam-8776	117	3	control	control	NOUN
bam-8776	117	4	2002;13:741	2002;13:741	NOUN
bam-8776	117	5	-	-	SYM
bam-8776	117	6	51	51	NUM
bam-8776	117	7	.	.	PUNCT
bam-8776	118	1	21	21	NUM
bam-8776	118	2	.	.	PUNCT
bam-8776	119	1	tournberg	tournberg	PROPN
bam-8776	119	2	s	s	PROPN
bam-8776	119	3	,	,	PUNCT
bam-8776	119	4	holm	holm	PROPN
bam-8776	119	5	l	l	PROPN
bam-8776	119	6	,	,	PUNCT
bam-8776	119	7	carstensen	carstensen	VERB
bam-8776	119	8	j.	j.	PROPN
bam-8776	119	9	breast	breast	PROPN
bam-8776	119	10	cancer	cancer	NOUN
bam-8776	119	11	risk	risk	NOUN
bam-8776	119	12	in	in	ADP
bam-8776	119	13	relation	relation	NOUN
bam-8776	119	14	to	to	PART
bam-8776	119	15	serum	serum	VERB
bam-8776	119	16	cholesterol	cholesterol	NOUN
bam-8776	119	17	,	,	PUNCT
bam-8776	119	18	serum	serum	NOUN
bam-8776	119	19	betalipoprotein	betalipoprotein	ADJ
bam-8776	119	20	,	,	PUNCT
bam-8776	119	21	height	height	NOUN
bam-8776	119	22	,	,	PUNCT
bam-8776	119	23	weight	weight	NOUN
bam-8776	119	24	,	,	PUNCT
bam-8776	119	25	and	and	CCONJ
bam-8776	119	26	blood	blood	NOUN
bam-8776	119	27	pressure	pressure	NOUN
bam-8776	119	28	.	.	PUNCT
bam-8776	120	1	acta	acta	PROPN
bam-8776	120	2	oncol	oncol	ADJ
bam-8776	120	3	1988;27:31	1988;27:31	NUM
bam-8776	120	4	-	-	SYM
bam-8776	120	5	7	7	NUM
bam-8776	120	6	.	.	NOUN
bam-8776	120	7	22	22	NUM
bam-8776	120	8	.	.	PUNCT
bam-8776	121	1	soler	soler	PROPN
bam-8776	121	2	m	m	PROPN
bam-8776	121	3	,	,	PUNCT
bam-8776	121	4	chatenoud	chatenoud	PROPN
bam-8776	121	5	l	l	NOUN
bam-8776	121	6	,	,	PUNCT
bam-8776	121	7	negri	negri	PROPN
bam-8776	121	8	e	e	PROPN
bam-8776	121	9	,	,	PUNCT
bam-8776	121	10	et	et	PROPN
bam-8776	121	11	al	al	PROPN
bam-8776	121	12	.	.	PUNCT
bam-8776	121	13	hypertension	hypertension	NOUN
bam-8776	121	14	and	and	CCONJ
bam-8776	121	15	hormone	hormone	NOUN
bam-8776	121	16	-	-	PUNCT
bam-8776	121	17	related	relate	VERB
bam-8776	121	18	neoplasms	neoplasm	NOUN
bam-8776	121	19	in	in	ADP
bam-8776	121	20	women	woman	NOUN
bam-8776	121	21	.	.	PUNCT
bam-8776	122	1	hypertension	hypertension	NOUN
bam-8776	122	2	1999;34:320	1999;34:320	NUM
bam-8776	122	3	-	-	SYM
bam-8776	122	4	5	5	NUM
bam-8776	122	5	23	23	NUM
bam-8776	122	6	.	.	PUNCT
bam-8776	123	1	manjer	manjer	PROPN
bam-8776	123	2	j	j	PROPN
bam-8776	123	3	,	,	PUNCT
bam-8776	123	4	kaaks	kaaks	PROPN
bam-8776	123	5	r	r	PROPN
bam-8776	123	6	,	,	PUNCT
bam-8776	123	7	riboli	riboli	ADJ
bam-8776	123	8	e	e	NOUN
bam-8776	123	9	,	,	PUNCT
bam-8776	123	10	berglund	berglund	PROPN
bam-8776	123	11	g.	g.	PROPN
bam-8776	123	12	risk	risk	NOUN
bam-8776	123	13	of	of	ADP
bam-8776	123	14	breast	breast	NOUN
bam-8776	123	15	cancer	cancer	NOUN
bam-8776	123	16	in	in	ADP
bam-8776	123	17	relation	relation	NOUN
bam-8776	123	18	to	to	PART
bam-8776	123	19	anthropometry	anthropometry	VERB
bam-8776	123	20	,	,	PUNCT
bam-8776	123	21	blood	blood	NOUN
bam-8776	123	22	pressure	pressure	NOUN
bam-8776	123	23	,	,	PUNCT
bam-8776	123	24	blood	blood	NOUN
bam-8776	123	25	lipids	lipid	NOUN
bam-8776	123	26	and	and	CCONJ
bam-8776	123	27	glucose	glucose	NOUN
bam-8776	123	28	metabolism	metabolism	NOUN
bam-8776	123	29	:	:	PUNCT
bam-8776	123	30	a	a	DET
bam-8776	123	31	prospective	prospective	ADJ
bam-8776	123	32	study	study	NOUN
bam-8776	123	33	within	within	ADP
bam-8776	123	34	the	the	DET
bam-8776	123	35	malmö	malmö	PROPN
bam-8776	123	36	preventive	preventive	ADJ
bam-8776	123	37	project	project	NOUN
bam-8776	123	38	.	.	PUNCT
bam-8776	124	1	eur	eur	PROPN
bam-8776	124	2	j	j	PROPN
bam-8776	124	3	cancer	cancer	NOUN
bam-8776	124	4	prev	prev	X
bam-8776	124	5	2001;10:33	2001;10:33	NUM
bam-8776	124	6	-	-	SYM
bam-8776	124	7	42	42	NUM
bam-8776	124	8	.	.	PUNCT
bam-8776	125	1	24	24	NUM
bam-8776	125	2	.	.	PUNCT
bam-8776	126	1	peeters	peeter	NOUN
bam-8776	126	2	ph	ph	VERB
bam-8776	126	3	,	,	PUNCT
bam-8776	126	4	van	van	PROPN
bam-8776	126	5	noord	noord	PROPN
bam-8776	126	6	pa	pa	PROPN
bam-8776	126	7	,	,	PUNCT
bam-8776	126	8	hoes	hoe	NOUN
bam-8776	126	9	aw	aw	INTJ
bam-8776	126	10	,	,	PUNCT
bam-8776	126	11	et	et	PROPN
bam-8776	126	12	al	al	PROPN
bam-8776	126	13	.	.	PUNCT
bam-8776	127	1	hypertension	hypertension	NOUN
bam-8776	127	2	and	and	CCONJ
bam-8776	127	3	breast	breast	NOUN
bam-8776	127	4	cancer	cancer	NOUN
bam-8776	127	5	risk	risk	NOUN
bam-8776	127	6	in	in	ADP
bam-8776	127	7	a	a	DET
bam-8776	127	8	19	19	NUM
bam-8776	127	9	-	-	PUNCT
bam-8776	127	10	year	year	NOUN
bam-8776	127	11	follow	follow	NOUN
bam-8776	127	12	-	-	PUNCT
bam-8776	127	13	up	up	ADP
bam-8776	127	14	study	study	NOUN
bam-8776	127	15	(	(	PUNCT
bam-8776	127	16	the	the	DET
bam-8776	127	17	dom	dom	NOUN
bam-8776	127	18	cohort	cohort	NOUN
bam-8776	127	19	)	)	PUNCT
bam-8776	127	20	.	.	PUNCT
bam-8776	128	1	j	j	PROPN
bam-8776	128	2	hypertens	hyperten	NOUN
bam-8776	128	3	2000;18:249	2000;18:249	PROPN
bam-8776	128	4	-	-	SYM
bam-8776	128	5	54	54	NUM
bam-8776	128	6	.	.	PUNCT
bam-8776	128	7	25	25	NUM
bam-8776	128	8	.	.	PUNCT
bam-8776	129	1	detection	detection	NOUN
bam-8776	129	2	epo	epo	PROPN
bam-8776	129	3	.	.	PUNCT
bam-8776	130	1	executive	executive	ADJ
bam-8776	130	2	summary	summary	NOUN
bam-8776	130	3	of	of	ADP
bam-8776	130	4	the	the	DET
bam-8776	130	5	third	third	ADJ
bam-8776	130	6	report	report	NOUN
bam-8776	130	7	of	of	ADP
bam-8776	130	8	the	the	DET
bam-8776	130	9	national	national	ADJ
bam-8776	130	10	cholesterol	cholesterol	PROPN
bam-8776	130	11	education	education	NOUN
bam-8776	130	12	program	program	NOUN
bam-8776	130	13	(	(	PUNCT
bam-8776	130	14	ncep	ncep	NOUN
bam-8776	130	15	)	)	PUNCT
bam-8776	130	16	expert	expert	NOUN
bam-8776	130	17	panel	panel	NOUN
bam-8776	130	18	on	on	ADP
bam-8776	130	19	detection	detection	NOUN
bam-8776	130	20	,	,	PUNCT
bam-8776	130	21	evaluation	evaluation	NOUN
bam-8776	130	22	,	,	PUNCT
bam-8776	130	23	and	and	CCONJ
bam-8776	130	24	treatment	treatment	NOUN
bam-8776	130	25	of	of	ADP
bam-8776	130	26	high	high	ADJ
bam-8776	130	27	blood	blood	NOUN
bam-8776	130	28	cholesterol	cholesterol	NOUN
bam-8776	130	29	in	in	ADP
bam-8776	130	30	adults	adult	NOUN
bam-8776	130	31	(	(	PUNCT
bam-8776	130	32	adult	adult	NOUN
bam-8776	130	33	treatment	treatment	NOUN
bam-8776	130	34	panel	panel	NOUN
bam-8776	130	35	iii	iii	PROPN
bam-8776	130	36	)	)	PUNCT
bam-8776	130	37	.	.	PUNCT
bam-8776	131	1	jama	jama	PROPN
bam-8776	131	2	2001;285:2486	2001;285:2486	NUM
bam-8776	131	3	-	-	SYM
bam-8776	131	4	497	497	NUM
bam-8776	131	5	.	.	NOUN
bam-8776	132	1	26	26	NUM
bam-8776	132	2	.	.	PUNCT
bam-8776	133	1	ford	ford	PROPN
bam-8776	133	2	es	es	PROPN
bam-8776	133	3	,	,	PUNCT
bam-8776	133	4	giles	giles	PROPN
bam-8776	133	5	wh	wh	PROPN
bam-8776	133	6	,	,	PUNCT
bam-8776	133	7	dietz	dietz	PROPN
bam-8776	133	8	wh	wh	PROPN
bam-8776	133	9	.	.	PUNCT
bam-8776	134	1	prevalence	prevalence	NOUN
bam-8776	134	2	of	of	ADP
bam-8776	134	3	the	the	DET
bam-8776	134	4	metabolic	metabolic	NOUN
bam-8776	134	5	syndrome	syndrome	NOUN
bam-8776	134	6	among	among	ADP
bam-8776	134	7	us	us	PROPN
bam-8776	134	8	adults	adult	NOUN
bam-8776	134	9	:	:	PUNCT
bam-8776	134	10	findings	finding	NOUN
bam-8776	134	11	from	from	ADP
bam-8776	134	12	the	the	DET
bam-8776	134	13	third	third	ADJ
bam-8776	134	14	national	national	PROPN
bam-8776	134	15	health	health	NOUN
bam-8776	134	16	and	and	CCONJ
bam-8776	134	17	nutrition	nutrition	NOUN
bam-8776	134	18	examination	examination	NOUN
bam-8776	134	19	survey	survey	NOUN
bam-8776	134	20	.	.	PUNCT
bam-8776	135	1	jama	jama	PROPN
bam-8776	135	2	2002;287:356	2002;287:356	NUM
bam-8776	135	3	-	-	SYM
bam-8776	135	4	9	9	NUM
bam-8776	135	5	.	.	NOUN
bam-8776	135	6	27	27	NUM
bam-8776	135	7	.	.	PUNCT
bam-8776	136	1	hauner	hauner	PROPN
bam-8776	136	2	d	d	PROPN
bam-8776	136	3	,	,	PUNCT
bam-8776	136	4	hauner	hauner	PROPN
bam-8776	136	5	h.	h.	PROPN
bam-8776	136	6	metabolic	metabolic	PROPN
bam-8776	136	7	syndrome	syndrome	PROPN
bam-8776	136	8	and	and	CCONJ
bam-8776	136	9	breast	breast	NOUN
bam-8776	136	10	cancer	cancer	NOUN
bam-8776	136	11	:	:	PUNCT
bam-8776	136	12	is	be	AUX
bam-8776	136	13	there	there	PRON
bam-8776	136	14	a	a	DET
bam-8776	136	15	link	link	NOUN
bam-8776	136	16	?	?	PUNCT
bam-8776	137	1	breast	breast	NOUN
bam-8776	137	2	care	care	NOUN
bam-8776	137	3	2014;9:277	2014;9:277	PROPN
bam-8776	137	4	-	-	PUNCT
bam-8776	137	5	81	81	NUM
bam-8776	137	6	.	.	PUNCT
bam-8776	138	1	28	28	NUM
bam-8776	138	2	.	.	PUNCT
bam-8776	139	1	eckel	eckel	PROPN
bam-8776	139	2	rh	rh	PROPN
bam-8776	139	3	,	,	PUNCT
bam-8776	139	4	grundy	grundy	PROPN
bam-8776	139	5	sm	sm	PROPN
bam-8776	139	6	,	,	PUNCT
bam-8776	139	7	zimmet	zimmet	NOUN
bam-8776	139	8	pz	pz	NOUN
bam-8776	139	9	.	.	PUNCT
bam-8776	140	1	the	the	DET
bam-8776	140	2	metabolic	metabolic	NOUN
bam-8776	140	3	syndrome	syndrome	NOUN
bam-8776	140	4	.	.	PUNCT
bam-8776	141	1	the	the	DET
bam-8776	141	2	lancet	lancet	PROPN
bam-8776	141	3	.	.	PUNCT
bam-8776	142	1	2005;365:1415	2005;365:1415	NUM
bam-8776	142	2	-	-	SYM
bam-8776	142	3	28	28	NUM
bam-8776	142	4	.	.	PUNCT
bam-8776	143	1	29	29	NUM
bam-8776	143	2	.	.	PUNCT
bam-8776	144	1	coughlin	coughlin	PROPN
bam-8776	144	2	ss	ss	PROPN
bam-8776	144	3	,	,	PUNCT
bam-8776	144	4	calle	calle	PROPN
bam-8776	144	5	ee	ee	PROPN
bam-8776	144	6	,	,	PUNCT
bam-8776	144	7	teras	teras	PROPN
bam-8776	144	8	lr	lr	PROPN
bam-8776	144	9	,	,	PUNCT
bam-8776	144	10	et	et	PROPN
bam-8776	144	11	al	al	PROPN
bam-8776	144	12	.	.	PROPN
bam-8776	145	1	diabetes	diabete	NOUN
bam-8776	145	2	mellitus	mellitus	NOUN
bam-8776	145	3	as	as	ADP
bam-8776	145	4	a	a	DET
bam-8776	145	5	predictor	predictor	NOUN
bam-8776	145	6	of	of	ADP
bam-8776	145	7	cancer	cancer	NOUN
bam-8776	145	8	mortality	mortality	NOUN
bam-8776	145	9	in	in	ADP
bam-8776	145	10	a	a	DET
bam-8776	145	11	large	large	ADJ
bam-8776	145	12	cohort	cohort	NOUN
bam-8776	145	13	of	of	ADP
bam-8776	145	14	us	us	PROPN
bam-8776	145	15	adults	adult	NOUN
bam-8776	145	16	.	.	PUNCT
bam-8776	146	1	am	be	AUX
bam-8776	146	2	j	j	PROPN
bam-8776	146	3	epidemiol	epidemiol	PROPN
bam-8776	146	4	2004;159:1160	2004;159:1160	NUM
bam-8776	146	5	-	-	SYM
bam-8776	146	6	7	7	NUM
bam-8776	146	7	.	.	NOUN
bam-8776	146	8	30	30	NUM
bam-8776	146	9	.	.	PUNCT
bam-8776	147	1	xue	xue	PROPN
bam-8776	147	2	f	f	PROPN
bam-8776	147	3	,	,	PUNCT
bam-8776	147	4	michels	michels	PROPN
bam-8776	147	5	kb	kb	PROPN
bam-8776	147	6	.	.	PUNCT
bam-8776	148	1	diabetes	diabetes	NOUN
bam-8776	148	2	,	,	PUNCT
bam-8776	148	3	metabolic	metabolic	NOUN
bam-8776	148	4	syndrome	syndrome	NOUN
bam-8776	148	5	,	,	PUNCT
bam-8776	148	6	and	and	CCONJ
bam-8776	148	7	breast	breast	NOUN
bam-8776	148	8	cancer	cancer	NOUN
bam-8776	148	9	:	:	PUNCT
bam-8776	148	10	a	a	DET
bam-8776	148	11	review	review	NOUN
bam-8776	148	12	of	of	ADP
bam-8776	148	13	the	the	DET
bam-8776	148	14	current	current	ADJ
bam-8776	148	15	evidence	evidence	NOUN
bam-8776	148	16	.	.	PUNCT
bam-8776	149	1	am	be	AUX
bam-8776	149	2	j	j	PROPN
bam-8776	149	3	clin	clin	PROPN
bam-8776	149	4	nutr	nutr	PROPN
bam-8776	149	5	2007;86	2007;86	NUM
bam-8776	149	6	:	:	PUNCT
bam-8776	149	7	s823	s823	PROPN
bam-8776	149	8	-	-	SYM
bam-8776	149	9	35	35	NUM
bam-8776	149	10	.	.	PUNCT
bam-8776	150	1	31	31	NUM
bam-8776	150	2	.	.	PUNCT
bam-8776	151	1	peairs	peair	NOUN
bam-8776	151	2	ks	ks	PROPN
bam-8776	151	3	,	,	PUNCT
bam-8776	151	4	barone	barone	PROPN
bam-8776	151	5	bb	bb	PROPN
bam-8776	151	6	,	,	PUNCT
bam-8776	151	7	snyder	snyder	PROPN
bam-8776	151	8	cf	cf	PROPN
bam-8776	151	9	,	,	PUNCT
bam-8776	151	10	et	et	PROPN
bam-8776	151	11	al	al	PROPN
bam-8776	151	12	.	.	PROPN
bam-8776	151	13	diabetes	diabete	VERB
bam-8776	151	14	mellitus	mellitus	NOUN
bam-8776	151	15	and	and	CCONJ
bam-8776	151	16	breast	breast	NOUN
bam-8776	151	17	cancer	cancer	NOUN
bam-8776	151	18	outcomes	outcome	NOUN
bam-8776	151	19	:	:	PUNCT
bam-8776	151	20	a	a	DET
bam-8776	151	21	systematic	systematic	ADJ
bam-8776	151	22	review	review	NOUN
bam-8776	151	23	and	and	CCONJ
bam-8776	151	24	meta	meta	ADJ
bam-8776	151	25	-	-	PUNCT
bam-8776	151	26	analysis	analysis	NOUN
bam-8776	151	27	.	.	PUNCT
bam-8776	152	1	j	j	PROPN
bam-8776	152	2	clin	clin	PROPN
bam-8776	152	3	oncol	oncol	PROPN
bam-8776	152	4	2011;29:40	2011;29:40	PROPN
bam-8776	152	5	-	-	SYM
bam-8776	152	6	6	6	NUM
bam-8776	152	7	.	.	NOUN
bam-8776	152	8	32	32	NUM
bam-8776	152	9	.	.	PUNCT
bam-8776	153	1	dibaba	dibaba	PROPN
bam-8776	153	2	dt	dt	PROPN
bam-8776	153	3	,	,	PUNCT
bam-8776	153	4	ogunsina	ogunsina	PROPN
bam-8776	153	5	k	k	PROPN
bam-8776	153	6	,	,	PUNCT
bam-8776	153	7	braithwaite	braithwaite	PROPN
bam-8776	153	8	d	d	PROPN
bam-8776	153	9	,	,	PUNCT
bam-8776	153	10	et	et	PROPN
bam-8776	153	11	al	al	PROPN
bam-8776	153	12	.	.	PROPN
bam-8776	153	13	metabolic	metabolic	PROPN
bam-8776	153	14	syndrome	syndrome	NOUN
bam-8776	153	15	and	and	CCONJ
bam-8776	153	16	risk	risk	NOUN
bam-8776	153	17	of	of	ADP
bam-8776	153	18	breast	breast	NOUN
bam-8776	153	19	cancer	cancer	NOUN
bam-8776	153	20	mortality	mortality	NOUN
bam-8776	153	21	by	by	ADP
bam-8776	153	22	menopause	menopause	NOUN
bam-8776	153	23	,	,	PUNCT
bam-8776	153	24	obesity	obesity	NOUN
bam-8776	153	25	,	,	PUNCT
bam-8776	153	26	and	and	CCONJ
bam-8776	153	27	subtype	subtype	NOUN
bam-8776	153	28	.	.	PUNCT
bam-8776	154	1	breast	breast	NOUN
bam-8776	154	2	cancer	cancer	NOUN
bam-8776	154	3	res	re	NOUN
bam-8776	154	4	treat	treat	VERB
bam-8776	154	5	2019;174:209	2019;174:209	NUM
bam-8776	154	6	-	-	SYM
bam-8776	154	7	218	218	NUM
bam-8776	154	8	.	.	PUNCT
bam-8776	155	1	33	33	NUM
bam-8776	155	2	.	.	PUNCT
bam-8776	156	1	yancik	yancik	PROPN
bam-8776	156	2	r	r	PROPN
bam-8776	156	3	,	,	PUNCT
bam-8776	156	4	wesley	wesley	PROPN
bam-8776	156	5	mn	mn	PROPN
bam-8776	156	6	,	,	PUNCT
bam-8776	156	7	ries	ries	PROPN
bam-8776	156	8	la	la	PROPN
bam-8776	156	9	,	,	PUNCT
bam-8776	156	10	et	et	PROPN
bam-8776	156	11	al	al	PROPN
bam-8776	156	12	.	.	PROPN
bam-8776	156	13	effect	effect	NOUN
bam-8776	156	14	of	of	ADP
bam-8776	156	15	age	age	NOUN
bam-8776	156	16	and	and	CCONJ
bam-8776	156	17	comorbidity	comorbidity	NOUN
bam-8776	156	18	in	in	ADP
bam-8776	156	19	postmenopausal	postmenopausal	ADJ
bam-8776	156	20	breast	breast	NOUN
bam-8776	156	21	cancer	cancer	NOUN
bam-8776	156	22	patients	patient	NOUN
bam-8776	156	23	aged	age	VERB
bam-8776	156	24	55	55	NUM
bam-8776	156	25	years	year	NOUN
bam-8776	156	26	and	and	CCONJ
bam-8776	156	27	older	old	ADJ
bam-8776	156	28	.	.	PUNCT
bam-8776	157	1	jama	jama	PROPN
bam-8776	157	2	2001;285:885	2001;285:885	PROPN
bam-8776	157	3	-	-	SYM
bam-8776	157	4	92	92	NUM
bam-8776	157	5	.	.	PUNCT
bam-8776	158	1	34	34	NUM
bam-8776	158	2	.	.	PUNCT
bam-8776	159	1	ayeni	ayeni	PROPN
bam-8776	159	2	o	o	PROPN
bam-8776	159	3	,	,	PUNCT
bam-8776	159	4	joffe	joffe	PROPN
bam-8776	159	5	m	m	PROPN
bam-8776	159	6	,	,	PUNCT
bam-8776	159	7	cubasch	cubasch	VERB
bam-8776	159	8	h	h	PROPN
bam-8776	159	9	,	,	PUNCT
bam-8776	159	10	et	et	PROPN
bam-8776	159	11	al	al	PROPN
bam-8776	159	12	.	.	PUNCT
bam-8776	160	1	prevalence	prevalence	NOUN
bam-8776	160	2	of	of	ADP
bam-8776	160	3	comorbidities	comorbiditie	NOUN
bam-8776	160	4	in	in	ADP
bam-8776	160	5	women	woman	NOUN
bam-8776	160	6	with	with	ADP
bam-8776	160	7	and	and	CCONJ
bam-8776	160	8	without	without	ADP
bam-8776	160	9	breast	breast	NOUN
bam-8776	160	10	cancer	cancer	NOUN
bam-8776	160	11	in	in	ADP
bam-8776	160	12	soweto	soweto	PROPN
bam-8776	160	13	,	,	PUNCT
bam-8776	160	14	south	south	PROPN
bam-8776	160	15	africa	africa	PROPN
bam-8776	160	16	:	:	PUNCT
bam-8776	160	17	results	result	NOUN
bam-8776	160	18	from	from	ADP
bam-8776	160	19	the	the	DET
bam-8776	160	20	sabc	sabc	PROPN
bam-8776	160	21	study	study	NOUN
bam-8776	160	22	.	.	PUNCT
bam-8776	161	1	s	s	PROPN
bam-8776	161	2	afr	afr	PROPN
bam-8776	161	3	med	med	PROPN
bam-8776	161	4	j	j	PROPN
bam-8776	161	5	2019;109:264	2019;109:264	NUM
bam-8776	161	6	-	-	SYM
bam-8776	161	7	271	271	NUM
bam-8776	161	8	.	.	X
bam-8776	161	9	35	35	NUM
bam-8776	161	10	.	.	PUNCT
bam-8776	162	1	lega	lega	PROPN
bam-8776	162	2	ic	ic	PROPN
bam-8776	162	3	,	,	PUNCT
bam-8776	162	4	austin	austin	PROPN
bam-8776	162	5	pc	pc	PROPN
bam-8776	162	6	,	,	PUNCT
bam-8776	162	7	fischer	fischer	PROPN
bam-8776	162	8	hd	hd	PROPN
bam-8776	162	9	,	,	PUNCT
bam-8776	162	10	et	et	PROPN
bam-8776	162	11	al	al	PROPN
bam-8776	162	12	.	.	PUNCT
bam-8776	163	1	the	the	DET
bam-8776	163	2	impact	impact	NOUN
bam-8776	163	3	of	of	ADP
bam-8776	163	4	diabetes	diabetes	NOUN
bam-8776	163	5	on	on	ADP
bam-8776	163	6	breast	breast	NOUN
bam-8776	163	7	cancer	cancer	NOUN
bam-8776	163	8	treatments	treatment	NOUN
bam-8776	163	9	and	and	CCONJ
bam-8776	163	10	outcomes	outcome	NOUN
bam-8776	163	11	:	:	PUNCT
bam-8776	163	12	a	a	DET
bam-8776	163	13	population	population	NOUN
bam-8776	163	14	-	-	PUNCT
bam-8776	163	15	based	base	VERB
bam-8776	163	16	study	study	NOUN
bam-8776	163	17	.	.	PUNCT
bam-8776	164	1	diabetes	diabetes	NOUN
bam-8776	164	2	care	care	VERB
bam-8776	164	3	2018;41:755	2018;41:755	NOUN
bam-8776	164	4	-	-	PUNCT
bam-8776	164	5	761	761	NUM
bam-8776	164	6	.	.	PUNCT
bam-8776	165	1	36	36	NUM
bam-8776	165	2	.	.	PUNCT
bam-8776	165	3	du	du	PROPN
bam-8776	165	4	w	w	PROPN
bam-8776	165	5	,	,	PUNCT
bam-8776	165	6	simon	simon	PROPN
bam-8776	165	7	ms	ms	PROPN
bam-8776	165	8	.	.	PROPN
bam-8776	165	9	racial	racial	ADJ
bam-8776	165	10	disparities	disparity	NOUN
bam-8776	165	11	in	in	ADP
bam-8776	165	12	treatment	treatment	NOUN
bam-8776	165	13	and	and	CCONJ
bam-8776	165	14	survival	survival	NOUN
bam-8776	165	15	of	of	ADP
bam-8776	165	16	women	woman	NOUN
bam-8776	165	17	with	with	ADP
bam-8776	165	18	stage	stage	NOUN
bam-8776	165	19	i	i	PROPN
bam-8776	165	20	–	–	PUNCT
bam-8776	165	21	iii	iii	NUM
bam-8776	165	22	breast	breast	NOUN
bam-8776	165	23	cancer	cancer	NOUN
bam-8776	165	24	at	at	ADP
bam-8776	165	25	a	a	DET
bam-8776	165	26	large	large	ADJ
bam-8776	165	27	academic	academic	ADJ
bam-8776	165	28	medical	medical	ADJ
bam-8776	165	29	center	center	NOUN
bam-8776	165	30	in	in	ADP
bam-8776	165	31	metropolitan	metropolitan	PROPN
bam-8776	165	32	detroit	detroit	PROPN
bam-8776	165	33	.	.	PUNCT
bam-8776	166	1	breast	breast	NOUN
bam-8776	166	2	cancer	cancer	NOUN
bam-8776	166	3	res	re	NOUN
bam-8776	166	4	treat	treat	VERB
bam-8776	166	5	2005;91:243	2005;91:243	NUM
bam-8776	166	6	-	-	PUNCT
bam-8776	166	7	8	8	NUM
bam-8776	166	8	.	.	PUNCT
bam-8776	166	9	37	37	NUM
bam-8776	166	10	.	.	PUNCT
bam-8776	167	1	chang	chang	PROPN
bam-8776	167	2	ys	ys	PROPN
bam-8776	167	3	,	,	PUNCT
bam-8776	167	4	seo	seo	NOUN
bam-8776	167	5	e	e	PROPN
bam-8776	167	6	-	-	PROPN
bam-8776	167	7	k	k	PROPN
bam-8776	167	8	,	,	PUNCT
bam-8776	167	9	gyllenhaal	gyllenhaal	PROPN
bam-8776	167	10	c	c	AUX
bam-8776	167	11	,	,	PUNCT
bam-8776	167	12	block	block	NOUN
bam-8776	167	13	ki	ki	PROPN
bam-8776	167	14	.	.	PUNCT
bam-8776	168	1	panax	panax	PROPN
bam-8776	168	2	ginseng	ginseng	PROPN
bam-8776	168	3	:	:	PUNCT
bam-8776	168	4	a	a	DET
bam-8776	168	5	role	role	NOUN
bam-8776	168	6	in	in	ADP
bam-8776	168	7	cancer	cancer	NOUN
bam-8776	168	8	therapy	therapy	NOUN
bam-8776	168	9	?	?	PUNCT
bam-8776	169	1	integr	integr	PROPN
bam-8776	169	2	cancer	cancer	PROPN
bam-8776	169	3	ther	ther	ADV
bam-8776	169	4	2003;2:13	2003;2:13	ADJ
bam-8776	169	5	-	-	SYM
bam-8776	169	6	33	33	NUM
bam-8776	169	7	.	.	PUNCT
bam-8776	170	1	review	review	NOUN
bam-8776	170	2	.	.	PUNCT
bam-8776	171	1	38	38	NUM
bam-8776	171	2	.	.	PUNCT
bam-8776	172	1	papa	papa	PROPN
bam-8776	172	2	v	v	PROPN
bam-8776	172	3	,	,	PUNCT
bam-8776	172	4	pezzino	pezzino	NOUN
bam-8776	172	5	v	v	NOUN
bam-8776	172	6	,	,	PUNCT
bam-8776	172	7	costantino	costantino	PROPN
bam-8776	172	8	a	a	PROPN
bam-8776	172	9	,	,	PUNCT
bam-8776	172	10	et	et	PROPN
bam-8776	172	11	al	al	PROPN
bam-8776	172	12	.	.	PROPN
bam-8776	172	13	elevated	elevate	VERB
bam-8776	172	14	insulin	insulin	NOUN
bam-8776	172	15	receptor	receptor	NOUN
bam-8776	172	16	content	content	NOUN
bam-8776	172	17	in	in	ADP
bam-8776	172	18	human	human	ADJ
bam-8776	172	19	breast	breast	NOUN
bam-8776	172	20	cancer	cancer	NOUN
bam-8776	172	21	.	.	PUNCT
bam-8776	173	1	j	j	PROPN
bam-8776	173	2	clin	clin	PROPN
bam-8776	173	3	invest	invest	VERB
bam-8776	173	4	1990;86:1503	1990;86:1503	NUM
bam-8776	173	5	-	-	SYM
bam-8776	173	6	10	10	NUM
bam-8776	173	7	.	.	PUNCT
bam-8776	173	8	39	39	NUM
bam-8776	173	9	.	.	PUNCT
bam-8776	174	1	sachdev	sachdev	PROPN
bam-8776	174	2	d	d	PROPN
bam-8776	174	3	,	,	PUNCT
bam-8776	174	4	yee	yee	PROPN
bam-8776	174	5	d.	d.	PROPN
bam-8776	174	6	the	the	DET
bam-8776	174	7	igf	igf	PROPN
bam-8776	174	8	system	system	NOUN
bam-8776	174	9	and	and	CCONJ
bam-8776	174	10	breast	breast	NOUN
bam-8776	174	11	cancer	cancer	NOUN
bam-8776	174	12	.	.	PUNCT
bam-8776	175	1	endocrine	endocrine	NOUN
bam-8776	175	2	-	-	PUNCT
bam-8776	175	3	related	relate	VERB
bam-8776	175	4	cancer	cancer	NOUN
bam-8776	175	5	2001;8:197	2001;8:197	PROPN
bam-8776	175	6	-	-	SYM
bam-8776	175	7	209	209	NUM
bam-8776	175	8	.	.	PUNCT
bam-8776	176	1	40	40	NUM
bam-8776	176	2	.	.	PUNCT
bam-8776	176	3	renehan	renehan	PROPN
bam-8776	176	4	ag	ag	PROPN
bam-8776	176	5	,	,	PUNCT
bam-8776	176	6	harvie	harvie	PROPN
bam-8776	176	7	m	m	PROPN
bam-8776	176	8	,	,	PUNCT
bam-8776	176	9	howell	howell	PROPN
bam-8776	176	10	a.	a.	NOUN
bam-8776	176	11	insulin	insulin	NOUN
bam-8776	176	12	-	-	PUNCT
bam-8776	176	13	like	like	ADJ
bam-8776	176	14	growth	growth	NOUN
bam-8776	176	15	factor	factor	NOUN
bam-8776	176	16	(	(	PUNCT
bam-8776	176	17	igf)-i	igf)-i	PROPN
bam-8776	176	18	,	,	PUNCT
bam-8776	176	19	igf	igf	PROPN
bam-8776	176	20	binding	bind	VERB
bam-8776	176	21	protein-3	protein-3	PROPN
bam-8776	176	22	,	,	PUNCT
bam-8776	176	23	and	and	CCONJ
bam-8776	176	24	breast	breast	NOUN
bam-8776	176	25	cancer	cancer	NOUN
bam-8776	176	26	risk	risk	NOUN
bam-8776	176	27	:	:	PUNCT
bam-8776	176	28	eight	eight	NUM
bam-8776	176	29	years	year	NOUN
bam-8776	176	30	on	on	ADP
bam-8776	176	31	.	.	PUNCT
bam-8776	177	1	endocr	endocr	PROPN
bam-8776	177	2	relat	relat	PROPN
bam-8776	177	3	cancer	cancer	NOUN
bam-8776	177	4	.	.	PUNCT
bam-8776	178	1	2006;13:273	2006;13:273	NUM
bam-8776	178	2	-	-	SYM
bam-8776	178	3	8	8	NUM
bam-8776	178	4	.	.	NOUN
bam-8776	178	5	41	41	NUM
bam-8776	178	6	.	.	PUNCT
bam-8776	179	1	vazquez	vazquez	PROPN
bam-8776	179	2	-	-	PUNCT
bam-8776	179	3	martin	martin	PROPN
bam-8776	179	4	a	a	PRON
bam-8776	179	5	,	,	PUNCT
bam-8776	179	6	oliveras	olivera	NOUN
bam-8776	179	7	-	-	NOUN
bam-8776	179	8	ferraros	ferraro	NOUN
bam-8776	179	9	c	c	X
bam-8776	179	10	,	,	PUNCT
bam-8776	179	11	del	del	PROPN
bam-8776	179	12	barco	barco	PROPN
bam-8776	179	13	s	s	PART
bam-8776	179	14	,	,	PUNCT
bam-8776	179	15	et	et	PROPN
bam-8776	179	16	al	al	PROPN
bam-8776	179	17	.	.	PUNCT
bam-8776	180	1	if	if	SCONJ
bam-8776	180	2	mammalian	mammalian	ADJ
bam-8776	180	3	target	target	NOUN
bam-8776	180	4	of	of	ADP
bam-8776	180	5	metformin	metformin	NOUN
bam-8776	180	6	indirectly	indirectly	ADV
bam-8776	180	7	is	be	AUX
bam-8776	180	8	mammalian	mammalian	ADJ
bam-8776	180	9	target	target	NOUN
bam-8776	180	10	of	of	ADP
bam-8776	180	11	rapamycin	rapamycin	NOUN
bam-8776	180	12	,	,	PUNCT
bam-8776	180	13	then	then	ADV
bam-8776	180	14	the	the	DET
bam-8776	180	15	insulinlike	insulinlike	NOUN
bam-8776	180	16	growth	growth	NOUN
bam-8776	180	17	factor-1	factor-1	NOUN
bam-8776	180	18	receptor	receptor	NOUN
bam-8776	180	19	axis	axis	NOUN
bam-8776	180	20	will	will	AUX
bam-8776	180	21	audit	audit	VERB
bam-8776	180	22	the	the	DET
bam-8776	180	23	efficacy	efficacy	NOUN
bam-8776	180	24	of	of	ADP
bam-8776	180	25	metformin	metformin	NOUN
bam-8776	180	26	in	in	ADP
bam-8776	180	27	cancer	cancer	NOUN
bam-8776	180	28	clinical	clinical	ADJ
bam-8776	180	29	trials	trial	NOUN
bam-8776	180	30	.	.	PUNCT
bam-8776	181	1	j	j	PROPN
bam-8776	181	2	clin	clin	PROPN
bam-8776	181	3	oncol	oncol	PROPN
bam-8776	181	4	.	.	PUNCT
bam-8776	182	1	2009;27	2009;27	NUM
bam-8776	182	2	:	:	PUNCT
bam-8776	182	3	e207	e207	NOUN
bam-8776	182	4	-	-	SYM
bam-8776	182	5	9	9	NUM
bam-8776	182	6	;	;	PUNCT
bam-8776	182	7	author	author	NOUN
bam-8776	182	8	reply	reply	NOUN
bam-8776	182	9	e210	e210	PRON
bam-8776	182	10	.	.	PROPN
bam-8776	183	1	42	42	NUM
bam-8776	183	2	.	.	PUNCT
bam-8776	184	1	bosco	bosco	PROPN
bam-8776	184	2	jlf	jlf	PROPN
bam-8776	184	3	,	,	PUNCT
bam-8776	184	4	antonsen	antonsen	PROPN
bam-8776	184	5	s	s	PROPN
bam-8776	184	6	,	,	PUNCT
bam-8776	184	7	sørensen	sørensen	PROPN
bam-8776	184	8	ht	ht	PROPN
bam-8776	184	9	,	,	PUNCT
bam-8776	184	10	et	et	PROPN
bam-8776	184	11	al	al	PROPN
bam-8776	184	12	.	.	PROPN
bam-8776	184	13	metformin	metformin	PROPN
bam-8776	184	14	and	and	CCONJ
bam-8776	184	15	incident	incident	NOUN
bam-8776	184	16	breast	breast	NOUN
bam-8776	184	17	cancer	cancer	NOUN
bam-8776	184	18	among	among	ADP
bam-8776	184	19	diabetic	diabetic	ADJ
bam-8776	184	20	women	woman	NOUN
bam-8776	184	21	:	:	PUNCT
bam-8776	184	22	a	a	DET
bam-8776	184	23	population	population	NOUN
bam-8776	184	24	-	-	PUNCT
bam-8776	184	25	based	base	VERB
bam-8776	184	26	case	case	NOUN
bam-8776	184	27	–	–	PUNCT
bam-8776	184	28	control	control	NOUN
bam-8776	184	29	study	study	NOUN
bam-8776	184	30	in	in	ADP
bam-8776	184	31	denmark	denmark	NOUN
bam-8776	184	32	.	.	PUNCT
bam-8776	185	1	cancer	cancer	NOUN
bam-8776	185	2	epidemiol	epidemiol	PROPN
bam-8776	185	3	biomarkers	biomarker	VERB
bam-8776	185	4	prev	prev	VERB
bam-8776	185	5	2011;20:101	2011;20:101	NUM
bam-8776	185	6	-	-	SYM
bam-8776	185	7	11	11	NUM
bam-8776	185	8	.	.	X
bam-8776	186	1	43	43	NUM
bam-8776	186	2	.	.	PUNCT
bam-8776	186	3	tang	tang	PROPN
bam-8776	186	4	gh	gh	PROPN
bam-8776	186	5	,	,	PUNCT
bam-8776	186	6	satkunam	satkunam	PROPN
bam-8776	186	7	m	m	PROPN
bam-8776	186	8	,	,	PUNCT
bam-8776	186	9	pond	pond	PROPN
bam-8776	186	10	gr	gr	PROPN
bam-8776	186	11	,	,	PUNCT
bam-8776	186	12	et	et	PROPN
bam-8776	186	13	al	al	PROPN
bam-8776	186	14	.	.	PROPN
bam-8776	186	15	association	association	PROPN
bam-8776	186	16	of	of	ADP
bam-8776	186	17	metformin	metformin	NOUN
bam-8776	186	18	with	with	ADP
bam-8776	186	19	breast	breast	NOUN
bam-8776	186	20	cancer	cancer	NOUN
bam-8776	186	21	incidence	incidence	NOUN
bam-8776	186	22	and	and	CCONJ
bam-8776	186	23	mortality	mortality	NOUN
bam-8776	186	24	in	in	ADP
bam-8776	186	25	patients	patient	NOUN
bam-8776	186	26	with	with	ADP
bam-8776	186	27	type	type	NOUN
bam-8776	186	28	ii	ii	NOUN
bam-8776	186	29	diabetes	diabetes	NOUN
bam-8776	186	30	:	:	PUNCT
bam-8776	186	31	a	a	DET
bam-8776	186	32	gradeassessed	gradeassesse	VERB
bam-8776	186	33	systematic	systematic	ADJ
bam-8776	186	34	review	review	NOUN
bam-8776	186	35	and	and	CCONJ
bam-8776	186	36	meta	meta	ADJ
bam-8776	186	37	-	-	PUNCT
bam-8776	186	38	analysis	analysis	NOUN
bam-8776	186	39	.	.	PUNCT
bam-8776	187	1	cancer	cancer	NOUN
bam-8776	187	2	epidemiol	epidemiol	PROPN
bam-8776	187	3	biomarkers	biomarkers	PROPN
bam-8776	187	4	prev	prev	VERB
bam-8776	187	5	2018;27:627635	2018;27:627635	NUM
bam-8776	187	6	.	.	PROPN
bam-8776	187	7	44	44	NUM
bam-8776	187	8	.	.	PUNCT
bam-8776	188	1	hong	hong	PROPN
bam-8776	188	2	j	j	PROPN
bam-8776	188	3	-	-	PUNCT
bam-8776	188	4	l	l	NOUN
bam-8776	188	5	,	,	PUNCT
bam-8776	188	6	funk	funk	NOUN
bam-8776	188	7	mj	mj	PROPN
bam-8776	188	8	,	,	PUNCT
bam-8776	188	9	buse	buse	PROPN
bam-8776	188	10	j	j	PROPN
bam-8776	188	11	,	,	PUNCT
bam-8776	188	12	et	et	PROPN
bam-8776	188	13	al	al	PROPN
bam-8776	188	14	.	.	PROPN
bam-8776	188	15	comparative	comparative	ADJ
bam-8776	188	16	effect	effect	NOUN
bam-8776	188	17	of	of	ADP
bam-8776	188	18	initiating	initiate	VERB
bam-8776	188	19	metformin	metformin	NOUN
bam-8776	188	20	versus	versus	ADP
bam-8776	188	21	sulfonylureas	sulfonylureas	X
bam-8776	188	22	on	on	ADP
bam-8776	188	23	breast	breast	NOUN
bam-8776	188	24	cancer	cancer	NOUN
bam-8776	188	25	risk	risk	NOUN
bam-8776	188	26	in	in	ADP
bam-8776	188	27	older	old	ADJ
bam-8776	188	28	women	woman	NOUN
bam-8776	188	29	.	.	PUNCT
bam-8776	189	1	epidemiology	epidemiology	NOUN
bam-8776	189	2	2017;28:446	2017;28:446	NOUN
bam-8776	189	3	-	-	SYM
bam-8776	189	4	454	454	NUM
bam-8776	189	5	.	.	PUNCT
bam-8776	190	1	45	45	NUM
bam-8776	190	2	.	.	PUNCT
bam-8776	190	3	belda	belda	NOUN
bam-8776	190	4	-	-	PUNCT
bam-8776	190	5	iniesta	iniesta	PROPN
bam-8776	190	6	c	c	PROPN
bam-8776	190	7	,	,	PUNCT
bam-8776	190	8	pernía	pernía	PROPN
bam-8776	190	9	o	o	NOUN
bam-8776	190	10	,	,	PUNCT
bam-8776	190	11	simó	simó	PROPN
bam-8776	190	12	r.	r.	PROPN
bam-8776	190	13	metformin	metformin	PROPN
bam-8776	190	14	:	:	PUNCT
bam-8776	190	15	a	a	DET
bam-8776	190	16	new	new	ADJ
bam-8776	190	17	option	option	NOUN
bam-8776	190	18	in	in	ADP
bam-8776	190	19	cancer	cancer	NOUN
bam-8776	190	20	treatment	treatment	NOUN
bam-8776	190	21	.	.	PUNCT
bam-8776	191	1	clin	clin	PROPN
bam-8776	191	2	transl	transl	PROPN
bam-8776	191	3	oncol	oncol	PROPN
bam-8776	191	4	2011;13:363	2011;13:363	PROPN
bam-8776	191	5	-	-	SYM
bam-8776	191	6	7	7	NUM
bam-8776	191	7	.	.	PUNCT
bam-8776	191	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=pooled+analysis+of+prospective+cohort+studies+on+height%2c+weight%2c+and+breast+cancer+risk.+american+journal+of+epidemiology	https://www.ncbi.nlm.nih.gov/pubmed/?term=pooled+analysis+of+prospective+cohort+studies+on+height%2c+weight%2c+and+breast+cancer+risk.+american+journal+of+epidemiology	NOUN
bam-8776	191	9	https://www.ncbi.nlm.nih.gov/pubmed/?term=pooled+analysis+of+prospective+cohort+studies+on+height%2c+weight%2c+and+breast+cancer+risk.+american+journal+of+epidemiology	https://www.ncbi.nlm.nih.gov/pubmed/?term=pooled+analysis+of+prospective+cohort+studies+on+height%2c+weight%2c+and+breast+cancer+risk.+american+journal+of+epidemiology	PROPN
bam-8776	191	10	https://www.ncbi.nlm.nih.gov/pubmed/?term=breast+cancer+risk+in+relation+to+serum+cholesterol%2c+serum+beta-lipoprotein%2c+height%2c+weight%2c+and+blood+pressure	https://www.ncbi.nlm.nih.gov/pubmed/?term=breast+cancer+risk+in+relation+to+serum+cholesterol%2c+serum+beta-lipoprotein%2c+height%2c+weight%2c+and+blood+pressure	PROPN
bam-8776	191	11	https://www.ncbi.nlm.nih.gov/pubmed/?term=risk+of+breast+cancer+in+relation+to+anthropometry%2c+blood+pressure%2c+blood+lipids+and+glucose+metabolism%3a+a+prospective+study+within+the+malm%c3%b6+preventive+project.+european+journal+of+cancer+prevention	https://www.ncbi.nlm.nih.gov/pubmed/?term=risk+of+breast+cancer+in+relation+to+anthropometry%2c+blood+pressure%2c+blood+lipids+and+glucose+metabolism%3a+a+prospective+study+within+the+malm%c3%b6+preventive+project.+european+journal+of+cancer+prevention	PROPN
bam-8776	191	12	.	.	PUNCT
bam-8776	191	13	https://www.ncbi.nlm.nih.gov/pubmed/?term=hypertension+and+breast+cancer+risk+in+a+19-year+follow-up+study+(the+dom+cohort	https://www.ncbi.nlm.nih.gov/pubmed/?term=hypertension+and+breast+cancer+risk+in+a+19-year+follow-up+study+(the+dom+cohort	PROPN
bam-8776	191	14	)	)	PUNCT
bam-8776	191	15	.	.	PUNCT
bam-8776	192	1	https://www.ncbi.nlm.nih.gov/pubmed/15191933	https://www.ncbi.nlm.nih.gov/pubmed/15191933	NUM
bam-8776	192	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=diabetes%2c+metabolic+syndrome%2c+and+breast+cancer%3a+a+review+of+the+current+evidence.+the+american+journal+of+clinical+nutrition	https://www.ncbi.nlm.nih.gov/pubmed/?term=diabetes%2c+metabolic+syndrome%2c+and+breast+cancer%3a+a+review+of+the+current+evidence.+the+american+journal+of+clinical+nutrition	NOUN
bam-8776	192	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+risk+of+breast+cancer+mortality+by+menopause%2c+obesity%2c+and+subtype.+breast+cancer+research+and+treatment	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+risk+of+breast+cancer+mortality+by+menopause%2c+obesity%2c+and+subtype.+breast+cancer+research+and+treatment	NOUN
bam-8776	192	4	.	.	PUNCT
bam-8776	193	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=prevalence+of+comorbidities+in+women+with+and+without+breast+cancer+in+soweto%2c+south+africa%3a+results+from+the+sabc+study.+samj%3a	https://www.ncbi.nlm.nih.gov/pubmed/?term=prevalence+of+comorbidities+in+women+with+and+without+breast+cancer+in+soweto%2c+south+africa%3a+results+from+the+sabc+study.+samj%3a	ADJ
bam-8776	193	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=the+impact+of+diabetes+on+breast+cancer+treatments+and+outcomes%3a+a+population-based+study	https://www.ncbi.nlm.nih.gov/pubmed/?term=the+impact+of+diabetes+on+breast+cancer+treatments+and+outcomes%3a+a+population-based+study	PROPN
bam-8776	193	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=racial+disparities+in+treatment+and+survival+of+women+with+stage+i%e2%80%93iii+breast+cancer+at+a+large+academic+medical+center+in+metropolitan+detroit	https://www.ncbi.nlm.nih.gov/pubmed/?term=racial+disparities+in+treatment+and+survival+of+women+with+stage+i%e2%80%93iii+breast+cancer+at+a+large+academic+medical+center+in+metropolitan+detroit	PROPN
bam-8776	193	4	.	.	PUNCT
bam-8776	194	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=elevated+insulin+receptor+content+in+human+breast+cancer.+the+journal+of+clinical+investigation	https://www.ncbi.nlm.nih.gov/pubmed/?term=elevated+insulin+receptor+content+in+human+breast+cancer.+the+journal+of+clinical+investigation	NOUN
bam-8776	194	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=elevated+insulin+receptor+content+in+human+breast+cancer.+the+journal+of+clinical+investigation	https://www.ncbi.nlm.nih.gov/pubmed/?term=elevated+insulin+receptor+content+in+human+breast+cancer.+the+journal+of+clinical+investigation	NOUN
bam-8776	194	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=insulin-like+growth+factor+(igf)-i%2c+igf+binding+protein-3%2c+and+breast+cancer+risk%3a+eight+years+on.+endocrine-related+cancer	https://www.ncbi.nlm.nih.gov/pubmed/?term=insulin-like+growth+factor+(igf)-i%2c+igf+binding+protein-3%2c+and+breast+cancer+risk%3a+eight+years+on.+endocrine-related+cancer	NOUN
bam-8776	194	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=insulin-like+growth+factor+(igf)-i%2c+igf+binding+protein-3%2c+and+breast+cancer+risk%3a+eight+years+on.+endocrine-related+cancer	https://www.ncbi.nlm.nih.gov/pubmed/?term=insulin-like+growth+factor+(igf)-i%2c+igf+binding+protein-3%2c+and+breast+cancer+risk%3a+eight+years+on.+endocrine-related+cancer	NOUN
bam-8776	194	5	https://www.ncbi.nlm.nih.gov/pubmed/19858375	https://www.ncbi.nlm.nih.gov/pubmed/19858375	PROPN
bam-8776	194	6	https://www.ncbi.nlm.nih.gov/pubmed/19858375	https://www.ncbi.nlm.nih.gov/pubmed/19858375	PROPN
bam-8776	194	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=metformin+and+incident+breast+cancer+among+diabetic+women%3a+a+population-based+case%e2%80%93control+study+in+denmark	https://www.ncbi.nlm.nih.gov/pubmed/?term=metformin+and+incident+breast+cancer+among+diabetic+women%3a+a+population-based+case%e2%80%93control+study+in+denmark	PROPN
bam-8776	194	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=metformin+and+incident+breast+cancer+among+diabetic+women%3a+a+population-based+case%e2%80%93control+study+in+denmark	https://www.ncbi.nlm.nih.gov/pubmed/?term=metformin+and+incident+breast+cancer+among+diabetic+women%3a+a+population-based+case%e2%80%93control+study+in+denmark	NOUN
bam-8776	194	9	https://www.ncbi.nlm.nih.gov/pubmed/29618465	https://www.ncbi.nlm.nih.gov/pubmed/29618465	PRON
bam-8776	194	10	https://www.ncbi.nlm.nih.gov/pubmed/28166101	https://www.ncbi.nlm.nih.gov/pubmed/28166101	NOUN
bam-8776	194	11	https://www.ncbi.nlm.nih.gov/pubmed/?term=metformin%3a+a+new+option+in+cancer+treatment.+clinical+and+translational+oncology	https://www.ncbi.nlm.nih.gov/pubmed/?term=metformin%3a+a+new+option+in+cancer+treatment.+clinical+and+translational+oncology	NOUN
bam-8776	194	12	.	.	PUNCT
bam-8776	195	1	metabolic	metabolic	PROPN
bam-8776	195	2	syndrome	syndrome	PROPN
bam-8776	195	3	and	and	CCONJ
bam-8776	195	4	breast	breast	NOUN
bam-8776	195	5	cancer	cancer	NOUN
bam-8776	195	6	patients	patient	NOUN
bam-8776	195	7	eur	eur	PROPN
bam-8776	195	8	j	j	PROPN
bam-8776	195	9	transl	transl	PROPN
bam-8776	195	10	myol	myol	ADV
bam-8776	195	11	30	30	NUM
bam-8776	195	12	(	(	PUNCT
bam-8776	195	13	3	3	NUM
bam-8776	195	14	):	):	PUNCT
bam-8776	195	15	xx1	xx1	PROPN
bam-8776	195	16	-	-	PUNCT
bam-8776	195	17	xx7	xx7	PROPN
bam-8776	195	18	,	,	PUNCT
bam-8776	195	19	2020	2020	NUM
bam-8776	195	20	6	6	NUM
bam-8776	195	21	46	46	NUM
bam-8776	195	22	.	.	PUNCT
bam-8776	196	1	jiang	jiang	PROPN
bam-8776	196	2	wg	wg	PROPN
bam-8776	196	3	,	,	PUNCT
bam-8776	196	4	douglas‐jones	douglas‐jone	VERB
bam-8776	196	5	a	a	DET
bam-8776	196	6	,	,	PUNCT
bam-8776	196	7	mansel	mansel	ADJ
bam-8776	196	8	re	re	NOUN
bam-8776	196	9	.	.	PUNCT
bam-8776	197	1	expression	expression	NOUN
bam-8776	197	2	of	of	ADP
bam-8776	197	3	peroxisome‐proliferator	peroxisome‐proliferator	NOUN
bam-8776	197	4	activated	activate	VERB
bam-8776	197	5	receptor‐gamma	receptor‐gamma	PROPN
bam-8776	197	6	(	(	PUNCT
bam-8776	197	7	pparγ	pparγ	NOUN
bam-8776	197	8	)	)	PUNCT
bam-8776	197	9	and	and	CCONJ
bam-8776	197	10	the	the	DET
bam-8776	197	11	pparγ	pparγ	ADJ
bam-8776	197	12	co‐	co‐	NOUN
bam-8776	197	13	activator	activator	NOUN
bam-8776	197	14	,	,	PUNCT
bam-8776	197	15	pgc‐1	pgc‐1	NOUN
bam-8776	197	16	,	,	PUNCT
bam-8776	197	17	in	in	ADP
bam-8776	197	18	human	human	ADJ
bam-8776	197	19	breast	breast	NOUN
bam-8776	197	20	cancer	cancer	NOUN
bam-8776	197	21	correlates	correlate	VERB
bam-8776	197	22	with	with	ADP
bam-8776	197	23	clinical	clinical	ADJ
bam-8776	197	24	outcomes	outcome	NOUN
bam-8776	197	25	.	.	PUNCT
bam-8776	198	1	int	int	NOUN
bam-8776	198	2	j	j	PROPN
bam-8776	198	3	cancer	cancer	NOUN
bam-8776	198	4	2003;106:752	2003;106:752	NUM
bam-8776	198	5	-	-	SYM
bam-8776	198	6	7	7	NUM
bam-8776	198	7	.	.	NUM
bam-8776	198	8	47	47	NUM
bam-8776	198	9	.	.	PUNCT
bam-8776	199	1	burstein	burstein	PROPN
bam-8776	199	2	hj	hj	PROPN
bam-8776	199	3	,	,	PUNCT
bam-8776	199	4	demetri	demetri	PROPN
bam-8776	199	5	gd	gd	PROPN
bam-8776	199	6	,	,	PUNCT
bam-8776	199	7	mueller	mueller	PROPN
bam-8776	199	8	e	e	PROPN
bam-8776	199	9	,	,	PUNCT
bam-8776	199	10	et	et	PROPN
bam-8776	199	11	al	al	PROPN
bam-8776	199	12	.	.	PUNCT
bam-8776	199	13	use	use	NOUN
bam-8776	199	14	of	of	ADP
bam-8776	199	15	the	the	DET
bam-8776	199	16	peroxisome	peroxisome	PROPN
bam-8776	199	17	proliferator	proliferator	NOUN
bam-8776	199	18	-	-	PUNCT
bam-8776	199	19	activated	activate	VERB
bam-8776	199	20	receptor	receptor	NOUN
bam-8776	199	21	(	(	PUNCT
bam-8776	199	22	ppar	ppar	NOUN
bam-8776	199	23	)	)	PUNCT
bam-8776	199	24	γ	γ	PROPN
bam-8776	199	25	ligand	ligand	NOUN
bam-8776	199	26	troglitazone	troglitazone	NOUN
bam-8776	199	27	as	as	ADP
bam-8776	199	28	treatment	treatment	NOUN
bam-8776	199	29	for	for	ADP
bam-8776	199	30	refractory	refractory	NOUN
bam-8776	199	31	breast	breast	NOUN
bam-8776	199	32	cancer	cancer	NOUN
bam-8776	199	33	:	:	PUNCT
bam-8776	199	34	a	a	DET
bam-8776	199	35	phase	phase	NOUN
bam-8776	199	36	ii	ii	NOUN
bam-8776	199	37	study	study	NOUN
bam-8776	199	38	.	.	PUNCT
bam-8776	200	1	breast	breast	NOUN
bam-8776	200	2	cancer	cancer	NOUN
bam-8776	200	3	res	re	NOUN
bam-8776	200	4	treat	treat	VERB
bam-8776	200	5	2003;79:391	2003;79:391	NOUN
bam-8776	200	6	-	-	SYM
bam-8776	200	7	7	7	NUM
bam-8776	200	8	.	.	NOUN
bam-8776	200	9	48	48	NUM
bam-8776	200	10	.	.	PUNCT
bam-8776	201	1	wilson	wilson	PROPN
bam-8776	201	2	c.	c.	PROPN
bam-8776	201	3	long	long	ADJ
bam-8776	201	4	-	-	PUNCT
bam-8776	201	5	term	term	NOUN
bam-8776	201	6	use	use	NOUN
bam-8776	201	7	of	of	ADP
bam-8776	201	8	insulin	insulin	NOUN
bam-8776	201	9	glargine	glargine	NOUN
bam-8776	201	10	might	might	AUX
bam-8776	201	11	increase	increase	VERB
bam-8776	201	12	the	the	DET
bam-8776	201	13	risk	risk	NOUN
bam-8776	201	14	of	of	ADP
bam-8776	201	15	breast	breast	NOUN
bam-8776	201	16	cancer	cancer	NOUN
bam-8776	201	17	.	.	PUNCT
bam-8776	202	1	nat	nat	PROPN
bam-8776	202	2	rev	rev	VERB
bam-8776	202	3	endocrinol	endocrinol	PROPN
bam-8776	202	4	2011;7:499	2011;7:499	NUM
bam-8776	202	5	.	.	PUNCT
bam-8776	203	1	doi	doi	NOUN
bam-8776	203	2	:	:	PUNCT
bam-8776	203	3	10.1038	10.1038	NUM
bam-8776	203	4	/	/	SYM
bam-8776	203	5	nrendo.2011	nrendo.2011	NOUN
bam-8776	203	6	.	.	NOUN
bam-8776	204	1	112	112	NUM
bam-8776	204	2	.	.	PUNCT
bam-8776	204	3	49	49	NUM
bam-8776	204	4	.	.	PUNCT
bam-8776	205	1	lahmann	lahmann	PROPN
bam-8776	205	2	ph	ph	PROPN
bam-8776	205	3	,	,	PUNCT
bam-8776	205	4	hoffmann	hoffmann	PROPN
bam-8776	205	5	k	k	PROPN
bam-8776	205	6	,	,	PUNCT
bam-8776	205	7	allen	allen	PROPN
bam-8776	205	8	n	n	PROPN
bam-8776	205	9	,	,	PUNCT
bam-8776	205	10	et	et	PROPN
bam-8776	205	11	al	al	PROPN
bam-8776	205	12	.	.	PROPN
bam-8776	205	13	body	body	NOUN
bam-8776	205	14	size	size	NOUN
bam-8776	205	15	and	and	CCONJ
bam-8776	205	16	breast	breast	NOUN
bam-8776	205	17	cancer	cancer	NOUN
bam-8776	205	18	risk	risk	NOUN
bam-8776	205	19	:	:	PUNCT
bam-8776	205	20	findings	finding	NOUN
bam-8776	205	21	from	from	ADP
bam-8776	205	22	the	the	DET
bam-8776	205	23	european	european	ADJ
bam-8776	205	24	prospective	prospective	ADJ
bam-8776	205	25	investigation	investigation	NOUN
bam-8776	205	26	into	into	ADP
bam-8776	205	27	cancer	cancer	NOUN
bam-8776	205	28	and	and	CCONJ
bam-8776	205	29	nutrition	nutrition	NOUN
bam-8776	205	30	(	(	PUNCT
bam-8776	205	31	epic	epic	ADJ
bam-8776	205	32	)	)	PUNCT
bam-8776	205	33	.	.	PUNCT
bam-8776	206	1	int	int	PROPN
bam-8776	206	2	j	j	PROPN
bam-8776	206	3	cancer	cancer	NOUN
bam-8776	206	4	2004;111:762	2004;111:762	NUM
bam-8776	206	5	-	-	SYM
bam-8776	206	6	71	71	NUM
bam-8776	206	7	.	.	PUNCT
bam-8776	206	8	50	50	NUM
bam-8776	206	9	.	.	PUNCT
bam-8776	207	1	ursin	ursin	NOUN
bam-8776	207	2	g	g	PROPN
bam-8776	207	3	,	,	PUNCT
bam-8776	207	4	longnecker	longnecker	PROPN
bam-8776	207	5	mp	mp	PROPN
bam-8776	207	6	,	,	PUNCT
bam-8776	207	7	haile	haile	PROPN
bam-8776	207	8	rw	rw	PROPN
bam-8776	207	9	,	,	PUNCT
bam-8776	207	10	greenland	greenland	PROPN
bam-8776	207	11	s.	s.	PROPN
bam-8776	208	1	a	a	DET
bam-8776	208	2	meta	meta	ADJ
bam-8776	208	3	-	-	PUNCT
bam-8776	208	4	analysis	analysis	NOUN
bam-8776	208	5	of	of	ADP
bam-8776	208	6	body	body	NOUN
bam-8776	208	7	mass	mass	NOUN
bam-8776	208	8	index	index	NOUN
bam-8776	208	9	and	and	CCONJ
bam-8776	208	10	risk	risk	NOUN
bam-8776	208	11	of	of	ADP
bam-8776	208	12	premenopausal	premenopausal	NOUN
bam-8776	208	13	breast	breast	NOUN
bam-8776	208	14	cancer	cancer	NOUN
bam-8776	208	15	.	.	PUNCT
bam-8776	209	1	epidemiology	epidemiology	NOUN
bam-8776	209	2	1995:6;137	1995:6;137	NUM
bam-8776	209	3	-	-	SYM
bam-8776	209	4	41	41	NUM
bam-8776	209	5	.	.	PUNCT
bam-8776	209	6	51	51	NUM
bam-8776	209	7	.	.	PUNCT
bam-8776	210	1	yumuk	yumuk	PROPN
bam-8776	210	2	pf	pf	PROPN
bam-8776	210	3	,	,	PUNCT
bam-8776	210	4	dane	dane	NOUN
bam-8776	210	5	f	f	PROPN
bam-8776	210	6	,	,	PUNCT
bam-8776	210	7	yumuk	yumuk	NOUN
bam-8776	210	8	v	v	NOUN
bam-8776	210	9	,	,	PUNCT
bam-8776	210	10	et	et	PROPN
bam-8776	210	11	al	al	PROPN
bam-8776	210	12	.	.	PROPN
bam-8776	210	13	impact	impact	NOUN
bam-8776	210	14	of	of	ADP
bam-8776	210	15	body	body	NOUN
bam-8776	210	16	mass	mass	NOUN
bam-8776	210	17	index	index	NOUN
bam-8776	210	18	on	on	ADP
bam-8776	210	19	cancer	cancer	NOUN
bam-8776	210	20	development	development	NOUN
bam-8776	210	21	.	.	PUNCT
bam-8776	211	1	j	j	PROPN
bam-8776	211	2	buon	buon	VERB
bam-8776	211	3	2008;13:55	2008;13:55	NUM
bam-8776	211	4	-	-	SYM
bam-8776	211	5	9	9	NUM
bam-8776	211	6	.	.	NOUN
bam-8776	211	7	52	52	NUM
bam-8776	211	8	.	.	PUNCT
bam-8776	212	1	pichard	pichard	PROPN
bam-8776	212	2	c	c	PROPN
bam-8776	212	3	,	,	PUNCT
bam-8776	212	4	plu	plu	PROPN
bam-8776	212	5	-	-	NOUN
bam-8776	212	6	bureau	bureau	NOUN
bam-8776	212	7	g	g	NOUN
bam-8776	212	8	,	,	PUNCT
bam-8776	212	9	neves	neve	NOUN
bam-8776	212	10	-	-	PUNCT
bam-8776	212	11	e	e	NOUN
bam-8776	212	12	castro	castro	PROPN
bam-8776	212	13	m	m	VERB
bam-8776	212	14	,	,	PUNCT
bam-8776	212	15	gompel	gompel	VERB
bam-8776	212	16	a.	a.	NOUN
bam-8776	212	17	insulin	insulin	NOUN
bam-8776	212	18	resistance	resistance	NOUN
bam-8776	212	19	,	,	PUNCT
bam-8776	212	20	obesity	obesity	NOUN
bam-8776	212	21	and	and	CCONJ
bam-8776	212	22	breast	breast	NOUN
bam-8776	212	23	cancer	cancer	NOUN
bam-8776	212	24	risk	risk	NOUN
bam-8776	212	25	.	.	PUNCT
bam-8776	213	1	maturitas	maturitas	VERB
bam-8776	213	2	2008;60:19	2008;60:19	NUM
bam-8776	213	3	-	-	SYM
bam-8776	213	4	30	30	NUM
bam-8776	213	5	.	.	PUNCT
bam-8776	214	1	53	53	NUM
bam-8776	214	2	.	.	PUNCT
bam-8776	215	1	jevtic	jevtic	PROPN
bam-8776	215	2	m	m	PROPN
bam-8776	215	3	,	,	PUNCT
bam-8776	215	4	velicki	velicki	ADV
bam-8776	215	5	r	r	NOUN
bam-8776	215	6	,	,	PUNCT
bam-8776	215	7	popovic	popovic	PROPN
bam-8776	215	8	m	m	PROPN
bam-8776	215	9	,	,	PUNCT
bam-8776	215	10	et	et	PROPN
bam-8776	215	11	al	al	PROPN
bam-8776	215	12	.	.	PUNCT
bam-8776	216	1	dietary	dietary	ADJ
bam-8776	216	2	influence	influence	NOUN
bam-8776	216	3	on	on	ADP
bam-8776	216	4	breast	breast	NOUN
bam-8776	216	5	cancer	cancer	NOUN
bam-8776	216	6	.	.	PUNCT
bam-8776	217	1	j	j	PROPN
bam-8776	217	2	buon	buon	VERB
bam-8776	217	3	.	.	PUNCT
bam-8776	218	1	2010;15:455	2010;15:455	NUM
bam-8776	218	2	-	-	SYM
bam-8776	218	3	61	61	NUM
bam-8776	218	4	.	.	PUNCT
bam-8776	219	1	54	54	NUM
bam-8776	219	2	.	.	PUNCT
bam-8776	220	1	carroll	carroll	PROPN
bam-8776	220	2	pa	pa	PROPN
bam-8776	220	3	,	,	PUNCT
bam-8776	220	4	healy	healy	PROPN
bam-8776	220	5	l	l	PROPN
bam-8776	220	6	,	,	PUNCT
bam-8776	220	7	lysaght	lysaght	PROPN
bam-8776	220	8	j	j	PROPN
bam-8776	220	9	,	,	PUNCT
bam-8776	220	10	et	et	PROPN
bam-8776	220	11	al	al	PROPN
bam-8776	220	12	.	.	PUNCT
bam-8776	220	13	influence	influence	NOUN
bam-8776	220	14	of	of	ADP
bam-8776	220	15	the	the	DET
bam-8776	220	16	metabolic	metabolic	NOUN
bam-8776	220	17	syndrome	syndrome	NOUN
bam-8776	220	18	on	on	ADP
bam-8776	220	19	leptin	leptin	NOUN
bam-8776	220	20	and	and	CCONJ
bam-8776	220	21	leptin	leptin	NOUN
bam-8776	220	22	receptor	receptor	NOUN
bam-8776	220	23	in	in	ADP
bam-8776	220	24	breast	breast	NOUN
bam-8776	220	25	cancer	cancer	NOUN
bam-8776	220	26	.	.	PUNCT
bam-8776	221	1	mol	mol	ADP
bam-8776	221	2	carcinog	carcinog	NOUN
bam-8776	221	3	2011;50:643	2011;50:643	PROPN
bam-8776	221	4	-	-	SYM
bam-8776	221	5	51	51	NUM
bam-8776	221	6	.	.	PUNCT
bam-8776	222	1	55	55	NUM
bam-8776	222	2	.	.	PUNCT
bam-8776	223	1	argolo	argolo	PROPN
bam-8776	223	2	df	df	PROPN
bam-8776	223	3	,	,	PUNCT
bam-8776	223	4	hudis	hudis	PROPN
bam-8776	223	5	ca	can	AUX
bam-8776	223	6	,	,	PUNCT
bam-8776	223	7	iyengar	iyengar	VERB
bam-8776	223	8	nm	nm	NOUN
bam-8776	223	9	.	.	PUNCT
bam-8776	224	1	the	the	DET
bam-8776	224	2	impact	impact	NOUN
bam-8776	224	3	of	of	ADP
bam-8776	224	4	obesity	obesity	NOUN
bam-8776	224	5	on	on	ADP
bam-8776	224	6	breast	breast	NOUN
bam-8776	224	7	cancer	cancer	NOUN
bam-8776	224	8	.	.	PUNCT
bam-8776	225	1	curr	curr	PROPN
bam-8776	225	2	oncol	oncol	PROPN
bam-8776	225	3	rep	rep	PROPN
bam-8776	225	4	2018;20:47	2018;20:47	NUM
bam-8776	225	5	.	.	PUNCT
bam-8776	226	1	56	56	NUM
bam-8776	226	2	.	.	PUNCT
bam-8776	227	1	gezgen	gezgen	PROPN
bam-8776	227	2	g	g	PROPN
bam-8776	227	3	,	,	PUNCT
bam-8776	227	4	roach	roach	PROPN
bam-8776	227	5	e	e	NOUN
bam-8776	227	6	,	,	PUNCT
bam-8776	227	7	kizilarslanoglu	kizilarslanoglu	PROPN
bam-8776	227	8	m	m	PROPN
bam-8776	227	9	,	,	PUNCT
bam-8776	227	10	et	et	PROPN
bam-8776	227	11	al	al	PROPN
bam-8776	227	12	.	.	PROPN
bam-8776	227	13	metabolic	metabolic	PROPN
bam-8776	227	14	syndrome	syndrome	PROPN
bam-8776	227	15	and	and	CCONJ
bam-8776	227	16	breast	breast	NOUN
bam-8776	227	17	cancer	cancer	NOUN
bam-8776	227	18	:	:	PUNCT
bam-8776	227	19	an	an	DET
bam-8776	227	20	overview	overview	NOUN
bam-8776	227	21	.	.	PUNCT
bam-8776	228	1	j	j	PROPN
bam-8776	228	2	buon	buon	NOUN
bam-8776	228	3	2012;17:223	2012;17:223	PROPN
bam-8776	228	4	-	-	SYM
bam-8776	228	5	9	9	NUM
bam-8776	228	6	.	.	NOUN
bam-8776	228	7	57	57	NUM
bam-8776	228	8	.	.	PUNCT
bam-8776	229	1	seretis	seretis	PROPN
bam-8776	229	2	a	a	X
bam-8776	229	3	,	,	PUNCT
bam-8776	229	4	cividini	cividini	PROPN
bam-8776	229	5	s	s	PROPN
bam-8776	229	6	,	,	PUNCT
bam-8776	229	7	markozannes	markozanne	NOUN
bam-8776	229	8	g	g	NOUN
bam-8776	229	9	,	,	PUNCT
bam-8776	229	10	et	et	PROPN
bam-8776	229	11	al	al	PROPN
bam-8776	229	12	.	.	PROPN
bam-8776	229	13	association	association	PROPN
bam-8776	229	14	between	between	ADP
bam-8776	229	15	blood	blood	NOUN
bam-8776	229	16	pressure	pressure	NOUN
bam-8776	229	17	and	and	CCONJ
bam-8776	229	18	risk	risk	NOUN
bam-8776	229	19	of	of	ADP
bam-8776	229	20	cancer	cancer	NOUN
bam-8776	229	21	development	development	NOUN
bam-8776	229	22	:	:	PUNCT
bam-8776	229	23	a	a	DET
bam-8776	229	24	systematic	systematic	ADJ
bam-8776	229	25	review	review	NOUN
bam-8776	229	26	and	and	CCONJ
bam-8776	229	27	metaanalysis	metaanalysis	NOUN
bam-8776	229	28	of	of	ADP
bam-8776	229	29	observational	observational	ADJ
bam-8776	229	30	studies	study	NOUN
bam-8776	229	31	.	.	PUNCT
bam-8776	230	1	sci	sci	PROPN
bam-8776	230	2	rep	rep	PROPN
bam-8776	230	3	2019;9:8565	2019;9:8565	PROPN
bam-8776	230	4	.	.	PUNCT
bam-8776	231	1	58	58	NUM
bam-8776	231	2	.	.	PUNCT
bam-8776	232	1	zhao	zhao	PROPN
bam-8776	232	2	y	y	PROPN
bam-8776	232	3	,	,	PUNCT
bam-8776	232	4	wang	wang	PROPN
bam-8776	232	5	q	q	PROPN
bam-8776	232	6	,	,	PUNCT
bam-8776	232	7	zhao	zhao	PROPN
bam-8776	232	8	x	x	PROPN
bam-8776	232	9	,	,	PUNCT
bam-8776	232	10	et	et	PROPN
bam-8776	232	11	al	al	PROPN
bam-8776	232	12	.	.	PROPN
bam-8776	232	13	effect	effect	NOUN
bam-8776	232	14	of	of	ADP
bam-8776	232	15	antihypertensive	antihypertensive	ADJ
bam-8776	232	16	drugs	drug	NOUN
bam-8776	232	17	on	on	ADP
bam-8776	232	18	breast	breast	NOUN
bam-8776	232	19	cancer	cancer	NOUN
bam-8776	232	20	risk	risk	NOUN
bam-8776	232	21	in	in	ADP
bam-8776	232	22	female	female	ADJ
bam-8776	232	23	hypertensive	hypertensive	ADJ
bam-8776	232	24	patients	patient	NOUN
bam-8776	232	25	:	:	PUNCT
bam-8776	232	26	evidence	evidence	NOUN
bam-8776	232	27	from	from	ADP
bam-8776	232	28	observational	observational	ADJ
bam-8776	232	29	studies	study	NOUN
bam-8776	232	30	.	.	PUNCT
bam-8776	233	1	clin	clin	PROPN
bam-8776	233	2	exp	exp	PROPN
bam-8776	233	3	hypertens	hyperten	NOUN
bam-8776	233	4	2018;40:22	2018;40:22	NUM
bam-8776	233	5	-	-	SYM
bam-8776	233	6	27	27	NUM
bam-8776	233	7	.	.	PUNCT
bam-8776	233	8	59	59	NUM
bam-8776	233	9	.	.	PUNCT
bam-8776	234	1	lindgren	lindgren	PROPN
bam-8776	234	2	a	a	PRON
bam-8776	234	3	,	,	PUNCT
bam-8776	234	4	pukkala	pukkala	PROPN
bam-8776	234	5	e	e	NOUN
bam-8776	234	6	,	,	PUNCT
bam-8776	234	7	tuomilehto	tuomilehto	PROPN
bam-8776	234	8	j	j	PROPN
bam-8776	234	9	,	,	PUNCT
bam-8776	234	10	et	et	PROPN
bam-8776	234	11	al	al	PROPN
bam-8776	234	12	.	.	PROPN
bam-8776	234	13	incidence	incidence	NOUN
bam-8776	234	14	of	of	ADP
bam-8776	234	15	breast	breast	NOUN
bam-8776	234	16	cancer	cancer	NOUN
bam-8776	234	17	among	among	ADP
bam-8776	234	18	postmenopausal	postmenopausal	NOUN
bam-8776	234	19	,	,	PUNCT
bam-8776	234	20	hypertensive	hypertensive	ADJ
bam-8776	234	21	women	woman	NOUN
bam-8776	234	22	.	.	PUNCT
bam-8776	235	1	int	int	PROPN
bam-8776	235	2	j	j	PROPN
bam-8776	235	3	cancer	cancer	NOUN
bam-8776	235	4	2007;121:641	2007;121:641	NUM
bam-8776	235	5	-	-	SYM
bam-8776	235	6	4	4	NUM
bam-8776	235	7	.	.	NOUN
bam-8776	235	8	60	60	NUM
bam-8776	235	9	.	.	PUNCT
bam-8776	236	1	largent	largent	PROPN
bam-8776	236	2	j	j	PROPN
bam-8776	236	3	,	,	PUNCT
bam-8776	236	4	mceligot	mceligot	VERB
bam-8776	236	5	a	a	DET
bam-8776	236	6	,	,	PUNCT
bam-8776	236	7	ziogas	ziogas	NOUN
bam-8776	236	8	a	a	X
bam-8776	236	9	,	,	PUNCT
bam-8776	236	10	et	et	PROPN
bam-8776	236	11	al	al	PROPN
bam-8776	236	12	.	.	PUNCT
bam-8776	236	13	hypertension	hypertension	NOUN
bam-8776	236	14	,	,	PUNCT
bam-8776	236	15	diuretics	diuretic	NOUN
bam-8776	236	16	and	and	CCONJ
bam-8776	236	17	breast	breast	NOUN
bam-8776	236	18	cancer	cancer	NOUN
bam-8776	236	19	risk	risk	NOUN
bam-8776	236	20	.	.	PUNCT
bam-8776	237	1	j	j	PROPN
bam-8776	237	2	hum	hum	PROPN
bam-8776	237	3	hypertens	hyperten	NOUN
bam-8776	237	4	2006;20:727	2006;20:727	X
bam-8776	237	5	-	-	SYM
bam-8776	237	6	32	32	NUM
bam-8776	237	7	.	.	PUNCT
bam-8776	237	8	61	61	NUM
bam-8776	237	9	.	.	PUNCT
bam-8776	238	1	li	li	PROPN
bam-8776	238	2	ci	ci	PROPN
bam-8776	238	3	,	,	PUNCT
bam-8776	238	4	malone	malone	PROPN
bam-8776	238	5	ke	ke	PROPN
bam-8776	238	6	,	,	PUNCT
bam-8776	238	7	weiss	weiss	X
bam-8776	238	8	ns	ns	PROPN
bam-8776	238	9	,	,	PUNCT
bam-8776	238	10	et	et	PROPN
bam-8776	238	11	al	al	PROPN
bam-8776	238	12	.	.	PUNCT
bam-8776	238	13	relation	relation	NOUN
bam-8776	238	14	between	between	ADP
bam-8776	238	15	use	use	NOUN
bam-8776	238	16	of	of	ADP
bam-8776	238	17	antihypertensive	antihypertensive	ADJ
bam-8776	238	18	medications	medication	NOUN
bam-8776	238	19	and	and	CCONJ
bam-8776	238	20	risk	risk	NOUN
bam-8776	238	21	of	of	ADP
bam-8776	238	22	breast	breast	NOUN
bam-8776	238	23	carcinoma	carcinoma	NOUN
bam-8776	238	24	among	among	ADP
bam-8776	238	25	women	woman	NOUN
bam-8776	238	26	ages	age	NOUN
bam-8776	238	27	65–79	65–79	ADP
bam-8776	238	28	years	year	NOUN
bam-8776	238	29	.	.	PUNCT
bam-8776	239	1	cancer	cancer	NOUN
bam-8776	239	2	2003;98:1504	2003;98:1504	NUM
bam-8776	239	3	-	-	SYM
bam-8776	239	4	13	13	NUM
bam-8776	239	5	.	.	PUNCT
bam-8776	239	6	62	62	NUM
bam-8776	239	7	.	.	PUNCT
bam-8776	240	1	terry	terry	PROPN
bam-8776	240	2	mb	mb	PROPN
bam-8776	240	3	,	,	PUNCT
bam-8776	240	4	perrin	perrin	PROPN
bam-8776	240	5	m	m	PROPN
bam-8776	240	6	,	,	PUNCT
bam-8776	240	7	salafia	salafia	PROPN
bam-8776	240	8	cm	cm	PROPN
bam-8776	240	9	,	,	PUNCT
bam-8776	240	10	et	et	PROPN
bam-8776	240	11	al	al	PROPN
bam-8776	240	12	.	.	PROPN
bam-8776	240	13	preeclampsia	preeclampsia	PROPN
bam-8776	240	14	,	,	PUNCT
bam-8776	240	15	pregnancy	pregnancy	NOUN
bam-8776	240	16	-	-	PUNCT
bam-8776	240	17	related	relate	VERB
bam-8776	240	18	hypertension	hypertension	NOUN
bam-8776	240	19	,	,	PUNCT
bam-8776	240	20	and	and	CCONJ
bam-8776	240	21	breast	breast	NOUN
bam-8776	240	22	cancer	cancer	NOUN
bam-8776	240	23	risk	risk	NOUN
bam-8776	240	24	.	.	PUNCT
bam-8776	240	25	am	be	AUX
bam-8776	240	26	j	j	PROPN
bam-8776	240	27	epidemiol	epidemiol	PROPN
bam-8776	240	28	2007;165:1007	2007;165:1007	NUM
bam-8776	240	29	-	-	SYM
bam-8776	240	30	14	14	NUM
bam-8776	240	31	.	.	PUNCT
bam-8776	240	32	63	63	NUM
bam-8776	240	33	.	.	PUNCT
bam-8776	241	1	fiorenza	fiorenza	PROPN
bam-8776	242	1	a	a	PRON
bam-8776	242	2	,	,	PUNCT
bam-8776	242	3	branchi	branchi	NOUN
bam-8776	242	4	a	a	X
bam-8776	242	5	,	,	PUNCT
bam-8776	242	6	sommariva	sommariva	PROPN
bam-8776	242	7	d.	d.	PROPN
bam-8776	242	8	serum	serum	VERB
bam-8776	242	9	lipoprotein	lipoprotein	PROPN
bam-8776	242	10	profile	profile	NOUN
bam-8776	242	11	in	in	ADP
bam-8776	242	12	patients	patient	NOUN
bam-8776	242	13	with	with	ADP
bam-8776	242	14	cancer	cancer	NOUN
bam-8776	242	15	.	.	PUNCT
bam-8776	243	1	a	a	DET
bam-8776	243	2	comparison	comparison	NOUN
bam-8776	243	3	with	with	ADP
bam-8776	243	4	non	non	ADJ
bam-8776	243	5	-	-	ADJ
bam-8776	243	6	cancer	cancer	ADJ
bam-8776	243	7	subjects	subject	NOUN
bam-8776	243	8	.	.	PUNCT
bam-8776	244	1	int	int	NOUN
bam-8776	245	1	j	j	PROPN
bam-8776	245	2	clin	clin	PROPN
bam-8776	245	3	lab	lab	NOUN
bam-8776	245	4	res	re	NOUN
bam-8776	245	5	2000;30:141	2000;30:141	PROPN
bam-8776	245	6	-	-	SYM
bam-8776	245	7	5	5	NUM
bam-8776	245	8	.	.	NOUN
bam-8776	245	9	64	64	NUM
bam-8776	245	10	.	.	PUNCT
bam-8776	246	1	ferraroni	ferraroni	PROPN
bam-8776	246	2	m	m	PROPN
bam-8776	246	3	,	,	PUNCT
bam-8776	246	4	gerber	gerber	PROPN
bam-8776	246	5	m	m	PROPN
bam-8776	246	6	,	,	PUNCT
bam-8776	246	7	decarli	decarli	VERB
bam-8776	246	8	a	a	PRON
bam-8776	246	9	,	,	PUNCT
bam-8776	246	10	et	et	PROPN
bam-8776	246	11	al	al	PROPN
bam-8776	246	12	.	.	PROPN
bam-8776	246	13	hdlcholesterol	hdlcholesterol	PROPN
bam-8776	246	14	and	and	CCONJ
bam-8776	246	15	breast	breast	NOUN
bam-8776	246	16	cancer	cancer	NOUN
bam-8776	246	17	:	:	PUNCT
bam-8776	246	18	a	a	DET
bam-8776	246	19	joint	joint	ADJ
bam-8776	246	20	study	study	NOUN
bam-8776	246	21	in	in	ADP
bam-8776	246	22	northern	northern	PROPN
bam-8776	246	23	italy	italy	PROPN
bam-8776	246	24	and	and	CCONJ
bam-8776	246	25	southern	southern	PROPN
bam-8776	246	26	france	france	PROPN
bam-8776	246	27	.	.	PUNCT
bam-8776	247	1	int	int	PROPN
bam-8776	247	2	j	j	PROPN
bam-8776	247	3	epidemiol	epidemiol	PROPN
bam-8776	247	4	1993;22:772	1993;22:772	PROPN
bam-8776	247	5	-	-	SYM
bam-8776	247	6	80	80	NUM
bam-8776	247	7	.	.	PUNCT
bam-8776	247	8	65	65	NUM
bam-8776	247	9	.	.	PUNCT
bam-8776	248	1	moorman	moorman	PROPN
bam-8776	248	2	pg	pg	PROPN
bam-8776	248	3	,	,	PUNCT
bam-8776	248	4	hulka	hulka	VERB
bam-8776	248	5	bs	bs	PROPN
bam-8776	248	6	,	,	PUNCT
bam-8776	248	7	hiatt	hiatt	PROPN
bam-8776	248	8	ra	ra	PROPN
bam-8776	248	9	,	,	PUNCT
bam-8776	248	10	et	et	PROPN
bam-8776	248	11	al	al	PROPN
bam-8776	248	12	.	.	PROPN
bam-8776	248	13	association	association	PROPN
bam-8776	248	14	between	between	ADP
bam-8776	248	15	high	high	ADJ
bam-8776	248	16	-	-	PUNCT
bam-8776	248	17	density	density	NOUN
bam-8776	248	18	lipoprotein	lipoprotein	ADJ
bam-8776	248	19	cholesterol	cholesterol	NOUN
bam-8776	248	20	and	and	CCONJ
bam-8776	248	21	breast	breast	NOUN
bam-8776	248	22	cancer	cancer	NOUN
bam-8776	248	23	varies	vary	VERB
bam-8776	248	24	by	by	ADP
bam-8776	248	25	menopausal	menopausal	ADJ
bam-8776	248	26	status	status	NOUN
bam-8776	248	27	.	.	PUNCT
bam-8776	249	1	cancer	cancer	NOUN
bam-8776	249	2	epidemiol	epidemiol	PROPN
bam-8776	249	3	biomarkers	biomarker	NOUN
bam-8776	249	4	prev	prev	VERB
bam-8776	249	5	1998;7:483	1998;7:483	NUM
bam-8776	249	6	-	-	SYM
bam-8776	249	7	8	8	NUM
bam-8776	249	8	.	.	PUNCT
bam-8776	250	1	66	66	NUM
bam-8776	250	2	.	.	PUNCT
bam-8776	251	1	dos	do	VERB
bam-8776	251	2	santos	santos	PROPN
bam-8776	251	3	cr	cr	PROPN
bam-8776	251	4	,	,	PUNCT
bam-8776	251	5	fonseca	fonseca	PROPN
bam-8776	251	6	i	i	PRON
bam-8776	251	7	,	,	PUNCT
bam-8776	251	8	dias	dias	PROPN
bam-8776	251	9	s	s	PROPN
bam-8776	251	10	,	,	PUNCT
bam-8776	251	11	et	et	PROPN
bam-8776	251	12	al	al	PROPN
bam-8776	251	13	.	.	PUNCT
bam-8776	251	14	plasma	plasma	NOUN
bam-8776	251	15	level	level	NOUN
bam-8776	251	16	of	of	ADP
bam-8776	251	17	ldl	ldl	NOUN
bam-8776	251	18	-	-	PUNCT
bam-8776	251	19	cholesterol	cholesterol	NOUN
bam-8776	251	20	at	at	ADP
bam-8776	251	21	diagnosis	diagnosis	NOUN
bam-8776	251	22	is	be	AUX
bam-8776	251	23	a	a	DET
bam-8776	251	24	predictor	predictor	NOUN
bam-8776	251	25	factor	factor	NOUN
bam-8776	251	26	of	of	ADP
bam-8776	251	27	breast	breast	NOUN
bam-8776	251	28	tumor	tumor	NOUN
bam-8776	251	29	progression	progression	NOUN
bam-8776	251	30	.	.	PUNCT
bam-8776	252	1	bmc	bmc	ADJ
bam-8776	252	2	cancer	cancer	NOUN
bam-8776	252	3	2014;14:132	2014;14:132	PROPN
bam-8776	252	4	.	.	PROPN
bam-8776	252	5	67	67	NUM
bam-8776	252	6	.	.	PUNCT
bam-8776	253	1	kim	kim	PROPN
bam-8776	253	2	y	y	PROPN
bam-8776	253	3	,	,	PUNCT
bam-8776	253	4	park	park	NOUN
bam-8776	253	5	sk	sk	PROPN
bam-8776	253	6	,	,	PUNCT
bam-8776	253	7	han	han	PROPN
bam-8776	253	8	w	w	PROPN
bam-8776	253	9	,	,	PUNCT
bam-8776	253	10	et	et	PROPN
bam-8776	253	11	al	al	PROPN
bam-8776	253	12	.	.	PROPN
bam-8776	253	13	serum	serum	VERB
bam-8776	253	14	high	high	ADJ
bam-8776	253	15	-	-	PUNCT
bam-8776	253	16	density	density	NOUN
bam-8776	253	17	lipoprotein	lipoprotein	ADJ
bam-8776	253	18	cholesterol	cholesterol	NOUN
bam-8776	253	19	and	and	CCONJ
bam-8776	253	20	breast	breast	NOUN
bam-8776	253	21	cancer	cancer	NOUN
bam-8776	253	22	risk	risk	NOUN
bam-8776	253	23	by	by	ADP
bam-8776	253	24	menopausal	menopausal	ADJ
bam-8776	253	25	status	status	NOUN
bam-8776	253	26	,	,	PUNCT
bam-8776	253	27	body	body	NOUN
bam-8776	253	28	mass	mass	PROPN
bam-8776	253	29	index	index	NOUN
bam-8776	253	30	,	,	PUNCT
bam-8776	253	31	and	and	CCONJ
bam-8776	253	32	hormonal	hormonal	ADJ
bam-8776	253	33	receptor	receptor	NOUN
bam-8776	253	34	in	in	ADP
bam-8776	253	35	korea	korea	PROPN
bam-8776	253	36	.	.	PUNCT
bam-8776	254	1	cancer	cancer	NOUN
bam-8776	254	2	epidemiol	epidemiol	PROPN
bam-8776	254	3	biomarkers	biomarker	VERB
bam-8776	254	4	prev	prev	VERB
bam-8776	254	5	2009;18:508	2009;18:508	NUM
bam-8776	254	6	-	-	SYM
bam-8776	254	7	15	15	NUM
bam-8776	254	8	.	.	PUNCT
bam-8776	255	1	68	68	NUM
bam-8776	255	2	.	.	PUNCT
bam-8776	255	3	kucharska	kucharska	PROPN
bam-8776	255	4	-	-	PUNCT
bam-8776	255	5	newton	newton	PROPN
bam-8776	255	6	am	am	PROPN
bam-8776	255	7	,	,	PUNCT
bam-8776	255	8	rosamond	rosamond	PROPN
bam-8776	255	9	wd	wd	PROPN
bam-8776	255	10	,	,	PUNCT
bam-8776	255	11	mink	mink	PROPN
bam-8776	255	12	pj	pj	PROPN
bam-8776	255	13	,	,	PUNCT
bam-8776	255	14	et	et	PROPN
bam-8776	255	15	al	al	PROPN
bam-8776	255	16	.	.	PUNCT
bam-8776	255	17	hdl	hdl	PROPN
bam-8776	255	18	-	-	PUNCT
bam-8776	255	19	cholesterol	cholesterol	NOUN
bam-8776	255	20	and	and	CCONJ
bam-8776	255	21	incidence	incidence	NOUN
bam-8776	255	22	of	of	ADP
bam-8776	255	23	breast	breast	NOUN
bam-8776	255	24	cancer	cancer	NOUN
bam-8776	255	25	in	in	ADP
bam-8776	255	26	the	the	DET
bam-8776	255	27	aric	aric	PROPN
bam-8776	255	28	cohort	cohort	PROPN
bam-8776	255	29	study	study	NOUN
bam-8776	255	30	.	.	PUNCT
bam-8776	256	1	ann	ann	PROPN
bam-8776	256	2	epidemiol	epidemiol	PROPN
bam-8776	256	3	2008;18:671	2008;18:671	PROPN
bam-8776	256	4	-	-	SYM
bam-8776	256	5	7	7	NUM
bam-8776	256	6	.	.	NUM
bam-8776	256	7	69	69	NUM
bam-8776	256	8	.	.	PUNCT
bam-8776	257	1	agnoli	agnoli	NOUN
bam-8776	257	2	c	c	NOUN
bam-8776	257	3	,	,	PUNCT
bam-8776	257	4	berrino	berrino	PROPN
bam-8776	257	5	f	f	PROPN
bam-8776	257	6	,	,	PUNCT
bam-8776	257	7	abagnato	abagnato	PROPN
bam-8776	257	8	ca	ca	PROPN
bam-8776	257	9	,	,	PUNCT
bam-8776	257	10	et	et	PROPN
bam-8776	257	11	al	al	PROPN
bam-8776	257	12	.	.	PROPN
bam-8776	257	13	metabolic	metabolic	PROPN
bam-8776	257	14	syndrome	syndrome	PROPN
bam-8776	257	15	and	and	CCONJ
bam-8776	257	16	postmenopausal	postmenopausal	NOUN
bam-8776	257	17	breast	breast	NOUN
bam-8776	257	18	cancer	cancer	NOUN
bam-8776	257	19	in	in	ADP
bam-8776	257	20	the	the	DET
bam-8776	257	21	ordet	ordet	PROPN
bam-8776	257	22	cohort	cohort	NOUN
bam-8776	257	23	:	:	PUNCT
bam-8776	257	24	a	a	DET
bam-8776	257	25	nested	nested	ADJ
bam-8776	257	26	case	case	NOUN
bam-8776	257	27	–	–	PUNCT
bam-8776	257	28	control	control	NOUN
bam-8776	257	29	study	study	NOUN
bam-8776	257	30	.	.	PUNCT
bam-8776	258	1	nutr	nutr	PROPN
bam-8776	258	2	metab	metab	PROPN
bam-8776	258	3	cardiovasc	cardiovasc	PROPN
bam-8776	258	4	dis	dis	PROPN
bam-8776	258	5	2010;20:41	2010;20:41	NUM
bam-8776	258	6	-	-	SYM
bam-8776	258	7	8	8	NUM
bam-8776	258	8	.	.	PUNCT
bam-8776	258	9	70	70	NUM
bam-8776	258	10	.	.	PUNCT
bam-8776	259	1	capasso	capasso	PROPN
bam-8776	259	2	i	i	PRON
bam-8776	259	3	,	,	PUNCT
bam-8776	259	4	esposito	esposito	PROPN
bam-8776	259	5	e	e	PROPN
bam-8776	259	6	,	,	PUNCT
bam-8776	259	7	pentimalli	pentimalli	PROPN
bam-8776	259	8	f	f	PROPN
bam-8776	259	9	,	,	PUNCT
bam-8776	259	10	et	et	PROPN
bam-8776	259	11	al	al	PROPN
bam-8776	259	12	.	.	PROPN
bam-8776	259	13	metabolic	metabolic	PROPN
bam-8776	259	14	syndrome	syndrome	PROPN
bam-8776	259	15	affects	affect	VERB
bam-8776	259	16	breast	breast	NOUN
bam-8776	259	17	cancer	cancer	NOUN
bam-8776	259	18	risk	risk	NOUN
bam-8776	259	19	in	in	ADP
bam-8776	259	20	postmenopausal	postmenopausal	ADJ
bam-8776	259	21	women	woman	NOUN
bam-8776	259	22	:	:	PUNCT
bam-8776	259	23	national	national	PROPN
bam-8776	259	24	cancer	cancer	PROPN
bam-8776	259	25	institute	institute	PROPN
bam-8776	259	26	of	of	ADP
bam-8776	259	27	naples	naples	PROPN
bam-8776	259	28	experience	experience	NOUN
bam-8776	259	29	.	.	PUNCT
bam-8776	260	1	cancer	cancer	NOUN
bam-8776	260	2	biol	biol	PROPN
bam-8776	260	3	ther	ther	VERB
bam-8776	260	4	2010;10:1240	2010;10:1240	NUM
bam-8776	260	5	-	-	SYM
bam-8776	260	6	3	3	NUM
bam-8776	260	7	.	.	NOUN
bam-8776	260	8	71	71	NUM
bam-8776	260	9	.	.	PUNCT
bam-8776	261	1	bjørge	bjørge	PROPN
bam-8776	261	2	t	t	PROPN
bam-8776	261	3	,	,	PUNCT
bam-8776	261	4	lukanova	lukanova	VERB
bam-8776	261	5	a	a	DET
bam-8776	261	6	,	,	PUNCT
bam-8776	261	7	jonsson	jonsson	PROPN
bam-8776	261	8	h	h	PROPN
bam-8776	261	9	,	,	PUNCT
bam-8776	261	10	et	et	PROPN
bam-8776	261	11	al	al	PROPN
bam-8776	261	12	.	.	PROPN
bam-8776	261	13	metabolic	metabolic	PROPN
bam-8776	261	14	syndrome	syndrome	PROPN
bam-8776	261	15	and	and	CCONJ
bam-8776	261	16	breast	breast	NOUN
bam-8776	261	17	cancer	cancer	NOUN
bam-8776	261	18	in	in	ADP
bam-8776	261	19	the	the	DET
bam-8776	261	20	me	me	PROPN
bam-8776	261	21	-	-	PUNCT
bam-8776	261	22	can	can	AUX
bam-8776	261	23	(	(	PUNCT
bam-8776	261	24	metabolic	metabolic	NOUN
bam-8776	261	25	syndrome	syndrome	NOUN
bam-8776	261	26	and	and	CCONJ
bam-8776	261	27	cancer	cancer	NOUN
bam-8776	261	28	)	)	PUNCT
bam-8776	261	29	project	project	NOUN
bam-8776	261	30	.	.	PUNCT
bam-8776	262	1	cancer	cancer	NOUN
bam-8776	262	2	epidemiol	epidemiol	PROPN
bam-8776	262	3	biomarkers	biomarker	NOUN
bam-8776	262	4	prev	prev	VERB
bam-8776	262	5	2010;19:1737	2010;19:1737	NUM
bam-8776	262	6	-	-	SYM
bam-8776	262	7	45	45	NUM
bam-8776	262	8	.	.	PUNCT
bam-8776	263	1	72	72	NUM
bam-8776	263	2	.	.	PUNCT
bam-8776	264	1	beaulieu	beaulieu	PROPN
bam-8776	264	2	lm	lm	PROPN
bam-8776	264	3	,	,	PUNCT
bam-8776	264	4	whitley	whitley	PROPN
bam-8776	264	5	br	br	PROPN
bam-8776	264	6	,	,	PUNCT
bam-8776	264	7	wiesner	wiesner	VERB
bam-8776	264	8	tf	tf	INTJ
bam-8776	264	9	,	,	PUNCT
bam-8776	264	10	et	et	PROPN
bam-8776	264	11	al	al	PROPN
bam-8776	264	12	.	.	PUNCT
bam-8776	264	13	breast	breast	NOUN
bam-8776	264	14	cancer	cancer	NOUN
bam-8776	264	15	and	and	CCONJ
bam-8776	264	16	metabolic	metabolic	NOUN
bam-8776	264	17	syndrome	syndrome	NOUN
bam-8776	264	18	linked	link	VERB
bam-8776	264	19	through	through	ADP
bam-8776	264	20	the	the	DET
bam-8776	264	21	plasminogen	plasminogen	NOUN
bam-8776	264	22	activator	activator	NOUN
bam-8776	264	23	inhibitor‐1	inhibitor‐1	PRON
bam-8776	264	24	cycle	cycle	NOUN
bam-8776	264	25	.	.	PUNCT
bam-8776	265	1	bioessays	bioessay	NOUN
bam-8776	265	2	2007;29:1029	2007;29:1029	NUM
bam-8776	265	3	-	-	SYM
bam-8776	265	4	38	38	NUM
bam-8776	265	5	.	.	PUNCT
bam-8776	266	1	73	73	NUM
bam-8776	266	2	.	.	PUNCT
bam-8776	266	3	stern	stern	PROPN
bam-8776	266	4	mp	mp	PROPN
bam-8776	266	5	.	.	PROPN
bam-8776	266	6	diabetes	diabetes	NOUN
bam-8776	266	7	and	and	CCONJ
bam-8776	266	8	cardiovascular	cardiovascular	ADJ
bam-8776	266	9	disease	disease	NOUN
bam-8776	266	10	:	:	PUNCT
bam-8776	266	11	the	the	DET
bam-8776	266	12	“	"	PUNCT
bam-8776	266	13	common	common	ADJ
bam-8776	266	14	soil	soil	NOUN
bam-8776	266	15	”	"	PUNCT
bam-8776	266	16	hypothesis	hypothesis	NOUN
bam-8776	266	17	.	.	PUNCT
bam-8776	267	1	diabetes	diabetes	NOUN
bam-8776	267	2	1995;44:369	1995;44:369	NUM
bam-8776	267	3	-	-	SYM
bam-8776	267	4	74	74	NUM
bam-8776	267	5	.	.	PUNCT
bam-8776	268	1	74	74	NUM
bam-8776	268	2	.	.	PUNCT
bam-8776	269	1	goodwin	goodwin	PROPN
bam-8776	269	2	pj	pj	PROPN
bam-8776	269	3	,	,	PUNCT
bam-8776	269	4	ennis	ennis	PROPN
bam-8776	269	5	m	m	PROPN
bam-8776	269	6	,	,	PUNCT
bam-8776	269	7	pritchard	pritchard	PROPN
bam-8776	269	8	ki	ki	PROPN
bam-8776	269	9	,	,	PUNCT
bam-8776	269	10	et	et	PROPN
bam-8776	269	11	al	al	PROPN
bam-8776	269	12	.	.	PUNCT
bam-8776	270	1	fasting	fast	VERB
bam-8776	270	2	insulin	insulin	NOUN
bam-8776	270	3	and	and	CCONJ
bam-8776	270	4	outcome	outcome	NOUN
bam-8776	270	5	in	in	ADP
bam-8776	270	6	early	early	ADJ
bam-8776	270	7	-	-	PUNCT
bam-8776	270	8	stage	stage	NOUN
bam-8776	270	9	breast	breast	NOUN
bam-8776	270	10	cancer	cancer	NOUN
bam-8776	270	11	:	:	PUNCT
bam-8776	270	12	results	result	NOUN
bam-8776	270	13	of	of	ADP
bam-8776	270	14	a	a	DET
bam-8776	270	15	prospective	prospective	ADJ
bam-8776	270	16	cohort	cohort	NOUN
bam-8776	270	17	study	study	NOUN
bam-8776	270	18	.	.	PUNCT
bam-8776	271	1	j	j	PROPN
bam-8776	271	2	clin	clin	PROPN
bam-8776	271	3	oncol	oncol	PROPN
bam-8776	271	4	2002;20:42	2002;20:42	NUM
bam-8776	271	5	-	-	SYM
bam-8776	271	6	51	51	NUM
bam-8776	271	7	.	.	PUNCT
bam-8776	271	8	75	75	NUM
bam-8776	271	9	.	.	PUNCT
bam-8776	272	1	khandekar	khandekar	PROPN
bam-8776	272	2	mj	mj	PROPN
bam-8776	272	3	,	,	PUNCT
bam-8776	272	4	cohen	cohen	PROPN
bam-8776	272	5	p	p	NOUN
bam-8776	272	6	,	,	PUNCT
bam-8776	272	7	spiegelman	spiegelman	NOUN
bam-8776	272	8	bm	bm	PROPN
bam-8776	272	9	.	.	PUNCT
bam-8776	273	1	molecular	molecular	ADJ
bam-8776	273	2	mechanisms	mechanism	NOUN
bam-8776	273	3	of	of	ADP
bam-8776	273	4	cancer	cancer	NOUN
bam-8776	273	5	development	development	NOUN
bam-8776	273	6	in	in	ADP
bam-8776	273	7	obesity	obesity	NOUN
bam-8776	273	8	.	.	PUNCT
bam-8776	274	1	nat	nat	PROPN
bam-8776	274	2	rev	rev	VERB
bam-8776	274	3	cancer	cancer	PROPN
bam-8776	274	4	2011;11:886	2011;11:886	PROPN
bam-8776	274	5	-	-	PROPN
bam-8776	274	6	95	95	NUM
bam-8776	274	7	.	.	PUNCT
bam-8776	275	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=expression+of+peroxisome%e2%80%90proliferator+activated+receptor%e2%80%90gamma+(ppar%ce%b3)+and+the+ppar%ce%b3+co%e2%80%90activator%2c+pgc%e2%80%901%2c+in+human+breast+cancer+correlates+with+clinical+outcomes.+international+journal+of+cancer	https://www.ncbi.nlm.nih.gov/pubmed/?term=expression+of+peroxisome%e2%80%90proliferator+activated+receptor%e2%80%90gamma+(ppar%ce%b3)+and+the+ppar%ce%b3+co%e2%80%90activator%2c+pgc%e2%80%901%2c+in+human+breast+cancer+correlates+with+clinical+outcomes.+international+journal+of+cancer	PROPN
bam-8776	275	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=use+of+the+peroxisome+proliferator-activated+receptor+(ppar)+%ce%b3+ligand+troglitazone+as+treatment+for+refractory+breast+cancer%3a+a+phase+ii+study.+breast+cancer+research+and+treatmen	https://www.ncbi.nlm.nih.gov/pubmed/?term=use+of+the+peroxisome+proliferator-activated+receptor+(ppar)+%ce%b3+ligand+troglitazone+as+treatment+for+refractory+breast+cancer%3a+a+phase+ii+study.+breast+cancer+research+and+treatmen	PROPN
bam-8776	275	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=use+of+the+peroxisome+proliferator-activated+receptor+(ppar)+%ce%b3+ligand+troglitazone+as+treatment+for+refractory+breast+cancer%3a+a+phase+ii+study.+breast+cancer+research+and+treatmen	https://www.ncbi.nlm.nih.gov/pubmed/?term=use+of+the+peroxisome+proliferator-activated+receptor+(ppar)+%ce%b3+ligand+troglitazone+as+treatment+for+refractory+breast+cancer%3a+a+phase+ii+study.+breast+cancer+research+and+treatmen	PROPN
bam-8776	275	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=long-term+use+of+insulin+glargine+might+increase+the+risk+of+breast+cancer.+nature+reviews+endocrinology	https://www.ncbi.nlm.nih.gov/pubmed/?term=long-term+use+of+insulin+glargine+might+increase+the+risk+of+breast+cancer.+nature+reviews+endocrinology	PROPN
bam-8776	275	5	https://www.ncbi.nlm.nih.gov/pubmed/15252848	https://www.ncbi.nlm.nih.gov/pubmed/15252848	PROPN
bam-8776	275	6	https://www.ncbi.nlm.nih.gov/pubmed/18404787	https://www.ncbi.nlm.nih.gov/pubmed/18404787	NUM
bam-8776	275	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=influence+of+the+metabolic+syndrome+on+leptin+and+leptin+receptor+in+breast+cancer.+molecular+carcinogenesis	https://www.ncbi.nlm.nih.gov/pubmed/?term=influence+of+the+metabolic+syndrome+on+leptin+and+leptin+receptor+in+breast+cancer.+molecular+carcinogenesis	NOUN
bam-8776	275	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=association+between+blood+pressure+and+risk+of+cancer+development%3a+a+systematic+review+and+meta-analysis+of+observational+studies	https://www.ncbi.nlm.nih.gov/pubmed/?term=association+between+blood+pressure+and+risk+of+cancer+development%3a+a+systematic+review+and+meta-analysis+of+observational+studie	NOUN
bam-8776	275	9	.	.	PUNCT
bam-8776	276	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=effect+of+antihypertensive+drugs+on+breast+cancer+risk+in+female+hypertensive+patients%3a+evidence+from+observational+studies	https://www.ncbi.nlm.nih.gov/pubmed/?term=effect+of+antihypertensive+drugs+on+breast+cancer+risk+in+female+hypertensive+patients%3a+evidence+from+observational+studie	NOUN
bam-8776	276	2	.	.	PUNCT
bam-8776	277	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=incidence+of+breast+cancer+among+postmenopausal%2c+hypertensive+women.+international+journal+of+cancer	https://www.ncbi.nlm.nih.gov/pubmed/?term=incidence+of+breast+cancer+among+postmenopausal%2c+hypertensive+women.+international+journal+of+cancer	PROPN
bam-8776	277	2	https://www.ncbi.nlm.nih.gov/pubmed/14508839	https://www.ncbi.nlm.nih.gov/pubmed/14508839	DET
bam-8776	277	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=preeclampsia%2c+pregnancy-related+hypertension%2c+and+breast+cancer+risk.+american+journal+of+epidemiology	https://www.ncbi.nlm.nih.gov/pubmed/?term=preeclampsia%2c+pregnancy-related+hypertension%2c+and+breast+cancer+risk.+american+journal+of+epidemiology	NOUN
bam-8776	277	4	https://www.ncbi.nlm.nih.gov/pubmed/11196072	https://www.ncbi.nlm.nih.gov/pubmed/11196072	NOUN
bam-8776	277	5	https://www.ncbi.nlm.nih.gov/pubmed/11196072	https://www.ncbi.nlm.nih.gov/pubmed/11196072	NUM
bam-8776	277	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=association+between+high-density+lipoprotein+cholesterol+and+breast+cancer+varies+by+menopausal+status	https://www.ncbi.nlm.nih.gov/pubmed/?term=association+between+high-density+lipoprotein+cholesterol+and+breast+cancer+varies+by+menopausal+status	NOUN
bam-8776	277	7	.	.	PUNCT
bam-8776	278	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=plasma+level+of+ldl-cholesterol+at+diagnosis+is+a+predictor+factor+of+breast+tumor+progression	https://www.ncbi.nlm.nih.gov/pubmed/?term=plasma+level+of+ldl-cholesterol+at+diagnosis+is+a+predictor+factor+of+breast+tumor+progression	NOUN
bam-8776	278	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=serum+high-density+lipoprotein+cholesterol+and+breast+cancer+risk+by+menopausal+status%2c+body+mass+index%2c+and+hormonal+receptor+in+korea.+cancer+epidemiology+and+prevention+biomarkers	https://www.ncbi.nlm.nih.gov/pubmed/?term=serum+high-density+lipoprotein+cholesterol+and+breast+cancer+risk+by+menopausal+status%2c+body+mass+index%2c+and+hormonal+receptor+in+korea.+cancer+epidemiology+and+prevention+biomarker	NOUN
bam-8776	278	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=serum+high-density+lipoprotein+cholesterol+and+breast+cancer+risk+by+menopausal+status%2c+body+mass+index%2c+and+hormonal+receptor+in+korea.+cancer+epidemiology+and+prevention+biomarkers	https://www.ncbi.nlm.nih.gov/pubmed/?term=serum+high-density+lipoprotein+cholesterol+and+breast+cancer+risk+by+menopausal+status%2c+body+mass+index%2c+and+hormonal+receptor+in+korea.+cancer+epidemiology+and+prevention+biomarkers	PROPN
bam-8776	278	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+postmenopausal+breast+cancer+in+the+ordet+cohort%3a+a+nested+case%e2%80%93control+study.+nutrition%2c+metabolism+and+cardiovascular+diseases	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+postmenopausal+breast+cancer+in+the+ordet+cohort%3a+a+nested+case%e2%80%93control+study.+nutrition%2c+metabolism+and+cardiovascular+diseases	PROPN
bam-8776	278	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+postmenopausal+breast+cancer+in+the+ordet+cohort%3a+a+nested+case%e2%80%93control+study.+nutrition%2c+metabolism+and+cardiovascular+diseases	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+postmenopausal+breast+cancer+in+the+ordet+cohort%3a+a+nested+case%e2%80%93control+study.+nutrition%2c+metabolism+and+cardiovascular+disease	VERB
bam-8776	278	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+affects+breast+cancer+risk+in+postmenopausal+women%3a+national+cancer+institute+of+naples+experience	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+affects+breast+cancer+risk+in+postmenopausal+women%3a+national+cancer+institute+of+naples+experience	NOUN
bam-8776	278	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+breast+cancer+in+the+me-can+(metabolic+syndrome+and+cancer)+project.+cancer+epidemiology+and+prevention+biomarkers	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+breast+cancer+in+the+me-can+(metabolic+syndrome+and+cancer)+project.+cancer+epidemiology+and+prevention+biomarker	NOUN
bam-8776	278	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+breast+cancer+in+the+me-can+(metabolic+syndrome+and+cancer)+project.+cancer+epidemiology+and+prevention+biomarkers	https://www.ncbi.nlm.nih.gov/pubmed/?term=metabolic+syndrome+and+breast+cancer+in+the+me-can+(metabolic+syndrome+and+cancer)+project.+cancer+epidemiology+and+prevention+biomarker	NOUN
bam-8776	278	9	https://www.ncbi.nlm.nih.gov/pubmed/?term=breast+cancer+and+metabolic+syndrome+linked+through+the+plasminogen+activator+inhibitor%e2%80%901+cycle	https://www.ncbi.nlm.nih.gov/pubmed/?term=breast+cancer+and+metabolic+syndrome+linked+through+the+plasminogen+activator+inhibitor%e2%80%901+cycle	NOUN
bam-8776	278	10	https://www.ncbi.nlm.nih.gov/pubmed/?term=molecular+mechanisms+of+cancer+development+in+obesity.+nature+reviews+cance	https://www.ncbi.nlm.nih.gov/pubmed/?term=molecular+mechanisms+of+cancer+development+in+obesity.+nature+reviews+cance	NOUN
bam-8776	278	11	metabolic	metabolic	PROPN
bam-8776	278	12	syndrome	syndrome	NOUN
bam-8776	278	13	and	and	CCONJ
bam-8776	278	14	breast	breast	NOUN
bam-8776	278	15	cancer	cancer	NOUN
bam-8776	278	16	patients	patient	NOUN
bam-8776	278	17	eur	eur	PROPN
bam-8776	278	18	j	j	PROPN
bam-8776	278	19	transl	transl	PROPN
bam-8776	278	20	myol	myol	ADV
bam-8776	278	21	30	30	NUM
bam-8776	278	22	(	(	PUNCT
bam-8776	278	23	3	3	NUM
bam-8776	278	24	):	):	PUNCT
bam-8776	278	25	xx1	xx1	PROPN
bam-8776	278	26	-	-	PUNCT
bam-8776	278	27	xx7	xx7	PROPN
bam-8776	278	28	,	,	PUNCT
bam-8776	278	29	2020	2020	NUM
bam-8776	278	30	7	7	NUM
bam-8776	278	31	76	76	NUM
bam-8776	278	32	.	.	PUNCT
bam-8776	279	1	nieman	nieman	PROPN
bam-8776	279	2	km	km	PROPN
bam-8776	279	3	,	,	PUNCT
bam-8776	279	4	romero	romero	PROPN
bam-8776	279	5	il	il	PROPN
bam-8776	279	6	,	,	PUNCT
bam-8776	279	7	van	van	PROPN
bam-8776	279	8	houten	houten	PROPN
bam-8776	279	9	b	b	PROPN
bam-8776	279	10	,	,	PUNCT
bam-8776	279	11	et	et	PROPN
bam-8776	279	12	al	al	PROPN
bam-8776	279	13	.	.	PROPN
bam-8776	280	1	adipose	adipose	NOUN
bam-8776	280	2	tissue	tissue	NOUN
bam-8776	280	3	and	and	CCONJ
bam-8776	280	4	adipocytes	adipocytes	ADJ
bam-8776	280	5	support	support	NOUN
bam-8776	280	6	tumorigenesis	tumorigenesis	NOUN
bam-8776	280	7	and	and	CCONJ
bam-8776	280	8	metastasis	metastasis	NOUN
bam-8776	280	9	.	.	PUNCT
bam-8776	281	1	biochim	biochim	PROPN
bam-8776	281	2	biophys	biophy	NOUN
bam-8776	281	3	acta	acta	PROPN
bam-8776	281	4	2013;1831:1533	2013;1831:1533	PROPN
bam-8776	281	5	-	-	SYM
bam-8776	281	6	41	41	NUM
bam-8776	281	7	.	.	PUNCT
bam-8776	282	1	77	77	NUM
bam-8776	282	2	.	.	PUNCT
bam-8776	283	1	byers	byers	PROPN
bam-8776	283	2	t	t	PROPN
bam-8776	283	3	,	,	PUNCT
bam-8776	283	4	sedjo	sedjo	PROPN
bam-8776	283	5	r.	r.	PROPN
bam-8776	283	6	does	do	AUX
bam-8776	283	7	intentional	intentional	ADJ
bam-8776	283	8	weight	weight	NOUN
bam-8776	283	9	loss	loss	NOUN
bam-8776	283	10	reduce	reduce	VERB
bam-8776	283	11	cancer	cancer	NOUN
bam-8776	283	12	risk	risk	NOUN
bam-8776	283	13	?	?	PUNCT
bam-8776	284	1	diabetes	diabetes	NOUN
bam-8776	284	2	obes	obes	PRON
bam-8776	284	3	metab	metab	ADJ
bam-8776	284	4	2011;13:1063	2011;13:1063	PROPN
bam-8776	284	5	-	-	SYM
bam-8776	284	6	72	72	NUM
bam-8776	284	7	.	.	PUNCT
bam-8776	285	1	78	78	NUM
bam-8776	285	2	.	.	PUNCT
bam-8776	286	1	rack	rack	PROPN
bam-8776	286	2	b	b	NOUN
bam-8776	286	3	,	,	PUNCT
bam-8776	286	4	andergassen	andergassen	NOUN
bam-8776	286	5	u	u	PROPN
bam-8776	286	6	,	,	PUNCT
bam-8776	286	7	neugebauer	neugebauer	PROPN
bam-8776	286	8	j	j	PROPN
bam-8776	286	9	,	,	PUNCT
bam-8776	286	10	et	et	PROPN
bam-8776	286	11	al	al	PROPN
bam-8776	286	12	.	.	PUNCT
bam-8776	287	1	the	the	DET
bam-8776	287	2	german	german	ADJ
bam-8776	287	3	success	success	NOUN
bam-8776	287	4	c	c	PROPN
bam-8776	287	5	study	study	NOUN
bam-8776	287	6	–	–	PUNCT
bam-8776	287	7	the	the	DET
bam-8776	287	8	first	first	ADJ
bam-8776	287	9	european	european	ADJ
bam-8776	287	10	lifestyle	lifestyle	PROPN
bam-8776	287	11	study	study	NOUN
bam-8776	287	12	on	on	ADP
bam-8776	287	13	breast	breast	NOUN
bam-8776	287	14	cancer	cancer	NOUN
bam-8776	287	15	.	.	PUNCT
bam-8776	288	1	breast	breast	NOUN
bam-8776	288	2	care	care	NOUN
bam-8776	288	3	(	(	PUNCT
bam-8776	288	4	basel	basel	PROPN
bam-8776	288	5	)	)	PUNCT
bam-8776	288	6	.	.	PUNCT
bam-8776	289	1	2010;5:395	2010;5:395	NUM
bam-8776	289	2	-	-	PUNCT
bam-8776	289	3	400	400	NUM
bam-8776	289	4	.	.	PUNCT
bam-8776	290	1	79	79	NUM
bam-8776	290	2	.	.	PUNCT
bam-8776	291	1	rock	rock	NOUN
bam-8776	291	2	cl	cl	PROPN
bam-8776	291	3	,	,	PUNCT
bam-8776	291	4	byers	byer	NOUN
bam-8776	291	5	te	te	PROPN
bam-8776	291	6	,	,	PUNCT
bam-8776	291	7	colditz	colditz	PROPN
bam-8776	291	8	ga	ga	PROPN
bam-8776	291	9	,	,	PUNCT
bam-8776	291	10	et	et	PROPN
bam-8776	291	11	al	al	PROPN
bam-8776	291	12	.	.	PUNCT
bam-8776	292	1	reducing	reduce	VERB
bam-8776	292	2	breast	breast	NOUN
bam-8776	292	3	cancer	cancer	NOUN
bam-8776	292	4	recurrence	recurrence	NOUN
bam-8776	292	5	with	with	ADP
bam-8776	292	6	weight	weight	NOUN
bam-8776	292	7	loss	loss	NOUN
bam-8776	292	8	,	,	PUNCT
bam-8776	292	9	a	a	DET
bam-8776	292	10	vanguard	vanguard	NOUN
bam-8776	292	11	trial	trial	NOUN
bam-8776	292	12	:	:	PUNCT
bam-8776	292	13	the	the	DET
bam-8776	292	14	exercise	exercise	NOUN
bam-8776	292	15	and	and	CCONJ
bam-8776	292	16	nutrition	nutrition	NOUN
bam-8776	292	17	to	to	PART
bam-8776	292	18	enhance	enhance	VERB
bam-8776	292	19	recovery	recovery	NOUN
bam-8776	292	20	and	and	CCONJ
bam-8776	292	21	good	good	ADJ
bam-8776	292	22	health	health	NOUN
bam-8776	292	23	for	for	ADP
bam-8776	292	24	you	you	PRON
bam-8776	292	25	(	(	PUNCT
bam-8776	292	26	energy	energy	NOUN
bam-8776	292	27	)	)	PUNCT
bam-8776	292	28	trial	trial	NOUN
bam-8776	292	29	.	.	PUNCT
bam-8776	293	1	contemp	contemp	NOUN
bam-8776	293	2	clin	clin	PROPN
bam-8776	293	3	trials	trial	NOUN
bam-8776	293	4	2013;34:282	2013;34:282	NUM
bam-8776	293	5	-	-	SYM
bam-8776	293	6	95	95	NUM
bam-8776	293	7	.	.	PUNCT
bam-8776	293	8	80	80	NUM
bam-8776	293	9	.	.	PUNCT
bam-8776	294	1	cottet	cottet	PROPN
bam-8776	294	2	v	v	NOUN
bam-8776	294	3	,	,	PUNCT
bam-8776	294	4	touvier	touvier	PRON
bam-8776	294	5	m	m	NOUN
bam-8776	294	6	,	,	PUNCT
bam-8776	294	7	fournier	fournier	PROPN
bam-8776	294	8	a	a	PROPN
bam-8776	294	9	,	,	PUNCT
bam-8776	294	10	et	et	PROPN
bam-8776	294	11	al	al	PROPN
bam-8776	294	12	.	.	PROPN
bam-8776	294	13	postmenopausal	postmenopausal	PROPN
bam-8776	294	14	breast	breast	PROPN
bam-8776	294	15	cancer	cancer	NOUN
bam-8776	294	16	risk	risk	NOUN
bam-8776	294	17	and	and	CCONJ
bam-8776	294	18	dietary	dietary	ADJ
bam-8776	294	19	patterns	pattern	NOUN
bam-8776	294	20	in	in	ADP
bam-8776	294	21	the	the	DET
bam-8776	294	22	e3n	e3n	ADJ
bam-8776	294	23	-	-	PUNCT
bam-8776	294	24	epic	epic	ADJ
bam-8776	294	25	prospective	prospective	ADJ
bam-8776	294	26	cohort	cohort	NOUN
bam-8776	294	27	study	study	NOUN
bam-8776	294	28	.	.	PUNCT
bam-8776	295	1	am	be	AUX
bam-8776	295	2	j	j	PROPN
bam-8776	295	3	epidemiol	epidemiol	PROPN
bam-8776	295	4	2009;170:1257	2009;170:1257	NUM
bam-8776	295	5	-	-	SYM
bam-8776	295	6	67	67	NUM
bam-8776	295	7	.	.	PUNCT
bam-8776	295	8	81	81	NUM
bam-8776	295	9	.	.	PUNCT
bam-8776	295	10	trichopoulou	trichopoulou	PROPN
bam-8776	295	11	a	a	PRON
bam-8776	295	12	,	,	PUNCT
bam-8776	295	13	bamia	bamia	NOUN
bam-8776	295	14	c	c	NOUN
bam-8776	295	15	,	,	PUNCT
bam-8776	295	16	lagiou	lagiou	NOUN
bam-8776	295	17	p	p	X
bam-8776	295	18	,	,	PUNCT
bam-8776	295	19	et	et	PROPN
bam-8776	295	20	al	al	PROPN
bam-8776	295	21	.	.	PROPN
bam-8776	295	22	conformity	conformity	NOUN
bam-8776	295	23	to	to	ADP
bam-8776	295	24	traditional	traditional	ADJ
bam-8776	295	25	mediterranean	mediterranean	PROPN
bam-8776	295	26	diet	diet	PROPN
bam-8776	295	27	and	and	CCONJ
bam-8776	295	28	breast	breast	NOUN
bam-8776	295	29	cancer	cancer	NOUN
bam-8776	295	30	risk	risk	NOUN
bam-8776	295	31	in	in	ADP
bam-8776	295	32	the	the	DET
bam-8776	295	33	greek	greek	ADJ
bam-8776	295	34	epic	epic	NOUN
bam-8776	295	35	(	(	PUNCT
bam-8776	295	36	european	european	ADJ
bam-8776	295	37	prospective	prospective	ADJ
bam-8776	295	38	investigation	investigation	NOUN
bam-8776	295	39	into	into	ADP
bam-8776	295	40	cancer	cancer	NOUN
bam-8776	295	41	and	and	CCONJ
bam-8776	295	42	nutrition	nutrition	NOUN
bam-8776	295	43	)	)	PUNCT
bam-8776	295	44	cohort	cohort	NOUN
bam-8776	295	45	.	.	PUNCT
bam-8776	296	1	am	be	AUX
bam-8776	296	2	j	j	PROPN
bam-8776	296	3	clin	clin	PROPN
bam-8776	296	4	nutr	nutr	PROPN
bam-8776	296	5	.	.	PUNCT
bam-8776	297	1	2010;92:620	2010;92:620	PROPN
bam-8776	297	2	-	-	PUNCT
bam-8776	297	3	5	5	NUM
bam-8776	297	4	.	.	NOUN
bam-8776	297	5	82	82	NUM
bam-8776	297	6	.	.	PUNCT
bam-8776	297	7	kashaki	kashaki	PROPN
bam-8776	297	8	m	m	PROPN
bam-8776	297	9	,	,	PUNCT
bam-8776	297	10	masoudi	masoudi	ADJ
bam-8776	297	11	samghabadi	samghabadi	NOUN
bam-8776	297	12	f	f	PROPN
bam-8776	297	13	,	,	PUNCT
bam-8776	297	14	bordbar	bordbar	ADJ
bam-8776	297	15	a.	a.	NOUN
bam-8776	297	16	effect	effect	NOUN
bam-8776	297	17	of	of	ADP
bam-8776	297	18	fortification	fortification	NOUN
bam-8776	297	19	of	of	ADP
bam-8776	297	20	breast	breast	NOUN
bam-8776	297	21	milk	milk	NOUN
bam-8776	297	22	in	in	ADP
bam-8776	297	23	conjugation	conjugation	NOUN
bam-8776	297	24	with	with	ADP
bam-8776	297	25	protein	protein	NOUN
bam-8776	297	26	supplement	supplement	NOUN
bam-8776	297	27	on	on	ADP
bam-8776	297	28	neurodevelopment	neurodevelopment	NOUN
bam-8776	297	29	of	of	ADP
bam-8776	297	30	preterm	preterm	NOUN
bam-8776	297	31	low	low	ADJ
bam-8776	297	32	birth	birth	NOUN
bam-8776	297	33	weight	weight	NOUN
bam-8776	297	34	infants	infant	NOUN
bam-8776	297	35	at	at	ADP
bam-8776	297	36	3	3	NUM
bam-8776	297	37	years	year	NOUN
bam-8776	297	38	.	.	PUNCT
bam-8776	298	1	med	med	ADJ
bam-8776	298	2	arch	arch	ADJ
bam-8776	298	3	2019;73:344–50	2019;73:344–50	NUM
bam-8776	298	4	.	.	PUNCT
bam-8776	299	1	83	83	NUM
bam-8776	299	2	.	.	PUNCT
bam-8776	299	3	kashaki	kashaki	PROPN
bam-8776	299	4	m	m	PROPN
bam-8776	299	5	,	,	PUNCT
bam-8776	299	6	mazouri	mazouri	PROPN
bam-8776	299	7	a	a	X
bam-8776	299	8	,	,	PUNCT
bam-8776	299	9	bordbar	bordbar	PROPN
bam-8776	299	10	a	a	X
bam-8776	299	11	,	,	PUNCT
bam-8776	299	12	e	e	PROPN
bam-8776	299	13	al	al	PROPN
bam-8776	299	14	.	.	PROPN
bam-8776	299	15	effect	effect	NOUN
bam-8776	299	16	of	of	ADP
bam-8776	299	17	protein	protein	NOUN
bam-8776	299	18	supplementation	supplementation	NOUN
bam-8776	299	19	on	on	ADP
bam-8776	299	20	the	the	DET
bam-8776	299	21	growth	growth	NOUN
bam-8776	299	22	of	of	ADP
bam-8776	299	23	infants	infant	NOUN
bam-8776	299	24	weighing	weigh	VERB
bam-8776	299	25	less	less	ADJ
bam-8776	299	26	than	than	ADP
bam-8776	299	27	1,000	1,000	NUM
bam-8776	299	28	grams	gram	NOUN
bam-8776	299	29	hospitalized	hospitalize	VERB
bam-8776	299	30	on	on	ADP
bam-8776	299	31	the	the	DET
bam-8776	299	32	neonatal	neonatal	ADJ
bam-8776	299	33	intensive	intensive	ADJ
bam-8776	299	34	care	care	NOUN
bam-8776	299	35	unit	unit	NOUN
bam-8776	299	36	of	of	ADP
bam-8776	299	37	akbar	akbar	PROPN
bam-8776	299	38	abadi	abadi	PROPN
bam-8776	299	39	hospital	hospital	PROPN
bam-8776	299	40	in	in	ADP
bam-8776	299	41	tehran	tehran	PROPN
bam-8776	299	42	,	,	PUNCT
bam-8776	299	43	iran	iran	PROPN
bam-8776	299	44	(	(	PUNCT
bam-8776	299	45	2015	2015	NUM
bam-8776	299	46	-	-	SYM
bam-8776	299	47	2016	2016	NUM
bam-8776	299	48	)	)	PUNCT
bam-8776	299	49	.	.	PUNCT
bam-8776	300	1	iranian	iranian	PROPN
bam-8776	300	2	j	j	PROPN
bam-8776	300	3	neonatol	neonatol	VERB
bam-8776	300	4	2018:9:49	2018:9:49	NUM
bam-8776	300	5	-	-	SYM
bam-8776	300	6	56	56	NUM
bam-8776	300	7	.	.	NOUN
bam-8776	300	8	84	84	NUM
bam-8776	300	9	.	.	PUNCT
bam-8776	301	1	bordbar	bordbar	PROPN
bam-8776	301	2	a	a	PROPN
bam-8776	301	3	,	,	PUNCT
bam-8776	301	4	mazouri	mazouri	PROPN
bam-8776	301	5	a	a	PROPN
bam-8776	301	6	,	,	PUNCT
bam-8776	301	7	kashaki	kashaki	NOUN
bam-8776	301	8	m	m	PROPN
bam-8776	301	9	,	,	PUNCT
bam-8776	301	10	et	et	PROPN
bam-8776	301	11	al	al	PROPN
bam-8776	301	12	.	.	PROPN
bam-8776	301	13	standard	standard	ADJ
bam-8776	301	14	multiple	multiple	ADJ
bam-8776	301	15	and	and	CCONJ
bam-8776	301	16	single	single	ADJ
bam-8776	301	17	daily	daily	ADJ
bam-8776	301	18	dosingof	dosingof	NOUN
bam-8776	301	19	amikacin	amikacin	PROPN
bam-8776	301	20	in	in	ADP
bam-8776	301	21	premature	premature	ADJ
bam-8776	301	22	infants	infant	NOUN
bam-8776	301	23	.	.	PUNCT
bam-8776	302	1	iranian	iranian	PROPN
bam-8776	302	2	j	j	PROPN
bam-8776	302	3	neonatol	neonatol	ADJ
bam-8776	302	4	2017;8:5764	2017;8:5764	NOUN
bam-8776	302	5	.	.	PUNCT
bam-8776	303	1	submission	submission	NOUN
bam-8776	303	2	:	:	PUNCT
bam-8776	303	3	december	december	PROPN
bam-8776	303	4	,	,	PUNCT
bam-8776	303	5	21	21	NUM
bam-8776	303	6	,	,	PUNCT
bam-8776	303	7	2019	2019	NUM
bam-8776	303	8	revision	revision	NOUN
bam-8776	303	9	received	receive	VERB
bam-8776	303	10	:	:	PUNCT
bam-8776	303	11	january	january	PROPN
bam-8776	303	12	22	22	NUM
bam-8776	303	13	,	,	PUNCT
bam-8776	303	14	2020	2020	NUM
bam-8776	303	15	acceptance	acceptance	NOUN
bam-8776	303	16	:	:	PUNCT
bam-8776	303	17	january	january	PROPN
bam-8776	303	18	29	29	NUM
bam-8776	303	19	,	,	PUNCT
bam-8776	303	20	2020	2020	NUM
bam-8776	303	21	https://www.ncbi.nlm.nih.gov/pubmed/21494405	https://www.ncbi.nlm.nih.gov/pubmed/21494405	PART
bam-8776	303	22	https://www.ncbi.nlm.nih.gov/pubmed/?term=conformity+to+traditional+mediterranean+diet+and+breast+cancer+risk+in+the+greek+epic+(european+prospective+investigation+into+cancer+and+nutrition)+cohort	https://www.ncbi.nlm.nih.gov/pubmed/?term=conformity+to+traditional+mediterranean+diet+and+breast+cancer+risk+in+the+greek+epic+(european+prospective+investigation+into+cancer+and+nutrition)+cohort	NOUN